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ABSTRACT
The mechanism of action of 2-thiotriazone (TTZ) was evaluated in adult and 
immature rats of both sexes. TTZ produced marked pulmonary toxicity in 
rats that was both age and sex-dependent. It was highly toxic in male rats 
(oral LD50 of 4.6 mg/kg and ip LD50 of 1.4 mg/kg). Female rats were more 
resistant than males and imm ature ra ts (30-40 days of age) were totally 
resistant to TTZ toxicity. Gross and histological examination of lung tissue 
from rats exposed to TTZ showed severe pulmonary edema, effusion and 
mottling of the lungs. Significant increases in lung weights were also 
observed.
Diethlymaleate (DEM) pretreatm ent potentiated the toxicity of TTZ in 
male, female, and immature rats, but L-buthionine-(SR)-sulfoxamine (BSO) 
did not affect TTZ toxicity. Lung weights in DEM-TTZ treated rats were 
twice as heavy as animals treated with TTZ alone.
Resistance to TTZ could be produced in adult male rats by administration 
of a sublethal dose of TTZ (lmg/kg). Survival from a toxic dose also 
induced resistance which lasted up to 8 weeks in orally dosed rats and 6 
weeks in ip dosed rats. p-Napthoflavone (BNF) induction of microsomal
mixed function monooxygenase enzymes and N-acetyl-L-cysteine (NAC) 
produced resistance to TTZ in  male rats. Diethylmaleate abolished both 
TTZ and BNF induced resistance to TTZ; however, BSO had no affect. - 
Phenobarbital (PB) induction and treatm ent of rats with P-estradiol or
xx
testosterone did not affect TTZ toxicity. Also, toxicity could not be 
correlated with the stage of estrus.
Cytochrome P-450 specific content was increased in female rats, and UDP- 
glucuronosyltransferase activity was decreased in both female and immature 
male rats treated with TTZ. Cytochrome P-450 specific content was 
decreased in male rats and PB induced male rats administered DEM-TTZ. 
All other specific contents and activities were unaffected.
2-Thiotriazone produced a dose-dependent decrease in lung glutathione 
(GSH) concentration in adult male rats. It also decreased GSH 
concentration in the lungs of female rats in a dose-independent manner. 
Diethylmaleate-TTZ depleted glutathione stores in the liver and lung of 
male and female rats. This study indicates that TTZ is probably 
metabolized to a short-lived reactive metabolite in the lungs by the 
cytochrome P-448 isozyme, although the involvement of the non-cytochrome 
containing flavin monooxygenase system can not be ruled out.
CHAPTER 1 
INTRODUCTION
2-Thiotriazone (TTZ) is a thiourea derivative developed by Triazone 
Corporation for use as a potential fertilizer. Acute toxicity testing performed 
with TTZ showed detrimental effects on mammalian species, specifically rats 
(Sprague Dawley). TTZ was found to be an acute pulmonary toxicant in 
adult male rats, producing severe pulmonary edema and effusion with death 
occurring within 2-3 hrs. Interest in this compound developed because of 
the striking pulmonary toxicity observed in rats a t very low doses. The 
toxic action of TTZ closely resembles tha t of alpha-napthylthiourea (ANTU), 
which is also a thiourea derivative (rodenticide) that produces pulmonary 
toxicity in rats (Richter, 1945). Thiourea (NH2CSNH2) and several of its 
derivatives, especially the N-monosubstituted compounds containing the 
thioredo moiety (-NHCSNH-), produced marked pulmonary toxicity in many 
animal species (Mackenzie and Mackenzie, 1943, Dieke and Richter, 1945, 
Dieke, et al., 1947). Alpha-napthylthiourea (ANTU) is one of the most 
potent of these derivatives. Because of it’s selective pulmonary toxicity at 
very low doses, ANTU has been widely used as a model toxin for investigat­
ing the pathophysiology of pulmonary edema (Richter, 1952).
Previous studies have shown that repeated administration of sublethal doses 
of ANTU and other thiono-sulfur containing compounds to experimental 
animals produces a state of prolonged resistance or "tolerance" to the 
pulmonary effects of a subsequent challenge with normal lethal doses (Bond 
and Neal, 1976). Although this tolerance has been studied, its biochemical
or molecular basis has not been established. Marked age and species 
differences in  susceptibility have also been demonstrated with thiourea 
compounds. Rodents are highly susceptible to thiourea toxicity, whereas 
other mammals such as cats and rabbits are not (Dieke and Richter, 1945, 
Richter, 1952). Young and immature rats are highly resistant to thiourea- 
induced lung toxicity indicating tha t toxicity increases with age (Dieke and 
Richter, 1945, 1946). Marked resistance to ANTU toxicity was induced by 
pretreatm ent of rats with toxic and nontoxic antithyroid drugs (Saunders 
and Spaulding, 1951; Van Den Brink et al., 1976) or with iodine or iodide 
(Byerrum, 1946; Van Den Brink et al., 1976). Sulfhydryl compounds, 
including cysteine, glutathione and 2-aminoethylisothiouronium bromide 
protected ra ts  against the lethal effects of thiourea derivatives (Dubois et 
al., 1946; Giri and Combs, 1970; Karel and Meyer, 1948). Pretreatm ent of 
rats with 3, 4-benzpyrene resulted in marked tolerance to the pulmonary 
toxicity of ANTU, but similar pretreatm ent with phenobarbital had little 
effect. Pretreatm ents with SKF-525A or piperonyl butoxide did not appear 
to modify ANTU toxicity consistently (Van Den Brink et al., 1976). 
Treatment of rats with ANTU intraperitoneally decreased pulmonary mixed 
function oxidase enzymes (Boyd and Neal 1976), suggesting tha t a toxic 
metabolite of ANTU was formed in vivo. Pretreatm ent of ra ts with a non- 
lethal dose of ANTU daily for 5 days decreased the activity of the lung 
mixed function oxidase enzyme systems th a t metabolize parathion and 
ANTU in vivo. The pretreatm ent with ANTU also caused a decrease in 
both the covalent binding and pulmonary toxicity of “ S-ANTU in vivo (Boyd 
and Neal, 1974). This suggested th a t a decreased rate of activation of
ANTU in ANTU pretreated rats might have been a t least partially 
responsible for the development of tolerance.
At least two enzymes systems are known to play a role in activating toxic 
thioureas. Cytochrome P-450-dependent oxidases th a t activate some 
thionosulfur compounds (Hunter and Neal, 1974; Bond and Dematteis, 1969) 
and the flavoprotein mixed function oxidase enzyme system described by 
Poulsen et al., (1974), for which ANTU has been shown to be a substrate. 
Previous studies have also shown that depletion of glutathione concentra­
tions in the lung and liver of rats caused increases in both pulmonary 
toxicity and in vivo covalent binding of ANTU (Boyd and Neal, 1976). Thus 
it seems reasonable to assume th a t glutathione may detoxify reactive species 
involved in the toxicities of thioureas, possibly by forming non-target 
conjugates (Hollinger et al., 1976). Despite the extensive research tha t has 
been conducted on thioureas, the mechanism by which these compounds 
specifically damage lung tissue is not known.
Many pharmacological and toxicological aspects previously observed in rats 
administered thiourea-like compounds are quite similar to those observed in 
animals exposed to atmospheric pollutants such as ozone and nitrogen 
dioxide (Farchild et al., 1959; Stokinger, 1965). These agents also exhibit 
differential toxicity in immature and m ature animals and induce tolerance. 
Cross-tolerance between several gaseous pulmonary irritan ts (ozone, nitrogen 
dioxide, phosgene, hydrogen disulfide) and thiourea-like compounds has been 
shown (Farchild, et al., 1959; Farchild, 1963; Stokinger, 1965). Thus
gaseous pulmonary irritants and thiourea-like compounds may share a 
common pathophysiological effect and a common toxicologic mechanism of 
action.
Although the prospects for the use of TTZ as a fertilizer has been dampened 
because of its pulmonary toxicity in rats, research on this compound is 
warranted since chemical compounds tha t produce selective acute pulmonary 
toxicities are rare. Therefore valuable insight into the biochemical basis for 
this specificity leading to an understanding of both normal and abnormal 
pulmonary physiology may be gained. 2-Thiotriazone could also be used as 
a model for investigating the pathophysiology of pulmonary edema since its 
toxic effects are specifically directed a t the lung, causing marked pulmonary 
edema in and around blood vessels, and because it produces toxicity a t 
relatively low doses. The objectives of this study were to characterize the 
acute toxicity of TTZ in rats; to determine if  toxicity is age or sex 
dependent; to characterize both innate and drug induced resistance to TTZ 
in rats; to determine the effects of TTZ on hepatic microsomal and cytosolic 
enzymes and enzyme activities; to determine the effect of TTZ on hepatic 
and pulmonary glutathione concentrations in rats, and to determine the 
effect of glutathione depletion on TTZ toxicity in rats.
CHAPTER 2
LITERATURE REVIEW
An increasing number of drugs and chemicals have been shown to produce 
pulmonary toxicity via systemic administration. These chemicals produce 
specific lung damage and they also produce damage to other tissues. The 
exact mechanisms by which pulmonary toxicants may cause lung damage 
includes: concentration of the agent within the lung, the absence of
adequate pulmonary detoxification systems and bioactivation to a toxic 
species within specific lung cells or within the liver or other metabolic sites. 
The biochemical and pathological changes associated with lung edema, the 
responses of individual lung cells, pulmonary repair processes to toxic 
agents, and species and age differences in susceptibility to lung damage 
have not been determined for most pulmonary toxins. Previous studies by 
Boyd (1980; 1982) and Minchin and Boyd (1983), have shown that some 
pulmonary toxicants require metabolic activation prior to producing lung 
damage, while some do not require activation.
Even though no previous toxicological research has been performed on 2- 
thiotriazone (TTZ), a new compound developed for use as a potential 
fertilizer, acute toxicity testing has shown it to be an acute selective 
pulmonary toxicant in rats. Its selective pulmonary toxicity has been found 
to be very similar to tha t of a-napthylthiourea (ANTU). Due to the fact 
that chemical compounds th a t produce selective pulmonary toxicity are rare, 
related acute selective pulmonary toxicants such as 4-ipomeanol and other
furans, paraquat, pyrrolizidine alkaloids and thioureas (specifically ANTU) 
along with their proposed mechanisms of toxicity will be reviewed in this 
study.
4-IPOMEANOL AND OTHER FURANS
At least 13 furan derivatives have been found to produce acute lung damage 
in rats via inhalation or systemic administration, (Boyd, 1980). Some occur 
naturally in the environment, others are used in industry and research, and 
some are found in food and drugs (Kehrer and Kareu, 1985). 4-Ipomeanol, 
a furanterpenoid which is the major component of the "lung edema factor" 
produced in mold (Fusarium solani), damages sweet potatoes (Ipomea 
batatas) (Boyd, 1980) and is the most extensively studied of the furan 
derivatives.
4-Ipomeanol produces marked pulmonary toxicity (William et al., 1971; Boyd 
et al., 1974; Dutcher and Boyd, 1978; 1979) in several laboratory animal 
species (rats, rabbits and guinea pigs). Lethal doses after oral, intravenous 
or intraperitoneal administration are between 10-60 mg/kg. Typical 
pathological findings in the lung included massive alveolar (interstitial) 
edema, congestion, pleural effusion and hemorrhage (Perkham et al., 1972) 
within 6-24 h r after administration (Boyd, 1976). Sabo et al., (1983) found 
tha t functional changes in the lungs may be attributed to swelling and 
necrosis of non-ciliated bronchiolar (Clara) cells, which is the characteristic 
pulmonary cellular lesion. This appeared to be the primary site of lung
damage produced by 4-ipomeanol (Boyd, 1982; 1980; 1976; 1977). This 
damage was restricted to the smaller airways a t low doses, but a t higher 
doses the cells of the larger airways were also affected. There are some 
species differences in pathological alterations produced by 4-ipomeanol. 
For example, liver damage is produced in hamsters (Dutcher and Boyd, 
1979; Boyd and Dutcher, 1981) and in birds, which lack non-ciliated 
bronchiolar cells (Clara cells) and alveolar Type II cells (Buckpitt et al., 
1982).
Tolerance to 4-ipomeanol, like thioureas, can be produced in rats by 
administration of sublethal doses of the toxin itself (Boyd et al., 1972; 1967). 
Pretreatm ent of rats with 4-ipomeanol (7 mg/kg) for 7 days triples the LD^. 
Protection against the toxicity of 4-ipomeanol is provided by pulmonary GSH 
and other sulfhydryl compounds which can react with a metabolite and 
prevent covalent binding and lung damage (Boyd et al., 1978; 1972). 
Studies both in vitro and in vivo indicated tha t the reactive metabolite 
formed by metabolism of 4-ipomeanol is a highly electrophillic species (Boyd 
and Burke, 1978; Boyd et al., 1978; 1979). Addition of the nucleophilic 
tripeptide, glutathione (GSH), or "soluble fraction" (which contains GSH and 
GSH-transferases) markedly inhibited the covalent binding of 4-ipomeanol 
in vitro (Boyd et al., 1978). Glutathione did not inhibit the formation of the 
reactive metabolite, but inhibited its covalent binding by acting as an 
alternate nucleophile (Boyd et al., 1978; Buckpitt and Boyd, 1979; Statham  
and Boyd, 1979). In vivo studies by Boyd and Burka (1978); Boyd et al., 
(1979); and Statham  and Boyd, (1979), have likewise implicated an
electrophillic metabolite in 4-ipomeanol toxicity and these authors also 
suggested tha t GSH may modulate susceptibility to the pulmonary damage, 
as it does with certain hepatotoxins, such as acetaminophen and 
bromobenzene (Mitchell et al., 1973; Mitchell and Boyd, 1978). Toxic doses 
of 4-ipomeanol selectively depleted lung GSH; this effect was prevented by 
pretreatment of the animals with piperonyl butoxide (Boyd et al., 1979). 
Prior depletion of tissue GSH by diethylmaleate (DEM) pretreatm ent 
markedly increased both covalent binding and the toxicity of 4-ipomeanol, 
although it did not alter the tissue distribution of the parent compound 
(Statham and Boyd, 1979). Administration of exogenous sulfhydryl 
compounds such as cysteine or cysteamine, decreased both covalent binding 
and the toxicity of the compound (Boyd et al., 1979). These studies 
suggested tha t endogenous GSH might play a protective role in 4-ipomeanol 
toxicity by reacting with the toxic metabolite(s) to form a nontoxic 
conjugate(s). However, GSH seemed to be acting only as an alternative 
nucleophile; there was no indication tha t it was preferentially depleted prior 
to alkylation of tissue nucleophiles.
Extensive research with 4-ipomeanol revealed tha t its toxicity is due to 
bioactivation by cytochrome P-450 (Boyd, 1982; 1976; 1977; Dutcher and 
Boyd, 1979). Pulmonary alveolar Type II cells have been found to 
metabolize 4-ipomeanol to an electrophillic species (Devereux, et al., 1981). 
This metabolite is highly reactive, and has been shown to covalently bind 
to lung tissue in vivo (Boyd et al., 1975; Boyd and Burka, 1978), and to 
microsomal proteins in vitro (Boyd et al., 1978) when 1 4C-ipomeanol was
incubated in the presence of NADPH with various subcellular fractions of 
ra t lung and liver homogenates. Radioactive material became predominately 
bound to the microsomal fractions (Boyd et al., 1978). The maximal rates 
of covalent binding of the toxin occurred only in the presence of NADPH 
and oxygen. Several inhibitors of monooxygenase enzymes decreased the 
covalent binding of 4-ipomeanol in ra t lung and liver microsomes in vitro. 
Pyrazole, piperonyl butoxide, and SKF-525A all inhibited the covalent 
binding, with piperonyl butoxide being the most effective (Boyd et al., 1978). 
Covalent binding of 4-ipomeanol was also markedly decreased in lung and 
liver microsomes from rats pretreated with cobaltous chloride, which causes 
a decrease in both pulmonary and hepatic cytochrome P-450 (Sesame and 
Boyd, 1978).
The activation of 4-ipomeanol was examined in lung and liver microsomes 
from rats pretreated with 3-methylcholanthrene or phenobarbital (Boyd et 
al., 1978). Both pretreatments produced the expected increase in liver 
cytochrome P-450 and also increased the in vitro hepatic microsomal 
covalent binding of 4-ipomeanol, indicating tha t 4-ipomeanol could be 
metabolized by forms of hepatic cytochrome P-450 induced by either 
phenobarbital or 3-methylcholanthrene. However, phenobarbital treatm ent 
did not alter in vivo covalent binding or the toxicity of 4-ipomeanol in the 
lungs, although it  did significantly increase the LD5 0  value (Boyd and Burka, 
1978). Covalent binding of the toxin was decreased in vivo in both lung 
and liver in phenobarbital treated animals compared to controls (Boyd and 
Burka, 1978). Thus, phenobarbital induction probably affected detoxifying
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pathways in vivo more than toxifying ones (Boyd, 1981; Boyd and Burke, 
1978). In 3-methylcholanthrene pretreated animals, liver necrosis resulted 
from metabolic activation of 4-ipomeanol by hepatic enzymes. The in vitro 
formation of an alkylating metabolite of 4-ipomeanol was greatly increased 
in liver microsomes but not in renal or pulmonary microsomes, from 
C57BL/6J mice pretreated with 3-methylcholanthrene (Boyd and Dutcher, 
1978). in vivo covalent binding of 4-ipomeanol was markedly elevated in 
livers of the induced mice, while covalent binding of the toxin was markedly 
decreased in the lungs and kidneys. 4-Ipomeanol caused striking 
centrilobular hepatic necrosis in the induced mice, but much less intense 
renal and pulmonary necrosis, as compared to non-induced controls. In 
contrast, 3-methylcholanthrene pretreatm ent had no significant effect on 
target organ alkylation and toxicity by 4-ipomeanol in "non-inducible" 
DBA/2J mice.
The furan moiety is clearly necessary for both binding and subsequent lung 
toxicity induced by 4-ipomeanol and related chemicals. Analogs in which 
the furan is replaced by methyl or phenyl substitutes do not covalently bind 
to lung tissue and are not toxic to the lung (Boyd and Burka, 1978; Boyd 
et al., 1978). Clara cells have the greatest metabolic capacity for 4- 
ipomeanol in mammalian systems indicating tha t its pulmonary toxicity is 
directly related to its site of metabolism. Altering the metabolism of 4- 
ipomeanol through the use of drug metabolism inducers shifts the toxicity 
from lung to liver (Boyd et al., 1980; Jones et ah, 1983).
Many other furan derivatives, such as 3 -methylfuran (Boyd et al., 1978; 
Statham  et al., 1978), furan carbonates (analogues of 4-ipomeanol) 
(Seawright and Mattocks, 1973; Boyd et al., 1974), perilla (mint plant) 
ketone (Wilson et al., 1977), and sulfur and nitrogen containing analogues 
of furans (Franklin and Boyd, 1978), have been shown to produce 
bronchiolar cell necrosis (both ciliated and non-ciliated) and hepatic and/or 
renal damage following systemic administration (Boyd, 1982; 1980). 3-
Methylfuran was also converted by a  cytochrome P-450 dependent pathway 
in mouse lung microsomes to a highly reactive metabolite tha t became 
covalently bound to microsomal protein in the same m anner as 4-ipomeanol. 
Microsomal alkylation of 3-methylfuran required NADPH and air, and it 
was strongly inhibited by a  carbon monoxide enriched atmosphere or by 
addition of piperonyl butoxide (Boyd et al., 1978; Statham  et al., 1978).
Other furans and related compounds such as the furan carbamates, perilla 
ketone, furan derivatives, thiophenes and pyrolles also require metabolic 
activation like 4-ipomeanol and 3 -methylfuran (McMurty et al., 1977; 
Franklin and Boyd, 1978; Boyd, 1980). Nitrofurantoin, another furan 
derivative, is widely used as a urinary tract antiseptic and produces a 
unique lung lesion different from bronchiolar, hepatic or renal necrosis seen 
with other furans (Israel et al., 1973). Although the pulmonary toxicity of 
nitrofurantoin is rare, it  has potentially serious side effects in patients 
treated with standard doses of the drug (Koch-Weser et al., 1971). Acute 
signs of nitrofurantoin induced lung damage begin a t 2  hour to 2  weeks 
after administration of the drug and include fever, cough, dyspnea, and
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cyanosis. Pulmonary infiltrates and pleural effusion also occur. This acute 
toxicity may develop into a chronic reaction resulting in pulmonary fibrosis 
(Rosenow, 1976). The mechanisms by which nitrofurantoin damages lung 
tissue are not known, but they appear to be significantly different from 
those of other furan derivatives. Earlier studies supported an allergic 
mechanism (Rosenow, 1976). Recent studies have shown tha t cyclic 
reduction and reoxidation of nitrofurantoin, like paraquat, may occur in 
vitro under aerobic conditions. This could lead to the production of 
superoxide radicals, the depletion of NADPH, and lung damage (Mason and 
Holtzman, 1975). Nitrofurantoin stimulates hydrogen peroxide production 
in lung microsomes (Sesame and Boyd, 1979). It is also more toxic to lungs 
of rats deficient in vitamin E or exposed to high concentrations of oxygen 
(Boyd et al., 1979). Several antioxidants, including superoxide dismutase 
and catalase, have protected lung explants from nitrofurantoin toxicity while 
hyperoxia enhanced it’s toxicity (Martin, 1983). Nitrofurantoin will oxidize 
GSH in an isolated perfused lung preparation (Dunbar et al., 1981). It also 
has the ability to inhibit glutathione reductase (Buzzard, 1960) which is 
involved in the glutathione antioxidant system of the lung. Inhibition of 
this enzyme has been postulated as a factor in the lung toxicity of the 
anticancer drug carmustine, 1,3 bis (2 chloroethyl)-l-nitrosurea (BCNU) 
(Kehrer and Paraidathathu, 1984).
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THIOUREAS (SPECIFICALLY ANTU)
Thiourea (NH2 CSNH2) and several of its derivatives, especially the N- 
monosubstituted ones containing the thioredo moiety (-NH CS NH-), produce 
marked pulmonary toxicity in many animal species (Mackenzie and 
Mackenzie, 1943; Dieke and Richter, 1945; Dieke et al., 1947). 
Phenylthiourea and ANTU produced massive pulmonary edema and effusion 
in rats (Mackenzie and Mackenzie, 1943; Dieke and Richter, 1945; Dieke et 
al., 1947). The rodenticide, ANTU, has been shown to be one of the most 
potent of these derivatives. Because of its selective pulmonary toxicity, 
ANTU is a widely used model for investigating the pathophysiology of 
pulmonary edema (Richter, 1952).
Alpha-napthylthiourea and other toxic thioureas produce a fibrin rich 
pulmonary edema (usually nonhemorrhagic) and, frequently, massive pleural 
effusion in susceptible animals (Mackenzie and Mackenzie, 1943); Dieke and 
Richter, 1945; Dieke et al., 1947; Richter, 1945; McClosky and Smith, 1945; 
Dieke and Richter, 1946; Richter, 1952; Bohm, 1966; Cunningham and 
Hurley, 1972; Meyrick et al., 1972). Oral LDa, values for ANTU range from 
7 mg/kg in some ra t strains to 4,250 mg/kg in monkeys and chickens (Dieke 
and Richter, 1946). Rodents such as rats and mice were found to be highly 
susceptible to thiourea toxicity, whereas other species such as cats and 
rabbits were much more resistant (Dieke and Richter, 1945; Richter, 1945; 
Dieke and Richter, 1946). ANTU has also been shown to produce fatal
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pulmonary edema in dogs (Michel et al., 1984) and sheep (Havill et al., 
1982).
Detailed descriptions of ANTU toxicity in rats by Cunningham and Hurley 
(1972) and Ven Den Brink et al., (1976), showed that a dose of 5 mg/kg 
given intraperitoneally (ip) produced evidence of pulmonary edema and 
effusion within 2 hr, which reached a maximum 4.5 hr. after injection. The 
damage was lethal to some animals a t 8-10 hr. post-injection. ANTU 
administered ip to rats a t doses of 3,10, and 50 mg/kg produced capillary 
endothelial damage (blebbing and scalloping) and pulmonary edema (Meyrick 
et al., 1972; Brun-Pascaud et al., 1983). The morphologic changes 
associated with thiourea-induced lung toxicity are primarily found in the 
endothelium of pulmonary capillaries and venules of rats (Cunningham and 
Hurley, 1972). Some damage to Type 1 alveolar epithelial cells has also 
been reported (Meyrick et al., 1972) although it is not clear whether this 
was a direct effect of ANTU or secondary to the endothelial cell lesion. 
Light and electron microscopic studies have shown gaps in the endothelium 
and occasional blebs protruding into the capillary lumen. These gaps 
appear to allow the leakage of fibrin rich fluid resulting in pulmonary 
edema and, often, massive pleural effusions (Cunningham and Hurley, 
1972). Hemorrhage is rare, and in surviving animals, edema resolves itself 
within 48 hr. and there is no evidence of an inflammatory response. Gaps 
a t the endothelial cell junction disappear when fluid leakage ceases and 
there is no evidence of perm anent damage to any lung cell (Cunningham 
and Hurley, 1972).
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Other thiourea and thiono-sulfur compounds cause other toxicities i.e., 
thioacetamide causes centrilobular hepatic necrosis (Hunter et al., 1977). 
It impairs the synthesis of messenger and transfer RNA or their transfer 
from the nucleus (Stocker and Yokyaman, 1966). Hanzlik et al., (1980) 
found that both thiobenzamide and thiobenzamide-S-oxide, a metabolite, 
produced a dose-related liver injury in rats. Dithioburet caused 
neurotoxicity in rats (William et al., 1987), characterized by delayed onset 
of skeletal muscle weakness and depressed nerve stimulated release of 
acetylcholine (Astwood et al., 1945; Atchison et al., 1981; Weiler et al., 1984, 
1986 and Atchison, 1984). Ethylenethiourea, a fungicide (Ludwig et al., 
1954; Czegkedijenka, 1967) produced tumors in mice (Innes et al., 1969), 
thyroid cancer in rats (Ulland et al., 1977), and was teratogenic in mice and 
rabbits (Khera, 1973). Tetamethylthiourea has also been found to be a weak 
embryotixic and teratogenic agent (Stula et al., 1979).
Some thiourea derivatives also have antithyroid activity. However, their 
pulmonary toxicity is not correlated with this activity (Mackenzie and 
Mackenzie, 1943; Dieke et al., 1947). Lethal doses of propylthiourea, 
thiouracil, and certain other related compounds having potent antithyroid 
activity did not cause significant lung damage. However, marked resistance 
to ANTU toxicity has been induced by pretreatm ent of rats with toxic and 
non-toxic antithyroid drugs (Saunders and Spaulding, 1951; Van Den Brink, 
et al., 1976) or with iodide or iodine (Beyerum, 1946; Van Den Brink, et al., 
1976).
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Young and immature animals, compared to adult animals, were generally 
highly resistant to the lung toxicity of thioureas (Dieke and Richter, 1945; 
1946. The prior treatm ent of susceptible older animals with small non- 
lethal doses of ANTU produced striking tolerance to subsequent large 
challenge doses of ANTU (McClosky and Smith, 1945; Van Den Brink, et 
al., 1976; Richter, 1946; Mayer and Saunders, 1949; Sabonya and 
Kleinerman, 1973). This tachyphylaxis was dose-related and occurred, even 
if  rats were pretreated a t an early age with ANTU (or with other toxic and 
non-toxic antithyroid drugs, or with iodine or iodide) before susceptibility to 
thiourea had developed (Van Den Brink et al., 1976).
Previous investigations with thiourea indicated tha t sulfhydryl compounds, 
including cysteine, (Dubois et al., 1946; Karel and Mayer, 1948) glutathione, 
(Giri and Combs, 1970; Karel and Mayer, 1948), and 2 - 
aminoethylisothiouronium bromide protected rats against the lethal effects 
of thiourea derivatives (Van Den Brink et al., 1976). Giri and Combs (1970) 
found tha t cysteine and reduced glutathione inhibited both the pulmonary 
edematogenic effect and the hyperglycemic effect of phenylthiourea in rats. 
Several experiments have suggested that sulfhydryl compounds could 
modulate susceptibility to the toxicity of thioureas. Because of this, the 
effect of diethylmaleate (DEM) pretreatm ent on the toxicity and covalent 
binding of “ S ANTU was studied by Boyd and Neal (1976). DEM 
pretreatment depleted liver and lung glutathione (GSH) levels by 80%. 
Both pulmonary toxicity and in vivo covalent binding were strikingly
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increased after ANTU pretreatment. These findings showed that GSH could 
possibly detoxify reactive species involved in the toxicities of thiourea by 
forming non-toxic conjugates (Hollinger et al., 1976).
Pretreatments of rats with 3,4-benzpyrene resulted in marked tolerance to 
the pulmonary toxicity of ANTU, but phenobarbital (PB) pretreatm ent had 
little effect. Pretreatm ent with SKF-525A or piperonyl butoxide did not 
appear to modify ANTU toxicity consistently (Van Den Brink et al., 1976). 
Treatment with aminophilline, nicotine, or atropine had no significant effect 
on ANTU toxicity. Actinomycin D has also been shown to potentiate 
thiourea toxicity (Giri et al., 1974).
Recent studies have shown tha t hyperoxia enhanced the toxicity of thiourea 
and th a t hydroxyl radicals may be the ultimate mediator responsible for 
lung injury (Fox et al., 1981). This highly reactive species could directly 
damage the lung or indirectly induce destructive reactions such as lipid 
peroxidation. Endotoxin pretreatment, which protects rats against 
pulmonary oxygen toxicity, also prevent pulmonary edema produced by 
thioureas (Hollinger et al., 1981). The mechanisms involved in endotoxin 
protection against thioureas are not clear, but may be related to the 
increased activity of pulmonary antioxidant defense systems induced by 
endotoxin (Frank et al., 1980). The beta-adrenergic system may also play 
a role in thiourea induced lung damage. Isoproterenol increased and 
propranolol decreased the endematogenic response (Combs and James, 1975). 
These effects may be related to changes in cardiac output which could alter
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the formation of edema fluid. Prostaglandin E treatm ent, which could 
increase ANTU uptake as well as produce platelet depletion, potentiated 
ANTU-induced lung injury, while neutrophil depletion had no apparent 
effect (Fantone et al., 1984). These factors suggest tha t ANTU induced lung 
toxicity may have a very complex mechanism.
Alpha-napthylthiourea and other thioureas caused disturbances in 
carbohydrate metabolism in ra ts and dogs. Thiourea-induced hyperglycemia 
could be antagonized by insulin, ergotamine, or adrenal demedullation, but 
none of these treatm ents prevented the pulmonary toxicity (Dubois et al., 
1946). Giri and Combs (1970) established tha t the degree of hyperglycemia 
induced by phenylthiourea in rats varied directly with age, as did 
susceptibility to pulmonary edema.
Treatment of rats with ANTU ip decreased pulmonary mixed function 
oxygenase enzymes (Boyd and Neal, 1976), suggesting tha t a toxic 
metabolite of ANTU was formed in vivo. Pretreatm ent of rats with a non- 
lethal dose of ANTU daily for 5 days decreased the activity of the lung 
mixed function oxygenasee enzyme systems tha t metabolized parathione and 
ANTU in vitro. A similar effect has been previously shown with CSa (Bond 
and DeMatteis, 1969) and other thiono-sulfur containing compounds (Hunter 
and Neal, 1975) on ra t liver mixed function monooxygenase activity. The 
pretreatment with ANTU also caused a decrease in both covalent binding 
and the pulmonary toxicity of “ S ANTU in vivo (Boyd and Neal, 1976). 
This suggested tha t a decreased rate of activation of ANTU in ANTU-
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pretreated rats might have been a t least partially responsible for the 
development of tolerance (Hollinger et al., 1976). Boyd and Neal (1976) 
have shown tha t on incubation of 14C lung and liver microsomes two types 
of binding occurred. One was NADPH dependent and the other was 
NADPH independent. Boiling of microsomes abolished the NADPH 
dependent covalent binding activity, suggesting th a t the binding in the 
absence of NADPH was nonenzymatic. The NADPH dependent covalent 
binding presumably reflected the metabolic conversion of the parent 
compound to a more reactive species capable of interacting covalently with 
tissue macromolecules. However, NADPH independent binding may have 
reflected nonenzymatic mixed disulfide formation between ANTU and tissue 
protein sulfhydryl groups (suggesting tha t the postulated mixed disulfide 
bond was cleaved in a m anner which left the sulfur atom of ANTU bound 
to the protein). Furthermore, the binding that occurred in the presence of 
NADPH led to decreases in cytochrome P-450 and mixed-function 
monooxygenase activities in  vitro, whereas tha t which occurred in the 
absence of NADPH had no effect on cytochrome P-450 or mixed function 
monooxygenase activities in vitro.
Hollinger et al., (1976) also observed two types of binding of radioactivity 
from 14C-thiourea incubated in vitro with ra t lung slices. One form of 
binding was low affinity, high capacity, and the other was characterized as 
high affinity/low capacity. I t  may be possible tha t these were analogues to 
the nonenzymatic and enzymatic binding, respectively, th a t had been 
observed with ANTU in lung microsomes (Boyd and Neal, 1976).
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At least two enzyme systems are known that might play a  role in activating 
toxic thioureas: cytochrome P-450 dependent monooxygenases (which are 
known to activate some thionosulfur compounds) (Dalvi et al.„ 1974; Hunter 
and Neal, 1975; Bond and Dematteis, 1969), and the flavoprotein mixed 
function oxidase system (Poulsen et al.„ 1974). The flavoprotein enzyme is 
capable to NADPH-dependent desulfuration of some thionocarbonyl 
compounds, and it  is reasonable to suspect tha t a chemically reactive, toxic 
intermediate could also be formed by this route. ANTU has been shown to 
be a substrate for this enzyme system. According to Hollinger et al., (1976), 
the pulmonary toxicity of thioureas is quite different from 4-ipomeanol 
toxicity (reversible lesions of endothelial cells and no bronchiolar necrosis). 
This suggested that, if metabolic activation is involved in thiourea toxicity, 
the metabolism of thioureas may occur by different pathways and/or 
different pulmonary cell types than 4-ipomeanol.
Despite the extensive research th a t has been performed with thiourea, the 
mechanisms by which these compounds specifically damage lung tissue are 
not known. The presence of specific binding sites is one mechanism proposed 
to explain the toxicity of various lung toxins including thioureas (Gregory, 
1970). Differences in the number of binding sites might explain the age 
and species variation in thiourea induced pulmonary toxicity (Gregory,
1970).
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Metabolic activation may be a necessary step in the pulmonary toxicity of 
the thioureas (Cunningham and Hurley, 1972; Meyrick et al., 1972; Gregory, 
1970; Van Den Brink et al., 1976). Previous studies have shown that 
ANTU and thioureas covalently bind to lung protein (Hollinger et al., 1974; 
Boyd and Neal, 1976; Hollinger et al., 1976), while a  non-toxic analogue, 
alphanapthylurea does not (Boyd and Neal, 1976). Binding occurred in vitro 
under both aerobic and anaerobic conditions. This binding was associated 
with a reduction in glutathione and was temperature dependent (Hollinger 
and Giri, 1979), suggesting th a t it  was mediated by a reactive metabolite 
(Boyd and Neal, 1976; Lee et al., 1980). While the greatest amount of 
evidence supports the hypothesis tha t thioureas are activated metabolically 
to a lung toxic oxidative species, the issue has not been completely resolved.
PARAQUAT
Paraquat ( l , l ’-dimethyl-4,4’-bipyridylium dichloride) is another specific lung 
toxicant in mammals. I t is known as methyl viologen and is a quaternary 
bipyridyl compound once widely used as a broad spectrum herbicide (Pasi, 
1978). Paraquat has become one of the most extensively studied pulmonary 
toxins because of its lethal toxicity in man (suicide attempts) and in 
domestic animals after accidental ingestion (Bullivant, 1966; Smith and 
Heath, 1976; and Haley, 1979). Paraquat is highly water soluble and 
aqueous solutions are irritating to most biological systems. Oral ingestion 
usually results in lesions of the mucosal lining of the mouth and throat and
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results in nausea and vomiting (Fairshter et al., 1976). Acute signs of 
toxicity include diarrhea and decreased kidney function, both of which 
disappear in a day or two with apparent recovery. This is deceiving, 
however, because, severe lung damage gradually develops and the mortality 
rate is high.
Twelve to 36 hrs. after receiving toxic doses of paraquat (10-60 mg/kg iv or 
ip in the rat), the lungs frequently appear edematous and plum colored. 
They are generally much heavier than normal, and light microscopic 
examination usually reveals extensive edema and hemorrhage. Lung 
damage caused by paraquat is characterized by a destructive phase, followed 
by a proliferative phase (Smith et al., 1974; Sykes et al., 1977). The 
destructive phase is the first morphologic change observed and includes 
damage to Type I and Type II alveolar epithelial cells. Damage to 
pulmonary capillaries can be seen within 48 hours but is much less 
extensive than damage to Type I and Type II alveolar cells (Dearden et al., 
1982) and there is some early necrosis of terminal bronchiolar cells 
(Etherton and Gershom, 1979). The destructive stage is also associated 
with interstitial edema and the collapse of lung parenchyma. This is 
followed by a proliferative phase where fibroblasts migrate into alveolar 
spaces and m ature into fibroblasts. They then synthesize excessive amounts 
of an abnormal collagen characteristic of intraalveolar fibrosis. Interstitial 
fibrosis is not commonly seen in rats (Panpenoe, 1979) and the proliferation 
phase of paraquat induced lung damage is independent of, and not always 
preceded by, the destructive phase.
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A number of endogenous amines, including norepinephrine, 5- 
hydroxytryptamine, histamine, and several drugs such as imipramine, 
propranolol, burimomide and betazole, were found to inhibit paraquat 
uptake by lung slices in  vitro (Rose et al., 1977; 1974; 1976; Locke et al., 
1973; Smith et al., 1976). Studies conducted on the relationship between 
lung uptake processes for paraquat and 5-hydroxytryptamine (5HT) 
suggested some cellular specificity for paraquat accumulation and toxicity 
in the lung. Both paraquat and 5HT uptake were energy dependent but 
the process or rate of accumulation was different for both compounds.
Paraquat, unlike 4-ipomeanol, 3-methylfuran, other furans and ANTU, does 
not become covalently bound to lung tissue in vivo (Ilette et al.„ 1974). 
Rose and Smith (1977) reported tha t the accumulation and retention of 
paraquat by lung tissue was not related to any binding phenomenon. It is 
highly unlikely that the pulmonary toxicity of paraquat involves the 
irreversible binding of the parent compound or its metabolites to lung 
tissue.
Phenobarbital pretreatm ent partially protected animals from paraquat 
toxicity (Bus et al., 1976). However, phenobarbital pretreatm ent was 
effective only when tissue levels were relatively high, suggesting tha t the 
protective effect was not due to induction of drug metabolizing enzymes. 
Ilette and co-workers (1974) also found no evidence of N-demethylation of 
paraquat by 9000xg supernatants of liver or lung from either rats or
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rabbits, although those tissues possessed measurable N-demethylase activity 
when codeine or ethylmorphine were used as substrates.
A stable free radical metabolite was produced when paraquat was incubated 
under anaerobic conditions with fresh ra t liver homogenates (Gage, 1968). 
Formation of the radical was prevented by heating the homogenate or by 
dialyzing it. NADH was a required cofactor for the mitochondrial 
preparation, whereas NADPH was required for the reduction of paraquat to 
a free radical by the microsomes. Paraquat will readily accept an electron 
from NADPH in pulmonary microsomal preparations (Bus et al., 1975), and 
under aerobic conditions will rapidly be metabolized with the resultant 
formation of superoxide or other oxygen radicals (Farrington et al., 1973). 
This reaction could lead to cell damage from NADPH depletion (Witschi et 
al.„ 1977; Ilette et al.„ 1974; Rose et al., 1976), free radical generation and 
lipid peroxidation (Bus gt al.„ 1976; Ilette et al., 1974).
The lethality of paraquat was markedly increased in ra ts exposed to an 
oxygen-enriched atmosphere (Fischer et al., 1973; Bus and Gibson, 1975; 
Witchi et al., 1977). Additionally, its toxicity was diminished in animals 
exposed to atmospheres deficient of oxygen. Greater lethality and histologic 
change in lungs occurred in mice given a lethal dose of paraquat and keep 
in room air, compared to those kept in a 10% oxygen atmosphere (Rhodes 
et al., 1976). Animals surviving the hypoxic atmosphere quickly died when 
exposed to air. Smith and Rose (1977) found the opposite effect of paraquat 
in  rats. Rats placed in 10% oxygen after a lethal dose of paraquat died
faster than comparable controls left in room air.
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Even though several mechanisms of oxygen toxicity have been proposed, the 
superoxide radical might be the species responsible for the lung lesions 
produced by exposure to oxygen (Carpo and Tierney, 1974). Exogenous 
superoxide dismutose (SOD) administered iv provided partial protection 
against paraquat toxicity (Autor, 1974; Wasserman and Block, 1975). The 
conversion of superoxide to H 2 0 2  is catalyzed by SOD. Superoxide dismutase 
activity in lung microsomes is low compared to other tissues, and this may 
be a significant factor in the pulmonary specificity of paraquat (Montgomery,
1976). Derivatives of SOD with longer circulating half-lives may be more 
effective. Pretreatm ent with endotoxin and hyperoxia, which stimulate 
endogenous antioxidant systems, provided significant protection (Frank, 
1981). Other studies suggest ascorbic acid might be an effective protective 
agent (Matkovics et al.„ 1980), but this could not be verified (Sullivan and 
Montgomery, 1984). in vitro work performed by Montgomery et al., (1982) 
suggested th a t ascorbic acid might increase paraquat toxicity. The singlet 
oxygen, derived from spontaneous dismutation of superoxide, could cause the 
peroxidative decomposition of lipids in vitro (Pederson and Aust, 1973). 
Further studies performed by Bus et al., (1974; 1977; 1978) and 
Montgomery (1976) suggested th a t paraquat caused lung lesions by 
stimulating lipid peroxidation. Similar mechanisms have also been proposed 
for paraquat induced damage in plants (Dodge and Harris, 1970; Dodge,
1971).
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Vitamin E deficient mice were sensitized to paraquat toxicity as measured 
by a single dose 7 day LDgo (Bus et al., 1975). Mice fed a selenium 
deficient diet were also sensitized to paraquat (Bus et al., 1975). This is 
supportive of an oxidative mechanism of paraquat toxicity because selenium 
is required for glutathione peroxidase activity (Gram, 1973) and glutathione 
peroxidase is thought to be a modulator of lipid peroxidation 
(Christopherson, 1969).
Pretreatm ent of mice with diethylmaleate (DEM), which depletes stores of 
reduced glutathione (GSH), and tri-o-cresylphosphate (an inhibitor of GSH- 
peroxidase) significantly enhanced paraquat toxicity (Bus et al., 1975). It 
has been speculated that the enhancement of paraquat toxicity by DEM was 
caused by removal of reducing equivalents necessary for GSH-peroxidase 
activity or possibly by the loss of the intrinsic antioxidant activity of GSH 
(Bus et al., 1975; 1976). Paraquat caused significant decreases in the 
concentration of GSH in the liver, bu t not in the lung (Bus et al., 1976). 
In contrast to its effects on lung and liver levels of GSH, paraquat 
decreased the level of lipid soluble antioxidants (primarily vitamin E) in the 
lung, but not in the liver. The paraquat-induced depression in lung lipid 
soluble antioxidants was very prolonged, recovery to control levels requiring 
nearly 200 hrs. (Bus et al., 1976). This might indicate possible differences 
in the cellular sites of paraquat toxicity or available pools of antioxidant in 
the liver and lung tissue.
Pretreatm ent of rats with 85% oxygen for 7 days induced tolerance to
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subsequent exposure to 1 0 0 % oxygen, and caused elevations in the lung 
activities of G-6 -P dehydrogenase (Bus et al., 1976), superoxide dismutase 
(Rose and Smith, 1977), and GSH-peroxidase (Bus et al., 1976). The survival 
time after a toxic dose of paraquat was increased in oxygen-tolerant rats as 
compared to control rats (Bus et al., 1976). The mechanism involved in 
lung damage appeared to be related to its specific uptake into this tissue 
and the redox capacity of paraquat, which may lead to depletion of NADPH 
and/or the generation of oxygen free radicals. Treatm ent of paraquat 
toxicity has focused on preventing active lung uptake and scavenging the 
potential oxygen radicals th a t are formed. Unfortunately, none of the 
previously mentioned treatm ents were effective against paraquat poisoning.
PYRROLIZIDINE ALKALOIDS (PA)
These chemicals are found in a variety of plant species. Toxic responses to 
these alkaloids vary between species and may be neurologic, hematologic, 
gastrointestinal, hepatic or pulmonary (McLean, 1970). Lung lesions are 
observed in most species several days after systemic treatm ent with a PA 
such as monocrotaline. The major initial sites of lung damage are the cells 
lining the arteries, capillaries, and veins. Thrombi appear on the surface 
of these cells (Huxtable, 1979), which then develop an increased 
permeability resulting in intraavleolar and interstitial edema and pleural 
effusion (Plestina and Stoner, 1972). This is followed by focal necrosis of 
the alveolar walls, changes in interstitial cells, endothelia and alveolar cell 
proliferation, medial thickening and intimal hyalinosis of arteries and
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pulmonary arterial hypertension (McLean, 1970; Valdina et al.„ 1967; 
Hayashi et al., 1984). There is a positive correlation between progressive 
pulmonary hypertension, increased thickness of the wall of pulmonary 
vessels and right ventricular hypertrophy (Ghodsi and Will, 1981).
The liver is the most prominent target organ of pyrrolizidine alkaloids, 
causing both acute and chronic liver toxicities. However, the lung is also 
an important target organ, and the toxicity may result from activation at 
a distant site, i.e., in the liver (Mattocks, 1972; 1973). The lung itself is 
not capable of activating PA’s (Mattocks and White, 1971; Guengerich,
1977). Previous studies have shown that a toxic metabolite is produced in 
the liver which may be responsible for the damage seen in both tissues 
(Culvenor et al., 1976).
Toxic pyrrolizidine alkaloids are metabolized both in vivo and in vitro to 
pyrrole derivatives which bind to macromolecular tissue constituents. The 
pyrrole derivatives are potent alkylating agents, and their reactivity is 
greatly enhanced by the presence of ester groups (Mattocks, 1972). These 
ester groups are the most reactive sites, due to conjugation with the ring 
nitrogen atom. The ester groups could be lost, leaving a positively charged 
dihydropyrrolizine moiety which could react with nucleophilic groups such 
as amines or thiols to form relatively stable alkylation products.
The in vitro characteristics of pyrrolic metabolite production mediated by ra t 
liver microsomes were studied by Mattocks and White (1970). Pyrrole 
formation required oxygen and NADPH, was inhibited by carbon monoxide
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and SKF-525A, and was increased in microsomes from phenobarbital 
pretreated rats. This reaction was typical of a  microsomal mixed function 
oxidation. This study showed th a t pyrrolic formation from pyrrolizidines 
can be mediated by a cytochrome P-450 dependent microsomal activity. 
Allen et al., (1972) showed tha t chronic phenobarbital treatm ent of rats 
prior to administration of monocrotaline considerably enhanced the pyrrolic 
metabolite in the liver and lungs and potentiated acute pulmonary toxicity. 
Phenobarbital did not induce ra t lung cytochrome P-450 enzymes, but it 
greatly enhanced the in vitro production of pyrrolic derivatives from 
monocrotoline in liver microsomes (Chesney et al., 1974). Chloramphenicol 
treatm ent prior to administration of monocrotalline markedly decreased both 
tissue pyrrole concentrations and the acute pulmonary toxicity (Chesney et 
al., 1974). Studies performed by Chesney et al., (1974), Allen et al., (1972), 
and Huxtable et al., (1978) collectively provide good metabolic evidence that 
pyrrolic metabolites are involved in causing acute monocrotaline-induced 
lung toxicity in vivo and they also support the view tha t toxic metabolites 
are produced primarily in the liver.
MECHANISMS OF TOXICITY OF PULMONARY TOXICANTS
According to previous studies by Boyd (1980), all of the acute specific 
pulmonary toxicants in this review are affected by GSH concentration 
(modulates toxicity). GSH could possibly play a  role in the metabolism of 
these compounds. According to the review by Boyd (1980) there are three 
potential mechanisms of lung toxicity by which metabolic activation could
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play an important role in their toxicity. Mechanism I is comprised of a 
reaction in which an "inert" parent compound is metabolized to a highly 
reactive ultimate toxin in situ in the lung. In mechanism II, the ultimate 
toxin is also a highly reactive metabolite of the parent compound, but 
formed primarily in the liver and is transported to the lung by the 
circulation. In mechanism III, the activated parent compound would only 
participate indirectly in the toxic reaction. Presumably the activated oxygen 
species (such as superoxide radicals and derivatives thereof) could act as the 
ultimate toxin(s) and/or the deficits in cellular energy metabolism and 
defense mechanisms resulting from depletion of essential cofactors could lead 
to pulmonary damage. The relatively high oxygen tensions in pulmonary 
tissue could possibly contribute to preferential damage to lungs by agents 
acting through mechanism III.
The pulmonary toxicities of 4-ipomeanol and 3-methylfuran are best 
described by mechanism I. Lung damage (particularly bronchiolar necrosis) 
by other furan derivatives and related compounds also occur by mechanism
I. Toxic thioureas may also cause lung damage by mechanism I. However, 
because these compounds damage primarily the pulmonary vascular 
endothelium and not bronchiilar cells or Type II pneumocytes, other 
mechanisms of lung injury (such as mechanism II or possibly a mechanism 
not involving metabolic activation) m ust be considered for the toxic 
thioureas. The pyrrolizidine alkaloids appear to best exemplify compounds 
causing lung damage by mechanism II. The available evidence strongly 
suggests that the ultimate toxic metabolites of these agents, which severely
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damage piolmonary vascular endothelium, are formed primarily in the liver 
and reach the lungs via the blood stream. Paraquat is capable of causing 
lung injury by redox cycling of paraquat in certain lung cells, which leads 
to the consumption of cellular NADPH, and the "activation" of molecular 
oxygen. The toxicological consequences of these effects are not certain, but 
there is considerable circumstantial evidence to suggest tha t the 
intracellular generation of superoxide and its derivatives (such as singlet 
oxygen, H 2 0 2  and OH.) leads to cell damage by stimulating the peroxidative 
decomposition of cellular lipids. Nitrofurantoin (antibacterial drug) is also 
capable of causing lung injury by mechanism III. In conclusion, despite 
decades of intensive research on specific pulmonary toxicants, the actual 
mechanisms by which they produce lung toxicity are not known.
CHAPTER 3 
EXPERIMENTAL GOALS AND DESIGN
The ultimate goal of this study was to characterize the toxicity of 2- 
thiotriazone (TTZ) and to determine the mechanism of toxic action of TTZ 
in Spraque Dawley rats. This study included 5 experiments:
(1) EXPERIMENT 1 -  ACUTE TOXICITY OF TTZ IN RATS.
The purpose of this study was to determine if TTZ was acutely toxic in 
mature and immature male and female rats. This study was designed to 
determine both oral and intraperitoneal (ip) LDgo’s, to document all clinical 
signs of intoxication, to determine if TTZ toxicity was age and sex 
dependent, and to characterize changes in the lung (target organ) of treated 
animals by macroscopic and histological examination.
(2) EXPERIMENT 2 -  INNATE AND DRUG INDUCED RESISTANCE 
TO TTZ IN RATS.
To better understand variations in response to TTZ based on age and sex 
differences in rats, both innate and drug induced resistance to TTZ was 
studied. This study was designed to characterize both innate and drug 
induced resistance in m ature and immature rats (both sexes). This was 
accomplished by determining the age a t which susceptibility to TTZ 
develops, if  resistance was dose-dependent, how long resistance lasts, effect 
of enzyme induction with (3-napthoflavone and phenobarbital on TTZ
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toxicity, effect of enzyme inhibition with a-napthoflavone and SKF525A on 
TTZ toxicity, effect of administration of hormones (^-estradiol and tes­
tosterone) on TTZ toxicity, if  changes in estrous cycle affected TTZ toxicity 
in female rats and the effects of N-acetyl-L-cysteine (glutathione precursor) 
on TTZ toxicity in male rats.
(3) EXPERIMENT 3 -  EFFECT OF TTZ ON HEPATIC MICROSOMAL 
AND CYTOSOLIC ENZYMES AND ENZYME ACTIVITIES IN RATS.
The purpose of this study was to determine if TTZ caused decreases or 
increases in hepatic microsomal mixed function monooxygenase enzyme 
systems and activities in mature (male and female) and immature (male) 
rats. This study was designed to determine the effect of TTZ on: 
cytochromes P-450 and b5, NADH cytochrome-b5  and NADPH cytochrome- 
C-reductases, glutathione-S-transferase and UDP-glucuronosyltransferase. 
Enzyme activities analyzed were aldrin epoxidase, 7 -ethoxycoumarin-O- 
deethylase (ECOD) and 7-ethoxyresorufin-O-deethylase (EROD). The effect 
of TTZ on P-napthoflavone and phenobarbital induced enzyme systems in 
rats was also determined.
(4) EXPERIMENT 4 -  EFFECT OF TTZ ON HEPATIC AND PUL­
MONARY GLUTATHIONE LEVELS IN RATS.
The purpose of this study was to determine if  glutathione was involved in 
the metabolism of TTZ. This was accomplished by dosing m ature male and 
female rats with increasing concentrations of TTZ and determining if there 
was a dose-dependent decrease in glutathione levels in liver and lungs of
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rats. Rats were administered diethylmaleate (DEM) which is a glutathione 
depletor to determine if glutathione levels were actually depleted. Animals 
were pretreated with diethylmaleate (DEM) and dosed with TTZ to 
determine if glutathione levels were depleted more than in animals 
administered DEM alone. Rats pretreated with N-acetyl-L-cysteine (NAC), 
which is a glutathione precursor and subsequently dosed with TTZ were 
used to determine if  glutathione levels were maintained.
(5) EXPERIMENT 5 -  EFFECT OF GLUTATHIONE DEPLETION BY 
DIETHYLMALEATE (DEM) AND l-BUTHIONINE-(SR)-SUL- 
FOXAMINE (BSO) ON TTZ TOXICITY IN RATS.
The purpose of this study was to determine if  DEM potentiates the toxicity 
of TTZ in adult and immature ra ts (both sexes). The effects of BSO 
(specific inhibitor of GSH synthesis) on TTZ toxicity was also studied. This 
study was designed to determine if toxicity was potentiated by pretreatm ent 
with DEM or BSO, to document all clinical signs of intoxication, to 
determine the effects of DEM pretreatm ent on age and sex dependent 
variations in TTZ toxicity, and to characterize changes in the lung of 
treated animals by macroscopic and histological examination. The effect 
of DEM pretreatm ent on hepatic microsomal mixed function monooxygenase 
enzyme systems (cytochromes P-450 and b6, NADH cytochrome-b5  and 
NADPH cytochrome-C-reductases), glutathione-S-transferase, UDP-glucurono- 
syltransferase and enzyme activities (aldrin epoxidase, ECOD and EROD) 
were also studied.
CHAPTER 4
SPECIFIC OBJECTIVES AND MATERIALS AND METHODS
EXPERIMENT 1 -  ACUTE TOXICITY OF TTZ IN RATS 
OBJECTIVES:
1. To determine oral and intraperitoneal LDgo’s.
2. To determine clinical signs of toxicity.
3. To determine if toxicity is age or sex dependent.
4. To determine the site of action or target organ.
MATERIALS AND METHODS:
A. Chemical:
2-Thiotriazone (Fig. 1 ) is a  thiourea derivative with a molecular weight of 
110 and 10% solubility in water. I t was obtained as a white crystalline 
solid (97% pure) from the Triazone Corporation (Geismar, LA).
B. Animals:
Adult (250-500g) and immature (60-180g) Sprague Dawley albino rats (male 
and female) were obtained from Hilltop Lab Animals, Inc. (Scottdale, PA). 
Food (Purina Rat Chow) and water were allowed ad libitum. Rats were 
housed in groups of three (3) in wire mesh bottom cages. The room where 
the rats were kept was environmentally controlled a t 20-22 degrees C with 
a 12 hr light/dark cycle. After seven (7) days of acclimatization, the rats 
were randomly assigned to control and treatm ent groups.
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FIGURE 1: STRUCTURE OF 2-THIOTRIAZONE (TTZ)
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C. LDm Studies:
1. Oral Treatm ent:
A lOmg/ml solution of TTZ was prepared by adding O.lg of TTZ to 10ml of 
distilled water. 2-Thiotriazone was administered via gavage with increasing 
doses of 1.25, 2.5, 5 and 10 mg TTZ/kg body weight (bw) to adult male rats 
(10 rats per group). Adult female rats were administered doses of 2.5, 5, 
10, 62.5, 100, 125, 250 and 1000 mg TTZ/kg bw. A total of 10 rats per 
treatm ent group were used except where noted. Immature rats (both sexes) 
were administered doses of 10, 100 and 1000 mg TTZ/kg bw (10 rats per 
group). Control rats (5 rats per group) were dosed with distilled water (10 
ml/kg). Rats were observed closely for 6  hrs. a t 15 min. intervals and at 
24 hr. post-treatment. Clinical signs were documented as they occurred. 
The total mortality within a 24 hr. period was documented and recorded for 
LD5 0  determination. Surviving animals were observed over a 7-day period 
to document any delayed effects. Results were evaluated and LD,*, values 
were calculated according to the method of Weil (1952). Postmortem 
examination of liver, kidney, lung, intestine, stomach, heart, and 
reproductive organs in affected animals was conducted to determine the 
toxic effects of TTZ and to establish the principle target organ.
2. Intraneritoneal Treatm ent:
Acute toxicity was also studied following single ip injections of 1.25, 2.5 and 
5 mg TTZ/kg bw to adult male rats ( 6  ra ts per group). Adult female rats 
(5 rats per group) were administered doses of 5, 10 and 100 mg TTZ/kg bw. 
Immature rats (both sexes) were administered doses of 10, 100 and 1000 mg
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TTZ/kg bw (10 rats each group). Responses were monitored in the same 
manner as for oral studies. Postmortem examination of affected animals 
was also performed.
D. Histological Examination:
Development of the onset of TTZ toxicity in the lung was monitored in adult 
male and female rats (6 rats per group) by histological examination of lungs 
taken from rats (adult male and female) exposed to TTZ (10 mg/kg ip) at 
1 and 2 hrs. Control rats were dosed with distilled water (10 ml/kg bw) 
and sacrificed 1 and 2 hrs later by a lethal injection of pentobarbital 
(O.lml/kg bw ip). Treatment animals were sacrificed in the same manner. 
The lungs of both control and treated rats were perfused with fixative prior 
to tissue collection. The trachea was intubated and the intratracheal tube 
was sutured into place. A mixture of 1.25% glutaraldehyde and 2% 
formaldehyde in 0.1M sodium cacodylate buffer pH 7.4 was infused slowly 
through the tube via syringe (50 ml) into the trachea until the lungs 
completely filled the thoracic cavity. After 5-10 min. the chest cavity was 
opened and the lungs were removed, cut into small pieces (O.lg) and 
immersed in the fixative solution. Specimens were dehydrated in ethyl 
alcohol, infiltrated with LKB basic resin (glycol methacrylate monomer, 
polyethylene glycol 400 and hydroquinone) and activator (benzoyl peroxide 
with 50% plasticizer) overnight or until the specimens sank to the bottom 
of the vial. They were then embedded in Historesin (LKB products AB, 
Brommar, Sweden) which consists of basic resin, activator and hardener 
(derivative of barbituric acid and DMSO) and sections were cut a t a
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thickness of 3-5pm with a  microtome (LKB Brommar 2218 Historange). 
Sections were then stained with hematoxylin and eosin, examined under a 
Zeiss Photomicroscope III equipped with a MC63 photomicrographic camera 
and photographed.
Tissue samples (liver, kidney, spleen, lungs, intestine and stomach) were 
removed from animals used in oral and ip LD5 0  studies for histological 
examination. Samples were immersed in fixative (1 0 % buffered formalin) 
for 24 hrs. After fixation the organs were dehydrated in ethyl alcohol, 
embedded in paraffin, and sections were cut a t a thickness of 5-7um with 
a microtome. Sections were then stained with hematoxylin and eosin and 
examined with a photomicroscope.
E. Organ weights and organ to body weight ratios:
The effect of TTZ on liver and lung weights was monitored as follows: 
Adult (male and female) and immature (male) rats were randomly assigned 
to control and treatm ent groups ( 6  rats per group). The animals were 
administered a  lethal dose of TTZ (10 mg/kg ip) and sacrificed after 1 hr. 
The lungs and livers (possible sites of metabolism) were removed and 
weighed to determine if TTZ caused a change (decrease and increase) in 
the weights of these organs.
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EXPERIMENT 2 - INNATE AND DRUG INDUCED RESISTANCE TO TTZ 
TOXICITY IN RATS:
OBJECTIVES:
1. To determine the age a t which TTZ becomes toxic in male rats.
2. To determine if resistance to TTZ is dose dependent.
3. To determine how long rats remain resistant to TTZ after a
single exposure.
4. To determine the effect of N-acetyl-L-cysteine (glutathione replenisher) 
on TTZ toxicity.
5. To determine the effect of p-napthoflavone (BNF) induction on TTZ 
toxicity.
6. To determine the effects of phenobarbital induction on TTZ toxicity.
7. To determine the effect of BNF induction and a-napthaflavone (ANF)
inhibition on TTZ toxicity.
8. To determine the effect of phenobarbital induction and SKF-525A
inhibition on TTZ toxicity.
9. To determine the effect of hormones (p-estradiol and testosterone) on
TTZ toxicity.




p-Napthoflavone (BNF), P-estradiol and testosterone (4-androsten-17P-ol-3- 
one) were purchased from Sigma Chemical Co. (St. Louis, MO). 
Phenobarbital (sterile phenobarbital sodium, USP, 120 mg/vial) (Eli Lilly & 
Co., Indianapolis, IN) was purchased from the Louisiana State University 
School of Veterinary Medicine Pharmacy. SKF-525A was a  generous gift 
of Smith, Klein, and French Laboratories, (Philadelphia, PA).
B. Innate Resistance:
Immature rats (both sexes) were weighed and randomly assigned to control 
and treatm ent groups (10 rats per group). The control animals were 
administered distilled water (10 mg/kg ip) and treatm ent animals were 
administered TTZ (10 mg/kg ip) a t 30, 40, 45, 50 and 55 days of age. 
Clinical signs and mortality were observed and documented over a 24 hour 
period.
C. 2-Thiotriazone Induced Resistance:
Adult male rats were weighed and randomly assigned to control and 
treatm ent groups (3 ra ts per group except where noted). Control animals 
were administered distilled water (10 ml/kg ip) and treated animals (12 
groups) were administered a  sublethal dose of TTZ (1 mg/kg ip). Animals 
in treatm ent groups were subsequently reweighed and administered a toxic 
dose of TTZ (10 or 100 mg/kg) either orally or intraperitoneally (ip) a t 1, 2, 
or 3 days, or 1, 2, 3, 4, 5, 6, 7, 8 or 9 weeks after administration of the
sublethal dose (1 group per time interval).
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D. Effect of N-acetvl-L-cvsteine on TTZ Toxicity:
Adult male control animals (6 rats per group) were dosed with N-acetyl-L- 
cysteine (150 mg/kg ip) alone while treated animals (6 ra ts per group) were 
dosed with N-acetyl-L-cysteine (150 mg/kg ip) 30 minutes prior to 
administration of TTZ (10 mg/kg ip). Clinical signs and mortality were 
observed and documented over a 24 hour period. Postmortem examinations 
were performed and tissue samples (lung and liver) were taken for 
histological examination.
E. Enzyme Induction:
1. B-Napthoflavone (BNF) and Phenobarbital:
The cytochrome P-450 monooxygenase system of adult male rats (10 rats per 
group) was induced by ip administration of BNF (50 mg/kg/day in com oil) 
or rats were induced by ip administration of phenobarbital (60 mg/kg/day 
in sterile water) for three (3) consecutive days. Rats were administered 
TTZ (10 mg/kg bw orally) 24 hours after the third dose. Phenobarbital 
control rats (3 per group) were administered sterile water (60 mg/kg ip) and 
BNF control ra ts (3 per group) were administered com oil (50 mg/kg/day ip) 
for three consecutive days. Clinical signs and mortality were observed and 
documented for 24 hours after administration of TTZ.
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F. Enzyme Inhibition:
1. oc-Napthoflavone (ANF) and SKF-525A Inhibition:
Adult male rats (10 rats per group) were induced with BNF (50 mg/kg/day 
in com oil); 24 hours later they were administered ANF (50 mg/kg in com 
oil ip), 1 hour before dosing with TTZ (10 mg/kg orally). A separate group 
of adult male rats (10 rats per group) were induced with phenobarbital (60 
mg/kg in sterile water ip). Twenty-four hours after the last dose of 
phenobarbital, the rats were administered SKF-525A (50 mg/kg in sterile 
water ip), 1 hour before dosing with TTZ (10 mg/kg orally). Clinical signs 
and mortality were observed and documented for 24 hours after 
administration of TTZ.
G. B-Estradiol and Testosterone:
p-Estradiol (2 mg/kg) was administered to adult male, female and immature 
(both sexes) rats for 7 consecutive days. The rats were administered TTZ 
(10 mg/kg ip) on the 8th day and were observed over a  24 hour period for 
clinical signs and mortality. Testosterone (10 mg/kg ip) was administered 
to adult female and immature of both sexes rats for 7 consecutive days and 
TTZ (10 mg/kg ip) was administered on the 8th day. These animals were 
also observed for 24 hrs for abnormal clinical signs or mortality.
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H. Effect of Changes in the Estrous Cycle on TTZ Toxicity in Female
Rats:
Five groups of female rats (5 rats per group) were administered a lethal 
dose of TTZ (62.5 mg/kg ip). One group per day was administered the 
compound for five consecutive days to determine if  changes in response 
(mortality) could possibly be related to changes in the estrous cycle 
(hormone levels on different days). In another experiment adult female 
rats were assigned to Estrus, Metestrus, Proestrus and Diestrus groups 
based on a vaginal smear taken with a cotton swab moistened with distilled 
water. A total of 10 animals were analyzed for each group except where 
noted. The animals were administered TTZ (10-2000 mg/kg) orally. Clinical 
signs and mortality were observed and documented over a 24 hour period.
45
EXPERIMENT 3 -  EFFECT OF TTZ ON HEPATIC MICROSOMAL AND 
CYTOSOLIC ENZYMES AND ENZYME ACTIVITIES:
OBJECTIVES:
1. To determine the effect of TTZ on cytochromes P-450 and b5,
NADH cytochrome-b5 and NADPH cytochrome-C-reductases, 
glutathione-S-transferase, and UDP-glucuronosyltransferase in rats.
2. To determine the effect of TTZ on aldrin epoxidase, 7- 
ethoxyresorufin and 7-ethoxycoumarin-0-deethylase activities in rats.
MATERIALS AND METHODS:
A. Chemicals:
Umbelliferone (99% pure) and 7-ethoxycoumarin (99% pure) were purchased 
from Sigma Chemical Co. (St. Lotus, MO). 7-Ethoxyresorufin (98% pure) 
was purchased from Molecular Probes, Inc. (Junction City, OR). Resorufin 
(75% dye content) was obtained from Aldrich Chemical Co., Inc. (Milwaukee, 
WI). Aldrin (99.4% pure) and dieldrin (99.8% pure) were obtained from the 
EPA (Research Triangle Park, NC). All other chemicals were of analytical 
grade or better and were obtained from commercial sources.
B. Animals:
Adult (male and female) and immature (male) rats were weighed and 
randomly assigned to control and treatm ent groups (3 rats per group). 
Control animals were administered distilled water (10 ml/kg ip) and 
sacrificed by decapitation at 1 hour post-dosing. Corresponding groups of
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adult (male and female) and immature (male) animals were administered 
TTZ (10 mg/kg ip) and sacrificed a t 1 hour post-dosing. In a  separate set 
of experiments adult male rats were induced either by administration of 
BNF (50 mg/kg in com oil ip) or administration of phenobarbital (60 mg/kg 
in sterile water ip) for 3 consecutive days and sacrificed 24 hours later 
(controls n=3). Similarly induced animals were administered TTZ (10 mg/kg 
ip) 24 hours after the last dose of BNF or phenobarbital and sacrificed at 
1 hour post-dosing of TTZ (treatm ent groups n=3).
C. Preparation of Hepatic Microsomes:
Animals were weighed and sacrificed by decapitation. Their lives were 
removed, weighed and placed on ice in 1.15% KCI (buffered with 0.1M 
potassium phosphate buffer to pH 7.4). Microsomes were prepared from 
pooled livers of 3 animals per group (treated and control). The livers were 
minced, rinsed in phosphate buffer and homogenized in 4 volumes of ice- 
cold Tris buffer (10 mM Tris; 0.25M sucrose, and 1.0M disodium EDTA, pH 
7.4). Homogenization was accomplished by using 4 to 5 passes of a motor 
driver Potter-Elvehjem type homogenizer with teflon tip. The homogenate 
was centrifuged a t 600g for 10 min and the supernatant was saved. This 
supernatant was then centrifuged a t 8,000 g for 10 minutes and the 
supernatant was decanted and saved. This supernatant was then centrifuged 
a t 14,500 g for 10 minutes and the resulting supernatant, containing the 
microsomal fraction, was retained. The microsomes were pelleted by 
centrifugation a t 105,000 g for 60 minutes. All centrifugation steps were 
conducted a t 4 degrees C. This final supernatant was saved for glutathione-
47
S-transferase analysis. The microsomal pellet was washed by 
homogenization in 1 volume of 0.125M KC1 (buffered with 0.1M potassium 
phosphate buffer to pH 7.4). Homogenization was carried out by using 2- 
3 passes of a hand held glass pestle and tube homogenizer. The homogenate 
was brought to the original volume with 0.125M KC1 (pH 7.4) and 
centrifuged again a t 105,000g for 60 minutes a t 4 degrees C. The 
microsomal pellet was resuspended by homogenization with a  glass pestle 
and tube homogenizer in 1 volume 0.125M KC1 in 20% glycerol to give a 
protein concentration of 20-50 mg protein/ml. The final suspension was 
stored a t -70°C until used. This microsomal suspension was used for assays 
of cytochromes P-450 and b5, NADH cytochrome b5 and NADPH cytochrome- 
C-reductases, UDP-glucuronosyltransferase, glutathione-S-transferase, 
aminopyrine-N-demethylase, aldrin epoxidase, 7-ethoxyresorufin-0-deethylase 
and 7-ethoxycoumarin-0-deethylase.
D. Protein Determination:
Microsomal protein concentration was determined according to the method 
of Lowry et al., (1951). Protein standards were prepared in  duplicate from 
stock bovine serum albumin (1 mg/ml) a t concentrations of 0, 10, 20, 30, 40, 
50 and 60 ug/ml, pipetted into clean glass test tubes and brought to a 
volume of 0.1 ml. Microsomal samples (duplicate) were diluted 1:100 and
0.1 ml pipetted into clean glass test tubes. To both standard and sample 
tubes was added 2.0 ml of buffer (2% sodium potassium tartrate  (1.0 part) 
+ 1% CuSo4 - 7H20 (1.0 part), 100 parts Na2C 03 (2%) + NaOH (0.4%). Each 
tube was mixed by vortexing and incubated for 10 minutes a t room
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temperature. To each tube 0.2ml of Folin reagent (2N phenol solution) was 
added with mixing. After incubating for 30 minutes the absorbance was 
measured a t 750 nm in a Shimadzu UV-visible spectrophotometer (UV - 
160, Kyoto, Japan). A standard curve was constructed from the standards 
and the concentration of protein in the samples were determined from the 
standard curve.
E. Cytochrome P-450:
The microsomal content of cytochrome P-450 was determined by the method 
of Omura and Sato (1964). Microsomes (125ul) were added to 2.375 ml of
0.1M potassium phosphate buffer (pH 7.4) in glass test tubes. 
Approximately O.lg (tip of small spatula) of sodium dithionite was added to 
the tubes and mixed by inverting. The mixture was divided into two 1.0 
ml plastic cuvettes (10 mm path length). The cuvettes were placed into 
the spectrophotometer and a  baseline was recorded between 350-490 nm. 
The sample was saturated with 30-40 bubbles of carbon monoxide (CO) a t 
a rate of about 1 bubble/second. The sample cuvette was returned to the 
spectrophotometer and the difference spectra was recorded a t 350-490nm. 
A peak usually occurred between 447-450nm. The microsomal content of 
cytochrome P-450 was determined from the difference in absorbance of the 
carbon monoxide complex of reduced cytochrome P-450 and the spectral 
contribution of reduced cytochrome P-450. The change in absorbance at 
450nm relative to 490nm was then converted to specific content of 
cytochrome P-450 using a molar extinction coefficient of OlmM1 cm'1 
(Haugen and Coon, 1976; Ryan et al., 1975). Cytochrome P-450 content was
49
determined utilizing the following formula: [(A450-490) observed - (A450-
490) baseline]/9 ImM'1 cm'1 = nmole P-450/volume of microsomes used 
[protein concentration (mg/ml)]. The final concentration was expressed as 
nmole cytochrome P-450/mg microsomal protein.
F. Cytochrome Be:
The microsomal content of cytochrome b5 was also determined by the 
method of Omura and Sato (1964). Microsomes (125ul) were added to 2.375 
ml of potassium phosphate buffer (0.1M, pH 7.4) in glass test tubes. 
Samples were mixed and divided into two 1.0 ml plastic cuvettes (10 mm 
path length) and the cuvettes were placed into the spectrophotometer 
(Shimadzu UV-visible) and a  baseline recorded between 350 and 490 nm. 
The sample cuvette was removed and 5 ul of freshly prepared NADH (30 
mg/ml) was added, mixed by inversion, placed back into the 
spectrophotometer, and scanned from 350-490 nm. A peak usually appeared 
a t 426 nm and a valley a t 409 nm. The concentration of cytochrome b5 in 
the microsomal suspension was determined from the NADH-reduced 
difference spectrum by using the millimolar extinction coefficient of 185 mM 
1 cm'1 for the absorbance difference between 426-409 nm. Cytochrome b5 
content was determined utilizing the following formula: [(A426-409) observed 
- (A426-409) baselinej/lSSmM'1 cm'1 = nmole cytochrome bs/volume of 
microsomes used [protein concentration (mg/ml)]. The final concentration 
was expressed as nmole cytochrome hjxag  microsomal protein.
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G. NADH cvtochrome-h. and NADPH Cvtochrome-C-Reductases: 
Reductase activities were assayed using the method of Phillips and Langdon 
(1962) as modified by Yasukochi and Masters (1976). The rate of 
cytochrome C reduction was followed spectrophotometrically a t 550 nM. The 
reaction mixture consisted of 2.5 ml of cytochrome C solution (31 mg 
cytochrome C; 17 ml of 1M potassium phosphate buffer (pH 7.4) diluted to 
50 ml with triple distilled water). The cytochrome C solution was brought 
to room temperature before use. The microsomal suspension was diluted 
1:10 with 0.125M KC1 and 5 ul was delivered into 4.0 ml plastic cuvettes 
containing 2.5 ml of cytochrome C solution. Reference and sample cuvettes 
were placed into the spectrophotometer and automatically balanced a t zero. 
The sample cuvette was removed and 10 ul of NADH (10 mg/ml) was 
added, the solution mixed by inversion, and returned to the 
spectrophotometer. The spectrophotometer was programmed in the kinetic 
mode and the reaction was monitored at 550 nm for 195 seconds. The 
specific activity of NADH cytochrome-b5-reductase was determined from 
AA/min using the millimolar extinction coefficient 29.5 mM'1 cm'1 for 
cytochrome C. Reductase activity = [AA/min] [2.5] [1000]/29.5 [0.005]: where
2.5 = volume in cuvette, 1000 = conversion factor to nmoles, 29.5 = 
millimolar extinction coefficient and 0.0005 = vol. of microsomes. Final units 
were expressed as nmoles cytochrome-C/min/mg protein. NADPH 
cytochrome-C-reductase activity was determined in the same manner, except, 
NADPH was used instead of NADH.
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H. UDP-Glucuronos vltransferase:
UDP-glucuronosyltransferase (UDPGT) was assayed according to the method 
of Burchell and WeatheriU (1981). The reaction mixture consisted of 20mM 
UDP-glucuronic acid (UDPGA), pH7.4 (75ul); Tris maleate buffer/4- 
nitrophenol pH 7.4 which consists of: ImM 4-nitrophenol; 9.5M tris-maleate 
and 10 mM MgCl2 (125ul); distilled water (25ul); and microsomal 
preparation (25ul). The reaction mixture was added to both blank (0 min.) 
and reaction (10 min.) tubes. The reaction tubes were placed into a water 
bath a t 37 degrees C to equilibrate for 5 minutes. The reaction was then 
initiated by the addition of 75 ul of UDPGA. After incubation a t 37 degrees 
C for 10 minutes the reaction was terminated by the addition of 0.5 ml of 
ice-cold 0.5M trichloroacetic acid (TCA). The reaction tubes were then 
placed on ice for 5 minutes. The blank tubes were placed on ice and 75 ul 
of UDPGA was added to the tubes after precipitation of proteins by the 
addition of 0.5M TCA (0.5ml). All tubes were centrifuged a t 2000xg for 10 
minutes. A 400ul aliquot of the supernatant was removed from each tube 
and added to a second tube containing 400 ul of 2M NaOH, followed by the 
addition of 2.2 ml of distilled water. The tubes were centrifuged again a t 
2000g for 10 minutes and the absorbance of the supernatant was measured 
a t 405 nm against a  distilled water blank in order to assess the reduction 
in color (4-nitrophenol) caused by the formation of colorless product (4- 
nitrophenolglucuronide). The molar extinction coefficient of 4-nitrophenol a t 
pH > 10 is 18.1 x 103/mol-cm. Final units were expressed as nmole p- 
nitrophenol conjugated/min/mg microsomal protein.
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I. Glutathione-S-Transferase:
Glutathione-S-transferase was determined by the method of Habig et al., 
(1974). Microsomal supernatant was diluted 1:50 with 0.125M KC1 and 50 
ul was delivered into 4.0 ml plastic cuvettes containing a  mixture of 
potassium phosphate buffer (0.2 M monobasic pH 6.5) 1.5ml, 1.34ml of triple 
distilled water and lOOul of reduced glutathione (30mM). Reference and 
sample cuvettes were placed into the spectrophotometer and automatically 
balanced a t zero. The sample cuvette was removed and 10 ul of substrate 
(300 mM l-chloro-2, 4-dinitrobenzene dissolved in ethanol) was added, mixed 
by inversion and placed into the spectrophotometer which was programed 
in the kinetic mode. Changes in absorbance were monitored a t 340 nm for 
32 seconds and the specific activity of glutathione-S-transferase was 
calculated from AA/min using the millimolar extinction coefficient 9f 9.6 
m M 1 cm'1 for the formation of the glutathione conjugate. Glutathione-S- 
transferase activity was calculated using the formula: activity = AA/min 
[3.0][1000]/9.6 [0.05]: where, 3.0 = volume in cuvette, 1000 = conversion 
factor to nmoles, 9.6 = millimolar extinction coefficient and 0.05 = volume 
of microsomes. Final units were expressed as nmoles l-chloro-2, 4- 
dinitrobenzene conjugated/min/mg microsomal protein.
J. Aldrin Epoxidase:
Aldrin epoxidase activity was determined from the amount of dieldrin 
produced as described by Riviere (1985) with modifications. The reaction 
mixture contained 50mM potassium phosphate buffer (pH 6.8), 0.25 mM 
NADP + 2.5mM glucose-6-phosphate, 1 I.U/ml of glucose-6-phosphate
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dehydrogenase, 50uM aldrin, 2 mg/ml microsomal protein and triple distilled 
water to a  final volume of 1 ml in glass screw cap test tubes (13 x 100 
mm). Microsomes were usually diluted 1:10 (female rats) or 1:20 (male 
rats). Incubation was carried out under air in a constant temperature 
shaker bath a t 37° C for 15 minutes. The reaction was initiated by the 
addition of aldrin (0.1 ml) and stopped by the addition of acetone (0.2 ml). 
Five milliliters of iso-octane (2,2,4-trimethylpentane) were added to the 
tubes. The tubes were then capped and vortexed for 45 seconds. Dieldrin 
standards (0.01, 0.05, 0.1, 0.5 and 1.0 ppm) were prepared in iso-octane. 
Aliquots (1.0ml) were removed from the sample and standard tubes and 
pipetted into sample vials. The samples were then subjected to gas 
chromatography. Dieldrin was quantified using a Hewlett Packard 5880A 
chromatograph equipped with an ECD detector (63Ni) using a  Quadrex 
column (15m long, 0.53mm ID, phase 007-17) (Quadux Corp. New Haven, 
CT). The column detector and injector port tem peratures were 220-240°C 
(10 °/min), 300°, and 180 °C, respectively. The injection of samples was 
made in the splittess mode using a direct flask injection liner. The carrier 
gas was 5% methane in argon a t a flow rate of 11 ml/min. Carrier gas was 
also used for detector make-up to a total flow of approximately 30 ml/min. 
The amount of dieldrin in the extract was quantitated by peak area from 
the standard curve. Aldrin epoxidase activity was calculated using the 
formula: activity = [ppm dieldrin formed] [.005]/380,100 mg/ 15 min/ mg 
protein/ml, where .005 = molar concentration of aldrin; 380,100 mg = 1 




The deethylation of 7-ethoxycoumarin was measured fluorometrically by the 
method of Lake (1987), using an Aminco Bowman spectrofluorometer, model 
J4-896 1A (Silver Springs, Maryland). This assay was carried out a t 37°C 
for 10 minutes under air. The reaction mixture contained 50 mM Tris HC1 
buffer pH 7.8 (1.0 ml); 5 mM MgS04 (0.1 ml); 0.5 mM NADH (0.1 ml); 
5mM NADPH generating system which consisted of 10 ul glucose-6- 
phosphate dehydrogenase (2000 I.U.) and 1.0 ml of glucose-6-phosphate 
(lOOuM) (0.1 ml); 0.5 mM 7-ethoxycoumarin (0.5ml), microsomal preparation 
(equivalent to 2-3 mg protein ) (10 ul); and triple distilled water (0.1 ml) 
in  a  final volume of 2 ml. This reaction was initiated with the addition of 
substrate and terminated by the addition of 1 ml of zinc sulfate solution (5 
% w/v) followed by the addition of 1 ml of barium hydroxide solution. The 
tubes were centrifuged a t 2000g to remove precipitate. A 1.5 ml aliquot of 
the supernatant was removed and added to 3 ml of 0.5M glycine sodium 
hydroxide buffer pH 10.5. 7-Ethoxycoumarin-O-deethylase activity was 
measured by fluorescent emission (380 nm  excitation, 452 nm emission) and 
compared to an umbelliferone (7-hydroxycoumarin) standard (4.0 nM). 
ECOD activity was calculated according to the formula: activity = standard 
concentration (nmole) / standard AOD [1/10 min] [sample AOD]/mg 




The EROD assay was also carried out a t 37° C for 10 minutes under air 
and contained all of the above components in the reaction mixture except 
tha t 5mM 7-ethoxyresorufin (0.2ml) was used for the substrate and 
microsomal protein concentration was 0.3-0.5 mg/ml. The reaction was 
initiated by the addition of substrate and terminated in  the same manner 
as ECOD. The tubes were centrifuged a t 2000g to remove precipitate. A
1.5 ml aliquot of the supernatant was removed and added to 3 ml of 0.5M 
glycine sodium hydroxide buffer (pH 8.5). EROD activity was measured by 
fluorescent emission (535 nm excitation, 582 nm emission) and quantitated 
with 7-hydroxyresorufin as a standard (1000 pmoles). EROD activity was 
calculated using the formula: activity = standard concentration (pmole) / 
standard AOD [1/10 min] [sample AOD]/mg protein/ml. Final units were 
expressed as pmoles resorufin formed/min/mg microsomal protein.
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EXPERIMENT 4 -  EFFECT OF TTZ ON HEPATIC AND PULMONARY 
GLUTATHIONE CONCENTRATIONS IN RATS
OBJECTIVE:
1. To determine the effect of TTZ on glutathione concentration in the 
liver and lung of male and female rats.
MATERIALS AND METHODS:
A. Chemicals:
Glutathione (reduced form), maleic acid dimethyl ester (dimethyl maleate) 
and N-acetyl-L-cysteine were purchased from Sigma Chemical Co. (St. Louis, 
MO). All other chemical were of analytical grade or better and were 
obtained from commercial sources.
B. Glutathione Determination:
Glutathione was determined according to the method of Mitchell et al (1973) 
as modified by Droy (1987). Glutathione content was analyzed in adult 
male and female ra ts (3 ra ts  per group). All animals were dosed 
intraperitoneally and sacrificed by decapitation a t 1 hour post-dosing. 
Control animals were administered distilled water (10 ml/kg) and treated 
animals were administered TTZ a t doses of 1.25, 2.5, 5 and 10 mg/kg. 
Diethylmaleate (DEM) control animals were administered DEM (485 mg/kg) 
alone, and DEM-TTZ treated animals were administered DEM (485 mg/kg) 
30 minutes prior to dosing with TTZ (10 mg/kg). N-Acetyl-L-cysteine control
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animals were administered N-acetyl-L-cysteine (150 mg/kg) and N-acetyl-L- 
cysteine + TTZ treated animals were administered N-acetyl-L-cysteine (150 
mg/kg) minutes prior to dosing with TTZ (10 mg/kg).
Livers and lungs were removed from each of the animals and quick frozen 
in liquid nitrogen. Duplicate sample pieces weighing approximately O.lg 
were broken off from frozen liver and lung tissues, placed on ice in 2ml of 
2% sulfosalicylic acid and homogenized using a Tekmar tissue homogenizer. 
The homogenate was centrifuged a t 10,000g for 15 minutes. Fifty microliter 
aliquots of the supernatant were added to cuvettes containing 1 ml of 0.1M 
phosphate buffer (pH 7.4; 10 ml 0.2M monobasic sodium phosphate, 81 ml
0.2M dibasic sodium phosphate, diluted to 200 ml with distilled water). 
Standards were prepared by adding 1ml of 2mM reduced glutathione stock 
to 1 ml of distilled water (1000 uM standard). Other standards were 
prepared by diluting the stock glutathione (lOOuM and 500uM). A 20 ul 
aliquot of 5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB) (0.4M in phosphate 
buffer pH 7.4), was added to each tube, mixed and incubated for 15 minutes 
a t room tem perature (22-25 degrees C). Absorbances of samples and 
standards were measured a t a wavelength of 400 nm on a Shimadzu UV 
visible spectrophotometer and the date recorded.
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EXPERIMENT 5 -  EFFECT OF GLUTATHIONE DEPLETION BY
DIETHYLMALEATE (DEM) AND L-BUTHIONINE-(SR)- 
SULFOXAMINE (BSO) ON TTZ TOXICITY IN 
RATS
OBJECTIVES:
1. To determine the effect of DEM and BSO on TTZ toxicity in rats.
2. To determine the effects of DEM and BSO on resistance to TTZ in
rats.
3. To determine the effect of DEM on microsomal mixed function 
monooxygenase enzyme systems and enzyme activities in rats.
MATERIALS AND METHODS:
A. Effect of Diethvlmaleate (DEM) and L-buthionine-
(SR)-sulfoxamine (BSO) on TTZ Toxicity in Rats:
Male rats were administered DEM (485 mg/kg ip) 30 minutes prior to 
administration of TTZ a t doses of 1 and 5 mg/kg ip (10 animals per group). 
Control animals were administered DEM (485 mg/kg ip) only. A separate 
group of male rats was also administered BSO (1,786 mg/kg ip) 30 minutes 
prior to administration of TTZ a t doses of 1-5 mg/kg ip (3 rats per group). 
Female ra ts were administered DEM in the same m anner as male rats 
except that TTZ was administered a t concentrations of 0.5, 1, 1.25, 2.5, 5, 
and 10 mg/kg ip (6 rats per group). Immature ra ts (both sexes) were also 
administered DEM (485 mg/kg ip) 30 minutes prior to administration of
TTZ a t concentrations of 1 and 10 mg/kg ip a t 30 and 40 days of age (10 
rats per group). The animals were observed over a 24 hour period and 
clinical signs and mortality were documented. Postmortem examinations 
were performed and samples of lung and liver were taken for histological 
examination. In a  separate treatm ent, adult (male and female) and 
immature (male) rats (6 per group) were administered DEM (485 mg/kg ip) 
30 minutes prior to dosing TTZ (10 mg/kg ip) and sacrificed 1 hour post- 
dosing with TTZ. Livers and lungs were removed and weighed to determine 
if  TTZ had an effect on organ weights.
B. Diethvlmaleate (DEM) and L-Buthionine-(SR)-
Sulfoxamine (BSO) effects on Resistance in Adult 
Male R ats:
Male rats (6 per group) were administered a sublethal dose of TTZ (1 
mg/kg). Twenty-four hours later the same animals were administered DEM 
(485 mg/kg ip), 30 minutes prior to administration of TTZ (10 mg/kg ip). 
A separate group of mature male ra ts (3 rats per group) received a 
sublethal dose of TTZ (1 mg/kg) and 24 hours later they were administered 
BSO (1,786 mg/kg), 30 minutes prior to dosing them with TTZ (10 mg/kg 
ip). The animals were observed over a 24 hour period and clinical signs 
and mortality were documented, p-napthoflavone induced resistant male 
rats had been administered BNF (50 mg/kg in com oil ip) for three 
consecutive days and 24 horn’s after the last dose of BNF they were 
administered DEM (485 mg/kg) or BSO (1,786 mg/kg ip) 30 minutes prior 
to dosing with TTZ (10 mg/kg ip). The animals were observed in the same
60
manner as for TTZ resistant animals. Postmortem examinations were 
performed on all animals.
C. Effect of Diethvlmaleate (DEM) and 2-Thiotriazone 
(TTZ) on Hepatic Microsomal and Cytosolic Enzymes 
Adult (male and female) and immature (male) rats were administered DEM 
(485 mg/kg) 30 minutes prior to administration of a lethal dose of TTZ (10 
mg/kg ip). The animals were sacrificed by decapitation 1 hour after 
exposure of TTZ. Their livers were removed, weighed and placed on ice 
in ice-cold 1.15% KC1 buffered to pH 7.4 with 0.1M potassium phosphate 
buffer. Microsomes were isolated from the livers according to methods 
described previously. Control animals were dosed with DEM (485 mg/kg ip) 
and sacrificed after 1 hour. Animals induced with (3-napthoflavone (BNF) 
or phenobarbital (PB) were administered DEM (485 mg/kg ip) and 24 hours 
following the last dose of BNF or PB and sacrificed 1 hour after dosing of 
DEM. Microsomes were again prepared as previously described. All groups 
contained three animals and livers were pooled from all three animals. The 
following enzyme systems were analyzed in male, female and immature 
(male) rats: cytochromes P450 and b5, NADH cytochrome-b5 and NADPH 
cytochrome-C-reductases, g lu tath ione-S-transferase, and UDP- 
glucuronosyltransferase. Enzyme activities analyzed were aldrin epoxidase, 
EROD and ECOD.
D. STATISTICAL ANALYSIS:
Analysis of variance (general linear model) and Duncan’s multiple range 
post test was used to determine the differences due to treatm ents with TTZ 
and DEM-TTZ in combination on ra t liver and lung weights, liver to body 
weight ratios, and lung to body weight ratios; to compare the effects of TTZ 
and DEM-TTZ in combination on enzymes (cytochromes P-450 and 
reductases, UDP-glucuronosyltansferases, and glutathione-S-transferase) and 
enzyme activities (aldrin epoxidase, EROD and ECOD) in rats; and to 
compare the effects of TTZ and DEM-TTZ in connection on hepatic and 
pulmonary glutathione (GSH) concentrations (including diethylmaleate and 
N-acetyl-L-cysteine effects) in  rats. Differences were considered significant 
a t the p < 0.05 level (Steel and Torrie, 1980).
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TABLE 1









1 Male Oral 1.25 10
( i i t i i 2.5 10
i i i i i i 5 10
II i i t i 10 10
2 Female i i 2.5 5
i t i t i i 5 5
• i i t i t 10 10
l l t i i t 62.5 10
l i i t i t 100 10
i i i t n 125 10
i i i i n 250 10




i t i i i i 100 10
i i i i i i 1000 10
4 Male Intraperitoneal 1.25 6
l l i i i i 2.5 6
i t i i i t 5 6
5 Female i i 5 6
i i i i i i 10 5
i t i i i t 100 5
6 Immature 
(Male and Female)
i t 10 10
i i i i i i 100 10
i t i i i i 1000 10
All animals were observed over a 24 hr period.
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TABLE 2
DESCRIPTION OF GROUPS AND TREATMENTS FOR STUDY OF 
EFFECT OF AGE ON TTZ TOXICITY IN RATS.
Group No. Description TTZ0 (mg/kg) Age (days)
la Immature Male 10 30
2a i i l l 40
3a i t t i 45
4a i t t i 50
5a i t l l 55
6a Immature Female n 30
7a i i i t 40
8a t i i i 45
9a i t l l 50
10a i t i t 55
“ Administered via ip injection in distilled water.
TABLE 3
DESCRIPTION OF GROUPS AND TREATMENTS FOR STUDY OF TTZ 





Route of exposure 
Subgroup b Subgroup c
Second dose 
TTZ (mer/k£?)b
lb 1 day Oral Intraperitoneal 10
lc i t t t 100
2b 2" t t t t 10
2c t i n 100
3b 3" t t i t 10
3c t t i t 100
4b 1 week t t t i 10
4c t t t t 100
5b 2" t t t i 10
5c i t t t 100
6b 3" t t t t 10
6c t t t i 100
7b 4" t t t t 10
7c t t t t 100
8b 5" t t t t 10
8c t t t t 100
9b 6” t t t i 10
9c i t t t 100
10b 7" t t t t 10
10c t t ' t i 100
l ib 8" t t i t 10
11c t t t t 100
12b 9" t t t t 10
12c t t i t 100
8 All rats received TTZ a t a dose (sublethal) of 1 mg/kg (ip) on day 1. 
b Lethal dose administered in distilled water a t redosing time shown.
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TABLE 4
DESCRIPTION OF GROUPS AND TREATMENTS FOR STUDY OF 
EFFECT OF N-ACETYL-L-CYSTEINE (NAC) ON TTZ TOXICITY.
Group No. Group Name NAC8 (mg/kg) TTZ8 (mg/kg)
Id NAC-Control 150 _
2d NAC - TTZ 150 10
8 Administered via ip injection in distilled water.
TABLE 5
DESCRIPTION OF GROUPS AND TREATMENTS FOR ENZYME 
INDUCTION AND INHIBITION STUDY.
Group Group TTZa Enzvme modifiers(mg/kg/dav)
No. Name (mg/kg) PBb BNFC ANFd SKFe
le BNF-Control _ 50
2e PB-Control - 60 -
3e BNF-TTZ 10 - 50
4e PB-TTZ 10 60 -
5e BNF-ANF-TTZ 10 - 50 50
6e PB-SKF-TTZ 10 60 50
a Administered via gavage in distilled water.
b Phenobarbital sodium administered via ip injection in sterile water.
' J3-Napthoflavone administered via ip injection in corn oil. 
d a-Napthoflavone administered via ip injection in com oil 1 h r prior to 
oral gavage with TTZ. 
e SKF-525A administered via ip injection in distilled water 1 h r prior to 
oral gavage with TTZ.
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TABLE 6












I f Male 10 2 _
2f Female 10 2 -
3f Immature 10 2 -
4f Male 10 - 10
5f Female 10 - 10
6f Immature 10 - 10
a All rats were administered TTZ in distilled water via ip injection on day 
8 .
b 13-Estradiol (2mg/kg) administered in distilled water via ip injection for 
days 1-7.




DESCRIPTION OF GROUPS AND TREATMENTS FOR STUDY OF THE 






lg Estrus 10 62.5 100 1000 2000
2g Metestrus 10 62.5 100 1000 2000
3g Proestrus 10 62.5 100 1000 2000
4g Diestrus 10 62.5 100 1000 2000
a Administered via ip injection in distilled water.
TABLE 8
DESCRIPTION OF GROUPS AND TREATMENTS FOR ENZYME STUDY.
Group Group TTZa Enzvme modifiers (mer/kg/dav)
No. Name (mg/kg) BNFb PBC
lh Male-Control _ _
lh Male-TTZ 10 -
2h Male-BNF-Control - 50
2h Male-BNF-TTZ 10 50
3h Male-PB-Control - 60
3h Male-PB-TTZ 10 60
4h Female-Control - -
4h Female-TTZ 10 -
5h Immature-Male-Control - -
5h Immature-Male-TTZ 10 -
a Administered via ip injection in distilled water. 
b 13-Napthoflavone administered via ip injection in corn oil 
c Phenobarbital sodium administered via ip injection in sterile water.
TABLE 9












Ii Male Control . . m
2i Male TTZ1 1.25 - -
3i Male TTZ2 2.5 - -
4i Male TTZ3 5 - -
5i Male TTZ4 10 - -
6i Male DEM Control - 485 -
7i Male DEM-TTZ 10 485 -
8i Male NAC Control - - 150
9i Male NAC-TTZ 10 - 150
lOi Female Control - - -
H i Female TTZ1 1.25 - -
12i Female TTZ2 2.5 - -
13i Female TTZ3 5 - -
14i Female TTZ4 10 - -
15i Female DEM Control - 485 -
16i Female DEM-TTZ 10 485 -
17i Female NAC Control - - 150
18i Female NAC-TTZ 10 - 150
a 2-Thiotriazone administered via ip injection in distilled water. 
b Diethylmaleate administered via ip injection 0.5 h r prior to ip injection 
of TTZ.
0 N-Acetyl-L-cysteine administered via ip injection in distilled water 0.5 hr 
prior to ip injection of TTZ.
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TABLE 10
DESCRIPTION OF GROUPS AND TREATMENTS FOR STUDY OF 
DIETHYLMALEATE (DEM) AND L-BUTHIONINE-(SR)-SULFOXAMINE 





Test comDounds (mer/ke) 
TTZa DEMb BSOb
lj Male 485 .
2j t i - - 1,786
3j i t 1 485 -
4j t i 5 485 -
5j t i 1 - 1,786
6j i i 5 - 1,786
7j i i 1 970 -
8j Female 0.5 485 -
9j t i 1 485 -
10j t i 1.25 i i -
l l j t t 2.5 i i -
12j i t 5 i t -
13j i i 10 t i -
14j Immature male 
(30 day old) 1 485
15j t t 10 i i -
16j Immature male 
(40 day old) 1 t t .
17j t i 10 i t -
18j Immature female 
(30 day old) 1 l l
19j t i 10 t i -
20j Immature Female 
(40 day old) 1 t i .
21j t t 10 t i -
a 2-Thiotriazone administered via ip injection in distilled water. 
b Diethylmaleate and L-buthionine-(SR)-sulfoxamine administered via ip 
injection 0.5 h r prior to ip injection of TTZ.
TABLE 11
DESCRIPTION OF GROUPS AND TREATMENTS FOR STUDY OF EFFECTS OF DIETHYLMALEATE 
(DEM) AND L-BUTHIONINE-(SR)-SULFOXAMINE (BSO) ON RESISTANCE.
Group
No.







Ik DEM-TTZ 1 _ 485 _ 10
2k BSO-TTZ 1 - - 1,786 10
3k BNF-DEM-TTZ - 50 485 - 10
4k BNF-BSO-TTZ - 50 - 1,786 10
a P-napthoflavone administered via ip injection in com oil.
b Diethylmaleate administered via ip injection 24 hr after ip injection of TTZ (sublethal dose) or 24 hr 
after the last dose of BNF and 0.5 h r prior to ip injection of a lethal dose of TTZ (10 mg/kg). 
c L-Buthionine-(SR)-sulfoxamine administered via ip injection 24 hr after ip injection of TTZ 
(sublethal dose)\or 24 hr after the last dose of BNF and 0.5 hr prior to ip injection of a lethal 
dose of TTZ (10 mg/kg). 
d 2-Thiotriazone administered via ip injection in distilled water (sublethal dose).
TABLE 12
DESCRIPTION OF GROUPS AND TREATMENTS FOR STUDY OF DIETHYLMALEATE (DEM) AND 2- 










Enzvme modifiers (me/ks) 
BNFC PBd
1L Male-DEM-Control 485
i i Male-DEM-TTZ 10 i i - -
2L Male-BNF-DEM - i i 50
i i Male-BNF-DEM-TTZ 10 t i 50 -
3L Male-PB-DEM - i t - 60
n Male-PB-DEM-TTZ 10 t i - 60
4L Female-DEM-Control - i t - -
i i Female-DEM-TTZ 10 i i - -
5L Immature Male- 
DEM-Control II i i
i t Immature Male- 
DEM-TTZ 10 t t _ _
a 2-Thiotriazone administered via ip injection in distilled water. 
b Diethylmaleate administered via ip injection 0.5 hr prior to ip injection of TTZ. 
c p-napthoflavone administered via ip injection in com oil. 
d Phenobarbital administered via ip injection in sterile water.
CHAPTER 5
RESULTS
EXPERIMENT 1 -  ACUTE TOXICITY OF TTZ IN RATS:
2-Thiotriazone (TTZ) is highly toxic to adult male ra ts causing 100% 
mortality when administered as a single oral dose of 10 mg/kg, (Table 13). 
The acute single oral dose LDr, was calculated to be 4.6 mg/kg. Maximum 
mortality produced by TTZ in adult female rats was 40% and an LD^ could 
not be determined. Immature rats showed no toxic response to TTZ a t any 
of the concentrations tested. Clinical signs of intoxication observed included 
severe respiratory distress, dyspnea, cyanosis, prostration or listlessness and 
ruffled fur. In ra ts that subsequently died, a white frothy nasal discharge 
was observed. These signs reached a maximum within 2-3 hours and death 
usually ensued, or the rats recovered. Clinical signs of intoxication were 
similar in female rats but lasted for longer periods of time (4-24 hours). 
Clinical signs of intoxication were not apparent in  immature rats. 
Macroscopic lesions observed in affected animals were mottling of the lungs, 
and pulmonary edema and effusion.
Administration of a single dose of TTZ (5 mg/kg) intraperitoneally (ip) 
produced 100% mortality in adult male ra ts (Table 14). Compared to oral 
treatment, ip administration of TTZ to adult male rats caused twice the 
mortality a t the same dose. The acute single dose LDgo was calculated to
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TABLE 13























3 Im m ature 10 0/10 0
(both sexes) 100 0/10 0
1000 0/10 0
>1000
a Confidence interval (95%) 
b N.D.= not determined
TABLE 14






















a Confidence interval (95%)
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be 1.4 mg/kg. Adult female and immature ra ts did not respond to ip 
administration of TTZ (0% mortality). Clinical signs of intoxication observed
in  adult male and female ra ts  were the same as clinical signs observed in
oral treatm ent, but im m ature rats did not show any signs of intoxication.
Macroscopic lesions observed in  affected animals were also the same as




Histopathologic evaluation of rats treated with TTZ showed no hepatic 
structural alterations but marked changes were observed in the lungs of 
treated rats. Macroscopic lesions included pulmonary edema, effusion and 
mottling of the lungs. The normal appearance of adult male ra t lung is 
shown in Figure 2. Light microscopic examination of adult male ra t lungs 
after 1 hour exposure (10 mg/kg ip) showed acute interstitial and 
perivascular edema (Figure 3). The edema fluid was largely restricted to 
areas around the blood vessels. Edema was also noted around the 
bronchioles with some seepage into the alveoli. Within the perivascular 
bundles, there was substantially more fluid in the loose periarterial 
interstitium  than around airways, and more edema was observed around 
larger bundles. This edema was associated with mild interstitial 
inflammatory response with minimal numbers of neutrophils, macrophages 
and lymphocytes. Peak response to TTZ occurred within 1 hour and there 
were no marked differences in the amounts of edema observed a t 2 hour 
(Figure 4) post-dosing. Animals usually died within 2 to 3 hours, or they 
recovered with no noticeable histopathological effects.
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Figure 2 . Photom icrograph o f  a  control m ale rat lung , show ing  
a connected bronchovascular bundle w ith  bronchiole, 
a = bronchiole ; b  = artery ; c = alveoli. Stained  
w ith  hem otoxylin-eosin ; x  109.
Figure 3 . Photom icrograph o f  broncho vascular bundle o f  a male 
rat after 1 hr exposure to TTZ (10 mg/kg), 
a = bronchiole ; b  = artery ; c = perivascular edema; 
d = interstitia l edema. Note preponderance of  
edem a around blood vessels. Stained w ith hemotoxylin- 
eosin  ; x 83.
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Figure 4 . Photom icrograph o f bronchovascular bundle o f a male 
rat after 2 hr exposure to TTZ (10 mg/kg), 
a = bronchiole ; b  = artery ; c  = perivascular edema; 
d = interstitial edem a. Note preponderance o f edema 
around blood vessels. Stained w ith hem otoxylin-eosin ; 
x 83.
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A section of control female ra t lung is shown in Figure 5. Female rats 
exhibited the same response 1 hour after exposure, but the effects were 
milder (Figure 6). Female ra t lungs were less edematous, with relatively 
smaller quantities of edema in and around blood vessels compared to male 
ra t lungs after 1 hour exposure (Figure 3). There was no interstitial edema 
or edema around peribronchial spaces. There was also no inflammatory 
response to TTZ observed in female ra t lung. However, perivascular edema 
was apparent. Histopathologic findings observed in both male and female 
rats were consistent with macroscopic observations and clinical signs of 
intoxication.
Results also showed that TTZ did not affect liver weights and liver to body 
weight ratios in male, female or immature male rats following 1 hour 
exposure (10 mg/kg ip) (Table 15). However, lung weights and lung to body 
weight ratios were significantly increased 1 hour after exposure in male, 
female and immature male ra ts  (Table 16). In all cases lung weights of 
treated animals were significantly increased compared to control groups.
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Figure 5 . Photom icrograph o f a control fem ale rat lung, show ing  
a connected bronchovascular bundle w ith  a bronchiole, 
a = bronchiole ; b = artery ; c = alveoli. Stained w ith  
hem otoxylin-eosin ; x 109.
Figure 6 . Photom icrograph o f a bronchovascular bundle o f a 
fem ale rat after lh r  exposure to TTZ (10 mg/kg), 
a = bronchiole ; b = artery ; c  = perivascular edema. 
Stained w ith hem otoxylin-eosin ; x 148.
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TABLE 15
LIVER WEIGHTS (g) AND LIVER TO BODY WEIGHT RATIOS FOR 
RATS DOSED WITH TTZa.
Group Sex Liver Wt.(g) Liver to Body Wt. Ratio
lh  (Control) Male 13.12 ± 1.15b 3.98 ± 0.23
lh  (TTZ) f t 13.48 ± 1.06b 3.98 ± 0.17
4h (Control) Female 8.92 ± 1.11 3.47 ± 0.35
4h (TTZ) f t 8.57 ± 0.83 3.32 + 0.32
5h (Control) Immature 8.46 ±  0.90 4.50 ± 0.44‘
5h (TTZ) t t 8.34 ±  0.49 4.46 ± 0.41°
a All animals were administered TTZ (10 mg/kg ip). Data represent Mean 
± SD for n=6 animals.
b Significantly different (p<0.05) from female or immature male liver
weights (control and treated). 
c Significantly different (p<0.05) from male and female liver to body 
weight ratios (control and treated).
TABLE 16
LUNG WEIGHTS (g) AND LUNG TO BODY WEIGHT RATIOS FOR 
RATS DOSED WITH TTZa.
Group Sex Liver Wt.(g) Liver to Body Wt. Ratio
lh  (Control) Male 1.69 ±  0.27 0.51 + 0.07
lh  (TTZ) i t 2.07 + 0.28b 0.61 ± 0.08b
4h (Control) Female 1.22 + 0.11 0.48 ± 0.05
4h (TTZ) i i 2.04 + 0.39° 0.78 ±  0.14c
5h (Control) Immature 1.18 + 0.07 0.62 + 0.05
5h (TTZ) i i 1.46 ± 0.14d 0.78 ±  0.07d
a All animals were administered TTZ (10 mg/kg ip). Data represent 
Mean ± SD for n=6 animals. 
b Significantly greater (p<0.Q5) than  male controls. 
c Significantly greater (p<0.05) than female controls. 
d Significantly greater (p<0.05) than immature male controls.
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EXPERIMENT 2 -  INNATE AND DRUG INDUCED RESISTANCE TO TTZ 
IN RATS.
Results show that immature ra ts have a specific innate resistance to TTZ. 
All immature rats (male and female), tested from 30-45 days of age, were 
resistant to TTZ a t concentrations ranging from 10-1000 mg/kg when dosed 
either orally or ip. This resistance began to diminish by 45 days of age and 
by 50 days of age 20% mortality was produced (Table 17). In immature 
male rats that were 55 days of age 90% mortality was also produced by 
TTZ (10 mg/kg ip), thus showing th a t there was an age-related effect of 
TTZ. Male rats that were 50 days of age and older exhibited clinical signs 
of intoxication to TTZ while younger animals did not. Female immature 
rats (30-55 days old) did not respond (0% mortality) to TTZ, but clinical 
signs of intoxication were also observed in female immature rats tha t were 
50-55 days of age.
2-Thiotriazone itself produced resistance in adult male rats, after either 
prior exposure to a sublethal dose (1 mg/kg) or in animals th a t survived a 
toxic dose of TTZ (10 mg/kg). This resistance lasted for 9-10 weeks in rats 
that were redosed orally with a  toxic dose (10 mg/kg) (Table 18). 2-
Thiotriazone induced resistance was not dose dependent because there were 
no differences in response when rats were dosed with 10 or 100 mg TTZ/kg 
orally. However, there were differences in response based on the route of 
exposure. When resistant animals were redosed intraperitoneally with a 
toxic dose of TTZ (10 mg/kg) the resistance lasted for only 7 weeks 
compared to 9 weeks for resistant animals redosed orally with a toxic dose.
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TABLE 17







la Male 30 0/10 0
2a 40 0/10 0
3a 45 0/10 0
4a 50 2/10 20
5a 55 9/10 90
6a Female 30 0/10 0
7a 40 0/10 0
8a 45 0/10 0
9a 50 0/10 0
10a 55 0/10 0
All rats were dosed orally with a lethal dose of TTZ (10 mg/kg).
TABLE 18
EXTENT OF TTZ INDUCED RESISTANCE IN MALE RATS8.
Group Post-treatment time ORAL INTRAPERITONEAL
No. (days and weeks) No. dead/ % No. dead/ %
No. Tested Mortality No.Tested Mortality
lb ,lc 1 day 0/6 0 0/3 0
2b,2c 2 " 0/6 0 0/3 0
3b,3c 3 " 0/3 0 0/3 0
4b,4c 1 week 0/3 0 0/3 0
5b,5c 2 " 0/6 0 0/3 0
6b,6c 3 " 0/6 0 0/3 0
7b,7c 4 " 0/3 0 0/3 0
8b,8c 5 " 0/3 0 0/3 0
9b,9c 6 " 0/3 0 0/3 0
10b,10c 7 " 0/6 0 2/3 67
l ib 8 " 0/6 0
12b 9 " 2/3 67
13b 10 " 3/3 100
8 All rats were administered a sublethal dose of TTZ (1 mg/kg ip) and redosed at a specified time with
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Adult male rats administered N-acetyl-L-cysteine (Glutathione precursor) 
prior to administration of TTZ (10 mg/kg) were shown to be resistant to the 
toxic effects of TTZ (Table 19). Only 30% mortality was produced in these 
animals, but clinical signs of intoxication were apparent in all animals 
tested. These signs lasted for longer periods of time and in animals that 
died, toxicity occurred after 6-8 hours post-dosing.
P-Napthoflavone induction of the microsomal mixed function monooxygenase 
enzyme system also produced resistance to TTZ in male ra ts (Table 20). In 
fact, no mortality was observed and none of the typical responses (clinical 
signs of intoxication and macroscopic lesions) were observed in BNF-induced 
rats administered TTZ (10 mg/kg) either orally or ip. The only symptom 
observed was ruffled yellow fur. Phenobarbital induction did not produce 
a noticeable increase or decrease in the toxicity in adult male rats. 2- 
Thiotriazone produced 70-100% mortality in phenobarbital induced rats and 
this mortality was dose-dependent. The administration of inhibitors such 
as a-napthoflavone did not affect BNF induced resistance in male rats (0% 
mortality). SKF-525A (inhibitor) did not increase or decrease the toxic 
effects of TTZ when administered to phenobarbital induced animals (Table 
21). There was a  slight decrease in mortality from 70-60% in animals 
induced with phenobarbital and administered SKF-525A prior to 
administration of TTZ (10 mg/kg ip).
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TABLE 19
EFFECT OF N-ACETYL-L-CYSTEINE (NAC) ON 2-THIOTRIAZONE 





No. dead/No. Tested % Mortality
Id 150 0 0/3 0
2d 150 10 2/6 33




EFFECT OF BETA-NAPTHOFLAVONE (BNF) AND 
PHEONBARBITAL (PB) INDUCTION ON 2-THIOTRIAZONE (TTZ) 
TOXICITY IN ADULT MALE RATS.
ENZYME MODIFIERS
TTZa BNFb PBC




8 All animals were administered TTZ orally.
b B-Napthoflavone (50 mg/kg) administered via ip injection in corn oil. 




EFFECT OF ENZYME INDUCTION AND INHIBITION ON 2- 
THIOTRIAZONE (TTZa) TOXICITY IN ADULT MALE RATS.
Group Treatment No. Dead/No. Tested % Mortality
le BNFb Control 0/5 0
2e PBb Control 0/5 0
3e BNFb-TTZ 0/10 0
4e PB-TTZ 7/10 70
5e BNF-ANFb-TTZ 0/10 0
6e PB-SKFb-TTZ 3/5 60
° All animals were administered TTZ (10 mg/kg orally), except groups le  
and 2e.
b fi-Napthoflavone (BNF) was administered ip (50 mg/kg); phenobarbital 
(PB) was administered ip (60 mg/kg); a-Napthoflavone (ANF) was 
administered ip (50 mg/kg); SKF525A (SKF) was administered ip 
(50 mg/kg). For dosing protocol see Table 5.
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The administration of sex steroids (P-estradiol or testosterone) did not affect 
the toxicity of TTZ in adult male ra ts (90% mortality) and immature rats 
(0% mortality). However, 60% mortality was produced in adult female rats 
(Table 22). Female rats responded differently when administered TTZ on 
different days of the week. Variation in responses (mortality) ranged from 
20% on Wednesday and Friday to 60% on Monday and Tuesday and 100% 
on Thursday (Table 23). The effect of changes in the estrous cycle (hormone 
levels) on toxicity in adult female rats was monitored (Table 24). Variations 
in toxic response were still observed in adult female rats th a t were in the 
same stage of estrus, and the responses were not dose-dependent. The 
highest mortality observed when rats were in estrus was 50% a t 2000 
mg/kg. When they were in metestrus it was 50% a t 100 mg/kg, in 
proestrus it  was 60% a t 62.5 mg/kg and, in diestrus it was 30% a t 2000 
mg/kg.
TABLE 22







No. Dead/No. Tested % Mortality
I f Male 9/10 90
2f,5f Female 6/10 60 6/10 60
3f,6f Immature 0/10 0 0/10 0
(Both sexes)
a All rats were administered TTZ ip. 
b B-Estradiol was administered ip (2 mg/kg). 
c Testosterone was administered ip (10 mg/kg). 





EFFECT OF DOSING ADULT FEMALE RATS WITH 2-THIOTRIAZONE 
(TTZ“) ON DIFFERENT DAYS OF THE WEEK.






• All ra ts were administered TTZ (62.5 mg/kg) orally. Animals th a t died 
did so within a 24 hr observation period.
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TABLE 24
VARIATION IN TOXICITY OF 2-THIOTRIAZONE (TTZ) AT 
DIFFERENT STAGES OF THE ESTROUS CYCLE IN FEMALE RATS0
Group Group TTZ (mer/ke)b
Name 10 62.5 100 1000 2000
No. Dead/No. Tested
lg Estrus 3/10 0/10 1/7 1/10 4/8
2g Metestrus 1/10 0/10 5/10 1/10 4/10
3g Proestrus 1/10 6/10 0/7 0/10 1/10
4g Diestrus 2/10 1/10 2/10 1/10 3/10
0 All rats were administered TTZ orally.
b All animals tha t died did so within a 24 hr observation period.
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EXPERIMENT 3 -  EFFECT OF TTZ ON HEPATIC MICROSOMAL AND
CYTOSOLIC ENZYMES AND ENZYME ACTIVITIES 
IN RATS.
2-Thiotriazone did not affect cytochrome P-450 content in adult male, 
immature male, (J-napthoflavone (BNF) induced or phenobarbital induced 
male rats, but it was significantly increased in adult female rats (Table 25). 
Cytochrome bs content (Table 26), NADPH cytochrome-C-reductase activities 
(Table 27), and glutathione-S-transferase activities (Table 28) were generally 
unaffected by TTZ treatm ent in adult (male and female) and immature male 
rats. NADH cytochrome b5-reductase activity in immature ra ts was 
significantly lower than  activity in non-induced male and female rats (Table 
29). UDP-glucuronosyltransferase (UDPGT) activity in adult female and 
immature male rats was significantly decreased, while activity in adult, 
BNF and PB induced male rats was not affected (Table 30). Cytochrome 
P-450 content in BNF and PB induced male rats was significantly higher 
than in non-induced rats (male, female and immature) (Table 25). The P- 
450 content of PB induced rats was also significantly higher than in BNF 
induced rats.
The effect of TTZ on cytochrome P-450 in  induced and non-induced male 
rats is shown in Figure 7. Cytochrome P-450 content in both PB and BNF 
induced rats was significantly increased, while cytochrome b5 content was 
generally unaffected in PB and BNF induced male rats (Figure 8). PB 
induced control and TTZ treated ra ts had significantly lower NADH
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TABLE 25
EFFECT OF 2-THIOTRIAZONE (TTZ) ON HEPATIC CYTOCHROME P- 
450 CONTENT IN INDUCED AND NON-INDUCED RATS8.
Cytochrome P-450 (nmoles/mg microsomal protein)
GROUP CONTROL TTZ
lh  (Male) 0.672 ± 0.049 0.718 ± 0.170
4h (Female) 0.456 ± 0.113 0.585 ± 0.044b
5h (Immature Male) 0.562 ± 0.230 0.487 ± 0.243
2h (Male BNF Induced) 0.934 ± 0.191° 0.899 ± 0.206°
3h (Male PB Induced) 1.534 ± 0.405°d 1.584 ± 0.338°,d
8 Data represent Mean ± SD for n=5 groups of 3 pooled livers per
group.
b Significantly different (p<0.05) from female controls.
c Significantly different (p<0.05) from non-induced animals.
d Significantly different (p<0.05) from male BNF induced animals.
For dosing protocol see Table 8.
TABLE 26
EFFECT OF 2-THIOTRIAZONE (TTZ) ON HEPATIC CYTOCHROME B5 




lh  (Male) 0.223 ± 0.049 0.236 ± 0.055
4h (Female) 0.214 ± 0.069 0.228 ± 0.058
5h (Immature Male) 0.174 ± 0.066b 0.160 ± 0.072b
2h (Male BNF Induced) 0.310 ± 0.125 0.268 ± 0.032
3h (Male PB Induced) 0.268 ± 0.059 0.281 ± 0.033
8 Data represent Mean ± SD for n=5 groups of 3 pooled livers per 
group.
b Significantly different (p<0.05) from non-induced (male and female) and 
PB and BNF induced rats.
For dosing protocol see Table 8.
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TABLE 27
EFFECT OF 2-THIOTRIAZONE (TTZ) ON HEPATIC MICROSOMAL 
NADPH CYTOCHROME-C-REDUCTASE ACTIVITY CONTENT IN 
INDUCED AND NON-INDUCED RATS8.
NADPH cytochrome-C-reductase 
(nmoles reduced/min/mg microsomal protein)
GROUP CONTROL TTZ
lh  (Male) 119.432 ± 32.687 129.481 ± 50.869
4h (Female) 107.254 ± 38.119 105.605 ± 29.083
5h (Immature Male) 101.884 ± 30.406 94.336 ± 17.163
2h (Male BNF Induced) 85.022 ± 30.227 89.224 ± 29.551
3h (Male PB Induced) 149.046 ± 55.532 210.522 ± 104.363b
8 Data represent Mean ± SD for n=5 groups of 3 pooled livers per 
group.
b Significantly different (p<0.05) from immature male and female control 
and treated rats.
For dosing protocol see Table 8.
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TABLE 28
EFFECT OF 2-THIOTRIAZONE (TTZ) ON HEPATIC CYTOSOLIC 
GLUTATHIONE-S-TRANSFERASE ACTIVITY IN INDUCED AND NON­
INDUCED RATSa.
Glutathione-S-transferase 
(nmoles 1 chloro-2,4 dinitrobenzene 
conjugated/min/mg microsomal protein)
GROUP CONTROL TTZ
lh  (Male) 1701.066 ± 502.263 1783.790 ± 493.839
4h (Female) 1480.552 ± 707.729 1368.984 ± 734.334
5h (Immature Male) 1579.632 ± 332.546 1370.162 ± 224.365
2h (Male BNF Induced) 1571.626 ± 386.389 1724.722 ± 323.825
3h (Male PB Induced) 2105.576 ± 468.469 2141.044 ± 702.964
a Data represent Mean ± SD for n=5 groups of 3 pooled livers per 
group.
For dosing protocol see Table 8.
TABLE 29
EFFECT OF 2-THIOTRIAZONE (TTZ) ON HEPATIC MICROSOMAL 
NADH CYTOCHROME-B5-REDUCTASE ACTIVITY IN INDUCED AND 
NON-INDUCED RATSa.
NADH cytochrome-b5-reductase 
(nmoles reduced/min/mg microsomal protein)
GROUP CONTROL TTZ
lh  (Male) 512.030
4h (Female) 533.526
5h (Immature Male) 373.316
2h (Male BNF Induced) 483.310
3h (Male PB Induced) 244.832
54.643 526.434 ± 139.828
167.126 617.310 ± 91.387
111.214f,B 329.194 ± 85.296fB
132.240 499.236 ± 148.890
59.575bc 271.626 ± 86.491dc
8 Data represent Mean ± SD for n=5 groups of 3 pooled livers per 
group.
b Significantly different (p<0.05) from non-induced male and female 
controls.
0 Significantly different (p<0.05) from male BNF controls.
d Significantly different (p<0.05) from non-induced male and female TTZ
treated animals.
8 Significantly different (p<0.05) from male BNF TTZ treated animals.
f Significantly different (p<0.05) from male and female controls.
8 Significantly different (p<0.05) from male and female TTZ treated rats.
For dosing protocol see Table 8.
TABLE 30
EFFECT OF 2-THIOTRIAZONE (TTZ) ON HEPATIC MICROSOMAL 
UDP-GLUCURONOSYL TRANSFERASE ACTIVITY IN INDUCED AND 
NON-INDUCED RATS°.
UDP-glucuronosyltransferase 
(nmoles p-nitrophenol conjugated 
/min/mg microsomal protein)
GROUP CONTROL TTZ
lh  (Male) 1.309 ± 0.871 0.968 ± 0.542
4h (Female) 3.269 ± 1.118 1.727 ± 0.381b
5h (Immature Male) 1.460 ± 0.543 0.618 ± 0.533c
2h (Male BNF Induced) 1.573 ± 0.847 1.685 ± 0.690
3h (Male PB Induced) 1.080 ± 0.229 1.137 ± 0.304
a Data represent Mean ± SD for n=5 groups of 3 pooled livers per 
group.
b Significantly different (p<0.05) from female control values.
0 Significantly different (p<0.05) from immature male control values. 
For dosing protocol see Table 8.
OONTROL TTZ BNFC BN FT PBC PBT
Figure 7 . E ffect o f TTZ on  hepatic m icrosom al cytochrom e P-450 
conten t in  induced and non-induced rats. TTZ = 
2-thiotriazone ; BNFC & P-napthoflavone induced  ; 
BNFT es P-napthoflavone induced + TTZ ; PBC = 
phenobarbital induced  ; PBT = phenobarbital induced  
+ TTZ . For dosing protocol see  table 8.






















CONTROL TTZ BNFC BN FT PBC PBT
Figure 8 . E ffect o f TTZ on  h ep atic cytochrom e ha con ten t in
induced  and non-induced m ale rats. For id en tifica tion  
o f abbreviations , see  F igure 7 . For dosing protocol 
see  Table 8 .
107
cytochrome-b5-reductase activities than non-induced (male, female and 
immature) and BNF induced (control and TTZ treated) ra ts (Table 29; 
Figure 9). Glutathione-S-transferase (Figure 10), NADPH cytochrome-C- 
reductase (Figure 11) and UDP-glucuronosyltransferase (Figure 12) activities 
were not significantly different (increased and decreased) from non-induced 
male rats.
Aldrin epoxidase (Table 31), 7-ethoxyresorufin-0-deethylase (Table 32) and 
7-ethoxycoumarin-0-deethylase (Table 33) activities were not affected by TTZ. 
However, aldrin epoxidase activity in female rats was significantly lower 
than male and immature male rats. Aldrin epoxidase EROD and ECOD 
activity in relation to cytochrome P-450 content was increased approximately 
two-fold in both control and TTZ treated female and immature male rats. 
These activities were also slightly higher in  male (non-induced), BNF 
induced male rats and slightly lower in PB induced male rats in relation 
to cytochrome P-450 content. Aldrin epoxidase (AE) and 7-ethoxycoumarin- 
0-deethylase (ECOD) activities in both PB and BNF induced male rats were 
significantly higher than those in non-induced animals (Tables 31 and 32; 
Figures 13 and 14).
7-Ethoxyresorufin-O-deethylase (EROD) activity in both BNF and PB induced 
rats was also significantly higher than activity in non-induced rats (Table 
32; Figure 15). Also, both EROD and ECOD activities in BNF induced 
























CONTROL TTZ BNFC BNFT PBC PBT
E ffect o f TTZ on  h ep atic  m icrosom al NADH cytochrom e* 
b,-reductase activ ity  in  ind uced  and non-induced m ale 
rats. F or id en tifica tion  o f  abbreviations see  F igure 7. 
For dosin g protocol, see  T able 8 . * S ign ifican tly  
d ifferen t (p < 0.05) from  con tro ls .
CONTROL TTZ BNFC BNFT PBC PBT
Figure 10 . E ffect o f TTZ on  h ep atic cy toso lic  glutathione-S-
transferase activ ity  in  induced  and non*induced m ale 
rats. For id en tifica tion  o f abbreviations, see  F igure 7. 
For dosing protocol see  Table 8 .
CONTROL TTZ BNFC BNFT PBC PBT
F igure 11 . E ffect o f TTZ on h ep atic m icrosom al NADPH
cytochrom e-C -reductase activ ity  in  induced and non- 
induced m ale rats. For id en tification  o f  abbreviations, 
see  F igure 7 . For dosing protocol see  Table 8 .
I l l
CONTROL TTZ BNFC BN FT PBC PBT
Figure 12 . E ffect o f TTZ on h ep atic m icrosom al UDP-
glucuronosyltransferase a ctiv ity  in  ind uced  and non- 
induced  m ale rats. For id en tifica tion  o f abbreviations, 
see  F igure 7 . For dosing protocol see  T able 8 .
TABLE 31
EFFECT OF 2-THIOTRIAZONE (TTZ) ON HEPATIC MICROSOMAL 
ALDRIN EPOXIDASE ACTIVITY IN INDUCED AND NON-INDUCED 
RATS8.
Aldrin epoxidase 
nmoles dieldrin formed/min/mg/microsomal protein 
(nmoles dieldrin formed/min/nmole P-450)
GROUP CONTROL TTZ
lh  (Male) 1.609 ± 0.965 1.414 ± 0.926
(2.609 ± 1.956) (2.261 ± 1.860)
4h (Female) 0.241 ± 0.287b 0.238 ± 0.234c
(0.555 ± 0.574) (0.421 ± 0.446)
5h (Immature Male) 1.933 ± 0.352 1.994 ± 0.819
(4.078 ± 2.233) (5.260 ± 3.923)
2h (Male BNF Induced) 0.674 ± 0.269d 0.474 ± 0.114e
(0.746 ± 0.231) (0.538 ± 0.122)
3h (Male PB Induced) 5.854 ± 1.399f 6.308 ± 1.109B
(4.297 ± 2.187) (4.104 ± 1.037)
8 Data represent Mean ± SD for n=5 groups of 3 pooled livers per 
group.
b Significantly lower (p<0.05) than male, immature male and induced 
male controls.
c Significantly different (p<0.05) than  male immature male and induced 
male TTZ treated animals. 
d Significantly lower (p<0.05) than non-induced male and immature male 
controls.
e Significantly lower (p<0.05) than non-induced male and immature male 
TTZ treated animals. 
f Significantly higher (p<0.05) than non-induced male, female, immature 
male and BNF induced male controls. 
g Significantly higher (p<0.05) than non-induced male, female, immature 
male and BNF induced male TTZ treated animals 
For dosing protocol see Table 8.
TABLE 32
EFFECT OF 2-THIOTRIAZONE (TTZ) ON HEPATIC MICROSOMAL 7-ETHOXYRESORUFIN-O- 
DEETHYLASE (EROD) ACTIVITY IN INDUCED AND NON-INDUCED RATSa.
EROD
pmoles resorufin formed/min/mg/microsomal protein 
(pmoles resorufin formed/min/nmole P-450)
GROUP CONTROL TTZ
lh  (Male) 116.558 ± 63.918 
(166.595 ± 76.932)
142.334 ± 87.806 
(184.884 ± 74.934)
4h (Female) 72.870 ± 52.751 
(148.511 ± 71.547)
60.042 ± 33.922 
(107.111 ± 56.903)
5h (Immature Male) 108.158 ± 60.252 
(186.668 ± 40.687)
84.022 ± 55.498 
(162.257 ± 34.72)
2h (Male BNF Induced) 4738.238 ± 770.045b 
(5044.185 ± 891.752)
4726.094 ± 392.997° 
(5487.357 ± 1429.831)
3h (Male PB Induced) 619.638 ± 464.583bd 
(362.608 ± 220.852)
518.750 ± 284.721ce 
(318.209 ± 132.954)
a Data represent Mean ± SD for n=5 groups of 3 pooled livers per group. 
b Significantly different (p<0.05) from all non-induced controls.
c Significantly different (p<0.05) from all non-induced TTZ treated animals.
d Significantly different (p<0.05) from BNF induced controls.
e Significantly different (p<0.05) from BNF induced TTZ treated animals.
For dosing protocol see Table 8.
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TABLE 33
EFFECT OF 2-THIOTRIAZONE (TTZ ON HEPATIC MICROSOMAL 7- 
ETHOXYCOUMARIN-O-DEETHYLASE (ECOD) ACTIVITY IN INDUCED 
AND NON-INDUCED RATS'*.
ECOD
nmoles 7-hydroxycoumarin formed/min/mg/microsomal protein 
(nmoles 7-hydroxycoumarin formed/min/nmole P-450)
GROUP CONTROL TTZ
lh  (Male) 1.262 ± 0.234 
(1.941 ± 0.596)
1.312 ± 0.317 
(1.916 ± 0.713)
4h (Female) 0.949 ± 0.800 
(1.890 ± 1.217)
0.953 ± 0.798 
(1.619 ± 1.346)
5h (Immature Male) 1.933 ± 0.352 
(4.708 ± 2.233)
1.994 ± 0.819 
(5.260 ± 3.923)
2h (Male BNF Induced) 13.572 ± 1.628b,d 
(15.405 ± 3.094)
12.524 ± 2.428°° 
(14.289 ± 3.462)
3h (Male PB Induced) 5.158 ± 1.204b 
(3.538 ± 1.088)
5.216 ± 0.931° 
(3.506 ± 1.327)
a Data represent Mean ± SD for n=5 groups of 3 pooled livers per 
group.
b Significantly different (p<0.05) from all non-induced controls. 
c Significantly different (p<0.05) from all non-induced TTZ treated 
animals.
d Significantly different (p<0.05) from male PB induced controls. 
e Significantly different (p<0.05) from male PB induced TTZ treated 
animals.
For dosing protocol see Table 8.
CONTROL TTZ BNFC BNFT PBC PBT
F igure 13 . E ffect o f TTZ on  hepatic m icrosom al aldrin  epoxidase  
activ ity  in  induced and non-induced m ale rats. For 
id en tification  o f  abbreviations , see  F igure 7. For 
dosing protocol see  Table 8 . * S ign ifican tly  d ifferent 
(p < 0.05) from  controls.
1  CONTROL TTZ BNFC BNFT PBC PBT
2 z
F igure 14 . E ffect o f TTZ on  hepatic m icrosom al ECOD
activ ity  in  induced  and non-induced m ale rats. 
For id en tification  o f abbreviations, see  F igure 7. 
F or dosing protocol see  Table 8 .




























CONTROL TTZ Bf'FC BN FT PBC PBT
F igure 15 . E ffect o f TTZ on h ep atic m icrosom al EROD activ ity  in  
induced and non-induced m ale rats. For id en tification  
o f  abbreviations, see  F igure 7 . For dosin g protocol 
see  Table 8 . * S ign ifican tly  d ifferent (p < 0.05) from  
controls.
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rats had significantly higher AE activity than BNF induced rats. Female 
rats had significantly less AE activity than male and immature male rats.
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EXPERIMENT 4 -  EFFECT OF TTZ ON HEPATIC AND PULMONARY 
GLUTATHIONE CONCENTRATION IN RATS:
2-Thiotriazone produced a dose-dependent decrease in glutathione (GSH) 
content in the lung of adult male ra ts  (Table 34). The decrease in GSH 
(non-protein sulfhydryl) was observed a t 1 hour following exposure of male 
rats to 1.25, 2.5, 5, and 10 mg TTZ/kg (Table 34). All treatm ent values 
were depressed from control values (93.5, 80.1, 62.7 and 22.7% of control 
following 1.25, 2.5, 5, and 10 mg TTZ/kg respectively; Figure 16). Activity 
of the 1.25 mg/kg group was significantly different from th a t of the 10 
mg/kg group; activity of the 2.5 mg/kg group was different from th a t of the 
10 mg/kg group; activity of the 5 mg/kg group was different from th a t of the 
control, 1.25 and the 10 mg/kg groups; and the activity of the 10 mg/kg 
groups was different from th a t of the control, 1.25, and 5 mg/kg groups. 
TTZ also decreased non-protein sulfhydryl (NPDH) concentration in the 
lungs of adult female rats. Concentrations of GSH in the lungs of female 
rats a t 1 hour following exposure to 1.25, 2.5, 5, and 10 mg TTZ/kg were 
variable and the values were not significantly different from each other 
(Table 34). However all treatm ent values were depressed from control 
values, (24.2, 9.83, 30.7, and 53.8% of controls following 1.25, 2.5, 5 and 
10 mg/kg respectively; Figure 17). Glutathione concentration was not 
decreased in the liver of adult male (Figure 18) and female ra ts (Figure 19) 
except tha t 1.25 mg TTZ/kg caused a significant decrease in male liver 
GSH concentration when compared to controls and 10 mg TTZ/kg caused a 
significant decrease in female liver GSH concentration.
TABLE 34












li Control Male 5.806 ± 0.679b 100 2.186 ± 0.363* 100
2i 1.25 it 5.166 ± 0.713' 88.9 2.043 ± 0.295f 93.5
3i 2.5 l i 6.386 ± 0.806 117.7 1.750 ± 0.298' 80.1
4i 5 i» 6.906 ± 0.360" 118.9 1.370 ± 0.433b 62.7
5i 10 i t 5.883 ± 0.003 103.3 0.493 ± 0.144* 22.5
lOi Control Female 5.530 ± 0.3831 100 1.790 ± 0.3341 100
l l i 1.25 •• 5.130 ± 1.508 92.7 0.433 ± 0.647 24.2
12i 2.5 " 4.543 ± 0.965 82.2 0.176 ± 0.280 9.83
13i 5 t i 5.293 ± 0.408 95.7 0.550 ± 0.334 30.7
14i 10 n 3.550 ± 0.175k 64.2 0.963 ± 0.150m 53.8
* Data represent Mean ± SD for n=3 rats.
b Significantly different (p<0.05) from group 4i.
* Significantly different (p<0.05) from groups 3i, 4i, and 5i.
d Significantly different (p<0.05) from groups li and 2i.
* Significantly different (p<0.05) from groups 4i and 5i. 
f Significantly different (p<0.05) from group 5i.
1 Significantly different (p<0.05) from groups 4i and 5i. 
h Significantly different (p<0.05) from groups 2i and 5i.
1 Significantly different (p<0.05) from groups 2i, 3i, and 4i.
J Significantly different (p<0.05) from group 14i.
k Significantly different (p<0.05) from groups Hi and 13i.
1 Significantly different (p<0.05) from groups l l i ,  12i, 13i, and 14i. 
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Figure 16 . E ffect o f TTZ on glutath ione concentration  in  th e lung











Figure 17 . E ffect o f TTZ on glutath ione concentration  in  the lung  
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Figure 18 . E ffect o f TTZ on glutath ione concentration  in  the liver

















Figure 19 . E ffect o f TTZ on  glu tath ione concentration  in  the liver




The importance of GSH in TTZ induced pulmonary toxicity was tested by 
pretreatment of adult male and female rats with diethylmaleate (DEM). 
Both liver and lung GSH levels were depleted by DEM (Table 35). DEM 
itself depleted liver GSH in male rats to 10.5% of control and 25.9% of 
control in female rats; lung GSH levels were depleted to 7.1% of control in 
males and 22.1% of control in females. DEM+TTZ treatm ent depleted liver 
GSH in male rats to 1.09% of control and 18.3% of control in females; lung 
GSH concentration in male ra ts was depleted to 27.1% of control and 43.7% 
of control in female rats. These results provide evidence tha t GSH is 
involved in the metabolism and mechanism of action of TTZ.
Experiments with N-acetyl-L-cysteine (NAC), a  GSH precursor, were 
conducted to determine if  maintenance of GSH levels in ra t liver would be 
protective against TTZ-induced toxicity in male and female rats. 
Administration of NAC maintained liver GSH concentrations significantly 
above control values even in the presence of a toxic dose of TTZ (10 mg/kg) 
in male rats (158.2% of control for NAC treated rats and 149.5% of control 
for NAC-TTZ treated rats). Also, fiver GSH concentrations were maintained 
a t 89.8% of control values for NAC treated female rats (Table 36). Lung 
GSH concentrations were maintained in male rats a t 96.9% of controls for 
NAC treated rats (NAC controls) and 87% of control for NAC-TTZ treated 
rats. However, female lung GSH concentrations were significantly decreased 
to 33-43% of control. Both the effects of NAC and DEM on glutathione
TABLE 35












li Control Male 5.806 ± 0.679b 100 2.186 ± 0.263d 100
6i DEMC i t 0.610 ± 0.723c 10.5 0.156 ± 0.028° 7.1
7i DEM-TTZ t i 0.063 ± 0.109c 1.09 0.593 ± 0.909° 27.1
lOi Control Female 5.530 ± 0.383f 100 1.790 ± 0.334h 100
15i DEMC t t 1.436 ± 0.274s 25.9 0.396 ± 0.04T 22.1
16i DEM-TTZ 11 1.016 ± 0.290g 18.3 0.783 ± 0.1221 43.7
° Data represent Mean ± SD for n=3 rats.
b Significantly different (p<0.05) from male DEMC and DEM-TTZ liver.
c Significantly different (p<0.05) from male control liver.
d Significantly different (p<0.05) from male DEMC and DEM-TTZ lung.
e Significantly different (p<0.05) from male control lung.
f Significantly different (p<0.05) from female DEMC and DEM-TTZ liver.
g Significantly different (p<0.05) from female control liver.
h Significantly different (p<0.05) from female control lung.
For dosing protocol see Table 9.
TABLE 36












li Control Male 5.806 ± 0.679 100 2.186 ± 0.263 100
8i NACC i t 9.186 ± 0.402b 158.2 2.120 ± 0.415 96.9
9i NAC-TTZ i t 8.680 ± 0.222b 149.5 1.906 ± 0.197 87.2
lOi Control Female 5.530 ± 0.383 100 1.790 ± 0.330 100
H i NACC i i 4.963 ± 1.447 89.8 0.793 ± 0.344° 43.3
12i NAC-TTZ t i 5.043 ± 0.479 91.2 0.593 ± 0.575° 33.1
a Data represent Mean ± SD for n=3 rats. 
b Significantly different (p<0.05) from control male liver. 
c Significantly different (p<0.05) from control female lung. 
For dosing protocol see Table 9.
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concentrations in liver and lung of male ra ts are shown in  Figures 20 and 
21 and the effects of these compounds on female ra t glutathione 
concentrations are shown in Figures 22 and 23.
CONTROL DEMC DEMT NACC NACT
F igure 20 . G lutahione concen tration  in  the liver  o f m ale rats
exposed  to d iethylm aleate (DEMC) ; d iethylm aleate + 
TTZ (DEMT) ; N -aceytyl-L -cysteine (NACC) and  
N -acetyl-L -cysteine + TTZ (NACT). For dosing protocol 
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CONTROL DEMC DEMT NACC NACT
F igure 21 . G lutathione concen tration  in  the lung o f m ale rats
exposed  to d iethylm aleate (DEMC) ; d iethylm aleate + 
TTZ (DEMT) ; N -aceytyl-L -cysteine (NACC) and  
N -acetyl-L -cysteine + TTZ (NACT). For dosing protocol 
see  Table 9 . * = S ign ifican tly  d ifferent (p < 0.05) from  
control.
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CONTROL DEMC DEMT NACC NACT
Figure 22 . G lutathione concentration  in  the liver o f fem ale rats 
exposed  to d iethylm aleate (DEMC) ; d iethylm aleate + 
TTZ (DEMT) ; N -aceytyl-L -cysteine (NACC) and  
N -acetyl-L -cysteine + TTZ (NACT). For dosing protocol 
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CONTROL DEMC DEMT NACC NACT
Figure 23 . G lutathione concentration  in  the lun g o f fem ale rats 
exposed  to  d iethylm aleate (DEMC) ; d iethylm aleate + 
TTZ (DEMT) ; N -aceytyl-L -cysteine (NACC) and  
N -acetyl-L -cysteine + TTZ (NACT). For dosin g protocol 
see  Table 9 . * = S ign ifican tly  d ifferent (p < 0.05) from  
control.
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EXPERIMENT 5 -  EFFECT OF GLUTATHIONE DEPLETION BY
DIETHYLMALEATE (DEM) AND L-BUTHIONINE-(SR) 
SULFOXAMINE (BSO) ON TTZ TOXICITY IN RATS.
The toxicity of TTZ was markedly increased in  male, female and immature 
rats by diethylmaleate (DEM) pretreatment. DEM (485 mg/kg) itself did not 
produce toxicity in male rats but when administered at 970 mg/kg produced 
toxicity in 20% of the animals tested (Table 37). DEM (485 mg/kg) 
pretreatm ent of adult male rats dosed with a sublethal dose of TTZ (1 
mg/kg) produced 50% mortality. Adult male rats pretreated with DEM 
(970 mg/kg) and 1 mg TTZ/kg produced 88% mortality. Previously, no 
mortality was observed a t 1 mg TTZ/mg ip. Pretreatm ent of ra ts with DEM 
(485 mg/kg) produced 100% mortality in adult male ra ts dosed with TTZ (5 
mg/kg). L-Buthionine-(SR)-sulfoxamine (inhibitor of glutathione synthesis) 
pretreatment decreased the toxicity of TTZ in male ra ts and no mortality 
was observed (Table 38).
Pretreatm ent with DEM potentiated the toxicity of TTZ in adult female and 
immature rats. The combination treatm ent with DEM and TTZ caused 
66% mortality a t 1 mg TTZ/kg; 83% mortality a t 1.25 and 5mg TTZ/kg and 
100% mortality a t 2.5 and 10 mg TTZ/kg in female rats (Table 39). The 
response of immature male rats to TTZ was also potentiated by DEM 
pretreatment, whereby 90% mortality was observed in both 30 and 40 day 
old immature male ra ts after administration of 10 mg TTZ/kg. Immature 
female ra ts showed a similar response, in which 60% mortality was
134
TABLE 37
EFFECT OF DIETHYLMALEATE (DEM) PRETREATMENT ON 2- 
THIOTRIAZONE (TTZ) TOXICITY IN ADULT MALE RATS'1
Group DEM TTZ No. Dead/No. Tested % Mortality
No. (mg/kg) (mg/kg)
Ik 485 0 0/5 0
3k II 1 5/10 50
4k II 5 10/10 100
2k 970 0 1/5 20
5k i t 1 8/9 88
a All rats were administered DEM 0.5 h r prior to administration of TTZ.
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TABLE 38
EFFECT OF DIETHYLMALEATE (DEM) AND L-BUTHIONINE-(SR)- 
SULFOXAMINE (BSO) PRETREATMENT ON 2-THIOTRIAZONE (TTZ) 
TOXICITY IN MALE RATS'*.
DEMb BSO°
TTZ Group No. Dead % Group No. Dead/ %
(mg/kg) No. Tested Mortality No. Tested Mortality
1 3j 5/10 50 5j 0/3 0
5 4j 10/10 100 6j 0/3 0
a All rats were administered TTZ ip 0.5 hr after administration of DEM 
or BSO.
b DEM was administered ip (485) mg/kg). 
c BSO was administered ip (1,786 mg/kg).
For dosing protocol see Table 10.
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TABLE 39







No. Dead/No. Tested % Mortality
8k Female 0.5 485 0/6 0
9k m 1 4/6 66
10k n 1.25 5/6 83
I lk i t 2.5 6/6 100
12k i i 5 5/6 83
13k i t 10 6/6 100
All rats were administered DEM 0.5 hrs prior to administration of 
TTZ.
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observed in 30 day old female rats and 90% mortality was observed in 
those 50 days of age (Table 40). Clinical signs of intoxication observed in 
DEM + TTZ treated male, female and immature rats were the same as 
signs observed in TTZ (10 mg/kg) dosed male rats. However, clinical signs 
were more severe and occurred much faster (reached a maximum between 
0.5-1 hour). Death usually occurred within 1-1.5 hours in both adult and 
immature animals. Macroscopic lesions were also more severe (mottling of 
the lungs, pulmonary edema, effusion and large swollen lungs tha t filled 
the chest cavity).
Histopathologic evaluation of rats treated with DEM and TTZ combination 
showed no hepatic structural alterations. Diethylmaleate itself did not 
cause any structural alterations in the lungs of male or female rats (Figures 
24, 25). Histological changes observed in adult male ra ts pretreated with 
DEM and subsequently dosed with TTZ (10 mg/kg ip) were the same as 
responses observed in male rats exposed to TTZ (10 mg/kg) alone (Figure 
26). Histological changes observed were severe perivascular and interstitial 
edema. Edema was located principally around blood vessels with slight 
infiltration of neutrophils, macrophages and lymphocytes. This shows that 
DEM did not potentiate the toxic effects of TTZ in male rats. However, 
diethylmaleate (DEM) pretreatm ent did potentiate the effect of TTZ in adult 
female rats, whereby histological examination of lung tissue of female rats 
pretreated with DEM and subsequently dosed with TTZ (10 mg/kg) showed 
the exact same response as male rats dosed with TTZ (10 mg/kg) alone. 
Large areas of perivascular and peribronchial edema with some distension
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TABLE 40
EFFECT OF DEM PRETREATMENT ON TTZ TOXICITY IN 
IMMATURE RATS0.
Group Sex Age TTZ DEM No. Dead/ %
No. (days) (mg/kg) No. Tested Mortality
14k Male 30 1 485 0/10 0
15k n i t 10 i t 9/10 90
16k i t 40 1 M 0/10 0
17k i t i t 10 i t 9/10 90
18k Female 30 1 485 0/10 0
19k n i t 10 i i 6/10 60
20k i t 40 1 i i 0/10 0
21k t i i t 10 i i 9/10 90
a All rats were administered DEM 0.5 hrs prior to administration of 
TTZ.
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Figure 24 . Photom icrograph o f a bronchovascular bundle o f a m ale 
rat after 1 hr exposure to DEM (485 m g/kg), 
a = bronchiole; b = artery; c  = a lveoli. S tained w ith  
hem otoxylin-eosin; x  112.
F igure 25 . Photom icrograph o f a bronchovascular bundle o f a 
fem ale rat after 1 hr exposure to DEM (485 m g/kg), 
a = bronchiole ; b  = artery ; c = a lveoli. Stained w ith  
hem otoxylin-eosin; x 113.
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F igure 26 . Photom icrograph o f  bronchovascular bundle o f a m ale 
rat exposed  to  DEM (485 mg/kg) , 0.5 hr prior to  
adm inistration o f TTZ (10 mg/kg) , and 1 hr after  
treatm ent w ith  TTZ . a = bronchiole ; b = artery ; 
c = perivascu lar edem a ; d = in terstitia l edem a. 
Stained  w ith  hem otoxylin-eosin  ; x 83.
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into the alveoli (interstitial edema) and also mild interstitial inflammatory 
response (infiltration of neutrophils, macrophages and lymphocytes) were 
observed (Figure 27). These histopathological findings correlate well with 
toxicity data for DEM and TTZ in combination.
Results show th a t the DEM and TTZ combination did not affect liver 
weights and liver to body weight ratios in adult male and female rats but 
did significantly increase liver weights in immature male rats (Table 41). 
Liver to body weight ratios in immature rats were also significantly 
increased from those of the control group. Lung weights and lung to body 
weight ratios were significantly increased in male, female and immature 
male rats after exposure to DEM and TTZ in combination (Table 42). In 
all cases treated groups had significantly increased values compared to 
controls.
Effect of DEM and BSO on Resistance in Rats:
Diethylmaleate pretreatm ent reversed the resistance obtained in adult male 
rats by prior exposure to a sublethal dose of TTZ or survival from a toxic 
dose (TTZ induced resistance). Diethylmaleate pretreatm ent caused TTZ (5 
mg/kg) to be toxic to 100% of the resistant rats tested (Table 43). L- 
Buthionine-(SR)-sulfoxamine did not reverse the resistance and animals 
remained non-susceptible to TTZ. The resistance produced by BNF in adult 
male rats was also reversed by DEM pretreatm ent and subsequent dosing 
of a toxic dose of TTZ (5 mg/kg), producing 100% mortality in the BNF
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Figure 27 . Photom icrograph o f a bronchovascular bundle o f a
fem ale rat exposed  to DEM (485 mg/kg) , 0.5 hr prior to 
adm inistration o f TTZ (10 mg/kg) , and 1 hr after the 
treatm ent w ith  TTZ. a = bronchiole ; b = artery ; 
c = perivascular edem a ; d = in terstitia l edem a . 
Stained w ith  hem otoxylin-eosin  ; x 83.
TABLE 41
LIVER WEIGHTS (g) AND LIVER TO BODY WEIGHT RATIOS FOR 
RATS DOSED WITH DEM-TTZ COMBINATION®.
Group Sex Liver Wt.(g) Liver to 
Body Wt.Ratio
1L (DEM-Control) Male 11.47 ± 1.17° 3.34 ± 0.23
1L (DEM-TTZ) f t 13.22 ± 1.71° 3.90 ± 0.33®
4L (DEM-Control) Female 7.62 ± 0.80 2.92 ± 0.49
4L (DEM-TTZ) t t 8.35 ± 0.93 3.18 ± 0.46
5L (DEM-Control) Immature 7.18 ± 0.69 4.02 ± 0.07
6L (DEM-TTZ) f t 10.19 ± 1.90 5.34 ± 0.72b
® All rats were administered DEM (485 mg/kg) 0.5 hr prior to exposure 
to TTZ (10 mg/kg). Data represent Mean ± SD for n=6 animals. 
b Significantly different (p<0.05) from male DEM-Control body to liver 
wt. ratio.
c Significantly different (p<0.05) from immature male DEM-Control liver 
to body wt. ratio. 




LUNG WEIGHT AND LUNG TO BODY WEIGHT RATIOS FOR RATS 
DOSED WITH DEM-TTZ COMBINATION®.
Group Sex Lung Wt.(g) Lung to 
Body Wt. Ratio
1L (DEM-Control) Male 2.02 ± 0.47 0.59 ± 0.15
1L (DEM-TTZ) i i 5.19 ± 0.98b 1.53 ± 0.23c
4L (DEM-Control) Female 1.66 ± 0.54 0.64 ± 0.24
4L (DEM-TTZ) i t 3.95 ± 1.07d 1.49 ± 0.378
5L (DEM-Control) Immature 1.06 ± 0.13 0.59 ± 0.03
6L (DEM-TTZ) i i 2.81 ± 0.71r 1.48 ± 0.33B
a All rats were administered DEM (485 mg/kg) 0.5 h r prior to dosing 
with TTZ (10 mg/kg)ip. Data represent Mean ± SD for n=6 animals.
b Significantly increased (p<0.05) from male DEM-Control weight .
0 Significantly increased (p<0.05) from male DEM-Control liver to body
wt. ratio.
d Significantly increased (p<0.05) from female DEM-Control weights.
8 Significantly increased (p<0.05) from female DEM-Control lung to body 
weight ratios.
f Significantly increased (p<0.05) from immature DEM-Control weights.




EFFECT OF DIETHYLMALEATE (DEM) AND L-BUTHIONINE-(SR)- 
SULFOXAMINE (BSO) ON 2-THIOTRIAZONE (TTZ)8 INDUCED 
RESISTANCE IN ADULT MALE RATS.
Group Treatment No. Dead/No. Tested % Mortality
lk DEMb 6/6 100
2k BSO' 0/3 0
8 All rats were administered TTZ (5 mg/kg ip). 
b Administered diethylmaleate (485 mg/kg ip). 
c Administered L-Buthionine-(SR)-sulfoxamine (1,786 mg/kg ip).
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induced resistant rats tested (Table 44). BSO did not alter or effect the 
BNF induced resistance in rats. The route of exposure or administration 
of TTZ affected the toxicity of TTZ in BNF induced animals (Table 45). 
Oral administration of TTZ produced 83% toxicity and ip administration of 
TTZ produced 100% mortality (10% increase), which is consistent with 
increased toxicity with ip administration of TTZ. However, this was not 
observed with phenobarbital induced animals. All PB induced rats died 
with 30-45 minutes when treated with DEM + TTZ.
Effect of DEM and TTZ in combination on hepatic microsomal enzymes and 
enzyme activities in rats:
Diethylmaleate (DEM) and 2-thiotriazone (TTZ) combination did not 
significantly affect hepatic microsomal cytochromes P-450 (Table 46) or b5 
content (Table 47), NADH cytochrome-b5 (Table 48) and NADPH cytochrome- 
C-reductase activities (Table 49), glutathione-S-transferase activity (Table 50) 
and UDP-glucuronosyltransferase activity (Table 51) in non-induced female 
and immature rats. However, cytochrome P-450 content was significantly 
decreased in adult male rats (Table 46), whereas cytochrome b5 and all 
other activities were not affected. Both PB and BNF induced rats had 
significantly higher P-450 content than non-induced rats. Cytochrome P- 
450 content in PB induced ra ts administered both DEM and TTZ was 
significantly lower than DEM controls (Table 46). Cytochrome P-450 content 
in PB induced DEM control ra ts was also significantly higher than in BNF 
induced animals (Figure 28). Hepatic cytochrome b5 content in BNF induced
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TABLE 44
EFFECT OF DIETHYLMALEATE (DEM) AND L-BUTHIONINE (SR)- 
SULFOXAMINE ON fi-NAPTHOFLAVONE (BNF) INDUCED RESISTANCE 
TO 2-THIOTRIAZONE (TTZ) IN ADULT MALE RATS8.
Group TTZ DEM BSO BNF No. Dead/ %
(mg/kg) No. Tested Mortality
3k 10 485 50 6/6 100
4k 10 1786 50 0/3 0
8 All rats were administered TTZ 24 hrs after BNF induction 
and 0.5 h r after pretreatm ent with DEM or BSO
TABLE 45
EFFECT OF DIETHYLMALEATE (DEM) PRETREATMENT ON 13- 
NAPTHOFLAVONE (BNF) OR PHENOBARBETAL (PB) INDUCED ADULT 
MALE RATS WHEN ADMINISTERED 2-THIOTRIAZONE (TTZ) EITHER 
















Oral 0 0/5 0 0/6 0
i t 10 5/6 83 6/6 100
IP 0 0/5 0 0/6 0
t t 10 6/6 100 6/6 100
° All rats were administered TTZ 24 hrs after induction with BNF and 0.5 
h r after pretreatm ent with DEM. 
b 13-Napthoflavone (50 mg/kg) administered via ip injection. 
c Phenobarbital (60 mg/kg) administered via ip injection.
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TABLE 46
EFFECT OF DIETHYLMALEATE (DEM) AND 2-THIOTRIAZONE (TTZ) IN 
COMBINATION ON HEPATIC CYTOCHROME P-450 CONTENT IN 




1L (Male) 0.572 ± 0.065 0.370 ± 0.234b
4L (Female) 0.575 ± 0.193 0.360 ± 0.106
5L (Immature Male) 0.541 ± 0.198 0.481 ± 0.105
2L (Male BNF Induced) 0.952 ± 0.323° 0.876 ± 0.327°
3L (Male PB Induced) 1.706 ± 0.184cd 1.075 ± 0.271°'
a Data represent Mean ± SD for n=5 groups of 3 pooled livers per group.
b Significantly different (p<0.05) from male DEM-Controls.
c Significantly different (p<0.05) from non-induced DEM-Controls.
d Significantly different (p<0.05) from BNF induced DEM-Controls.
e Significantly different (p<0.05) from non-induced DEM-TTZ treated 
animals.
f Significantly different (p<0.05) from male PB induced DEM-Controls. 
For dosing protocol see Table 12.
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TABLE 47
EFFECT OF DIETHYLMALEATE (DEM) AND 2-THIOTRIAZONE (TTZ) IN 





1L (Male) 0.219 ± 0.027 0.184 ± 0.040
4L (Female) 0.218 ± 0.061 0.190 ± 0.033
5L (Immature Male) 0.250 ± 0.088 0.189 ± 0.045
2L (Male BNF Induced) 0.329 ± 0.081b 0.293 ± 0.082b
3L (Male PB Induced) 0.243 ± 0.059 0.242 ± 0.057
a Data represent Mean ± SD for n=5 groups of 3 pooled livers per group. 
b Significantly different (p<0.05) from male DEM-Controls and all DEM- 
TTZ treated animals.
For dosing protocol see Table 12.
TABLE 48
EFFECT OF DIETHYLMALEATE (DEM) AND 2-THIOTRIAZONE (TTZ) IN 
COMBINATION ON HEPATIC MICROSOMAL NADH CYTOCHROME-B5- 
REDUCTASE ACTIVITY IN INDUCED AND NON-INDUCED RATS°.
NADH cytochrome-b6-reductase 
(nmoles cytochrome-b5 reduced 
min/mg microsomal protein)
Group DEM-CONTROL DEM-TTZ
1L (Male) 468.366 ± 48.069 521.564 ± 279.899
4L (Female) 585.546 ± 115.481 499.968 ± 48.715
5L (Immature Male) 478.700 ± 80.485 478.760 ± 275.233
2L (Male BNF Induced) 526.076 ± 93.426b 587.562 ± 199.962
3L (Male PB Induced) 234.958 ± 40.493bc 304.246 ± 91.634
a Data represent Mean ± SD for n=5 groups of 3 pooled livers per group. 
b Significantly different (p<0.05) from non-induced DEM-Controls and DEM- 
TTZ treated animals. 
c Significantly different (p<0.05) from BNF induced DEM-Controls and BNF 
induced DEM-TTZ treated animals.
For dosing protocol see Table 12.
TABLE 49
EFFECT OF DIETHYLMALEATE (DEM) AND 2-THIOTRIAZONE (TTZ) IN 
COMBINATION ON HEPATIC MICROSOMAL NADPH CYTOCHROME-C- 
REDUCTASE ACTIVITY IN INDUCED AND NON-INDUCED RATS'1.
NADPH cytochrome-C-reductase 
(nmoles cytochrome-C reduced 
min/mg microsomal protein)
Group DEM-CONTROL DEM-TTZ
1L (Male) 128.194 ± 45.114 89.108 ± 17.501
4L (Female) 118.504 ± 40.582 83.152 ± 15.720
5L (Immature Male) 167.224 ± 128.862 102.213 ± 49.166
2L (Male BNF Induced) 142.868 ± 90.464 109.904 ± 61.908
3L (Male PB Induced) 285.888 ± 155.582b,c 118.164 ± 51.546
a Data represent Mean ± SD for n=5 groups of 3 pooled livers per group. 
b Significantly different (p<0.05) from non-induced DEM-Controls and DEM- 
TTZ treated animals. 
c Significantly different (p<0.05) from male BNF induced DEM-Controls and 
BNF induced DEM-TTZ treated animals.
For dosing protocol see Table 12.
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TABLE 50
EFFECT OF DIETHYLMALEATE (DEM) AND 2-THIOTRIAZONE (TTZ) IN 
COMBINATION ON HEPATIC CYTOSOLIC GLUTATHIONE-S- 





1L (Male) 1643.186 ± 362.269 1638.380 ± 559.287
4L (Female) 1686.776 ± 543.289 1764.322 ± 375.091
5L (Immature Male) 2189.010 ± 564.719 2306.694 ± 753.281
2L (Male BNF Induced) 2003.072 ± 369.029 1903.526 ± 506.138
3L (Male PB Induced) 2599.830 ± 542.83l bc 1963.354 ± 428.114
a Data represent Mean ± SD for n=5 groups of 3 pooled livers per group. 
b Significantly different (p<0.05) from male DEM-Controls.
0 Significantly different (p<0.05) from female DEM-Controls.
For dosing protocol see Table 12.
TABLE 51
EFFECT OF DIETHYLMALEATE (DEM) AND 2-THI0TRIAZ0NE (TTZ) IN 
C O M B I N A T I O N  ON H E P A T I C  M I C R O S O M A L  U D P -  






1L (Male) 0.987 ± 0.423 0.706 ± 0.591
4L (Female) 1.799 ± 1.732 1.230 ± 0.727
5L (Immature Male) 2.202 ± 1.530 1.031 ± 1.528
2L (Male BNF Induced) 1.788 ± 1.544 1.479 ± 0.752
3L (Male PB Induced) 1.110 ± 0.689 1.089 ± 0.732
" Data represent Mean ± SD for n=5 groups of 3 pooled livers per group. 
For dosing protocol see Table 12.
DEMC DEMT BNFDC BNFDT PBDC PBDT
Figure 28 . E ffect o f d iethylm aleate (DEM) + TTZ in  com bination  
on  hepatic m icrosom al cytochrom e P-450 con ten t in  
induced and non*induced rats. DEMC = DEM -Control ; 
DEMT = DEM + TTZ ; BNFDT = (i-napthoflavone 
induced + DEM ; PBDC = phenobarhital induced  + 
DEM ; PBDT = phenobarhital induced  + DEM + TTZ . 
For dosing protocol see  Table 12 . * * S ign ifican tly  
different (p < 0.05) from  DEM controls .
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male control rats was significantly higher than content in non-induced male, 
female, immature and PB induced animals (Table 47; Figure 29). NADH 
cytochrome-bg-reductase activities in PB induced DEM control male rats 
were significantly decreased from non-induced and BNF induced rats (Table 
48; Figure 30), and NADPH cytochrome-C-reductase in PB induced DEM 
controls were significantly increased from non-induced and BNF induced 
rats (Table 49; Figure 31). Glutathione-S-transferase activity in PB induced 
male rats was also significantly higher than adult male and female non- 
induced rats (Table 50; Figure 32). UDP-glucuronosyltransferase activity 
was not affected by induction with PB or BNF (Figure 33).
Diethylmaleate and TTZ in combination did not significantly affect hepatic 
aldrin epoxidase (Table 52), EROD (Table 53), or ECOD (Table 54) activities 
in non-induced adult male and immature male rats. However, female rats 
had significantly lower AE activity than non-induced (adult male and 
immature male) and induced male rats. Aldrin epoxidase, EROD and 
ECOD activities in relation to cytochrome P-450 content was increased 
approximately 2-fold in  male (DEM-TTZ), female (Controls and DEM-TTZ), 
and immature male (Controls and DEM-TTZ). These activities in relation 
to cytochrome P-450 content was slightly higher in BNF and slightly lower 
in PB induced male rats. In  all cases where animals were induced with 
BNF or PB, activities were significantly higher than  activities in non- 
induced rats. An exception is th a t aldrin epoxidase activity in BNF induced 
rats was significantly lower than in non-induced male and immature male 





















DEMC DEMT BNFDC BNFDT PBDC PBDT
Figure 29 . E ffect o f DEM + TTZ in  com bination on  hepatic
m icrosom al cytochrom e bs conten t in  induced  and non- 
induced  m ale rats . For id en tifica tion  o f abbreviations 
see  F igure 28 . For dosing protocol see  Table 12 .
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DEMC DEMT BNFDC BNFDT PBDC PBDT
Figure 30 . E ffect o f DEM + TTZ in  com bination on hepatic
m icrosom al NADH cytochrom e-bs-reductase activ ity  in  
induced  and non-induced m ale rats . F or id en tifica tion  
o f abbreviations see  F igure 28 . For dosin g protocol 


























DEMC DEMT BNFDC BNFDT PBDC PBDT
Figure 31 . E ffect o f DEM + TTZ in  com bination on hepatic
m icrosom al NADPH cytochrom e-C -reductase activ ity  in  
induced  and non-induced m ale rats . For id en tification  
o f abbreviations see  F igure 28 . F or dosing protocol 























DEMC DEMT BNFDC BNFDT PBDC PBDT
Figure 32 . E ffect o f DEM + TTZ in  com bination on hepatic
cytoso lic  glutathione-S-transferase activ ity  in  induced  
and non-induced m ale rats . For id en tifica tion  o f  
abbreviations see  F igure 28 . For dosing protocol see  
Table 12 . * «  S ign ifican tly  d ifferent (p < 0.05) from  
DEM controls.
DEMC DEMT BNFDC BNFDT PBDC PBDT
F igure 33 . E ffect o f DEM + TTZ in  com bination on  hepatic
m icrosom al U D P-glucuronosyltransferase activ ity  in  
induced and non-induced m ale rats . F or id en tification  
o f abbreviations see  F igure 28 . For d osin g  protocol 
see  Table 12 .
TABLE 52
EFFECT OF DIETHYLMALEATE (DEM) AND 2-THIOTRIAZONE (TTZ) ON HEPATIC MICROSOMAL
ALDRIN EPOXIDASE ACTIVITY IN INDUCED AND NON-INDUCED RATS*.
Aldrin epoxidase 
nmoles dieldrin formed/min/mg/microsomal protein 
(nmoles dieldrin formed/min/nmole P-450)
DEM-CONTROL DEM-TTZ
1L (Male) 1.728 ± 0.303 1.129 ± 0.551
(3.099 ± 0.823) (3.227 ± 0.451)
4L (Female) 0.138 ± 0.146b 0.149 ± 0.151'
(0.320 ± 0.453) (0.417 ± 0.539)
5L (Immature Male) 1.158 ± 0.401 0.879 ± 0.228
(2.190 ± 0.476) (2.056 ± 0.605)
2L (Male BNF Induced) 0.755 ± 0.183d-* 0.558 ± 0.2111-®
(0.918 ± 0.474) (0.737 ± 0.517)
3L (Male PB Induced) 5.339 ± 1.838w 3.962 ± 1.256s*
(3.140 ± 1.155) (3.760 ± 1.208)
* Data represent Mean ± SD for n=5 groups of 3 pooled livers per group.
b Significantly lower (p<0.05) than male, immature male and induced (BNF or PB) male controls.
c Significantly lower (p<0.05) than male, immature male and induced male (BNF or PB) DEM-TTZ treated
animals.
d Significantly lower (p<0.05) than non-induced male and immature male DEM-Controls.
* Significantly higher (p<0.05) than non-induced female DEM-Controls.
' Significantly lower (p<0.05) than non-induced male, and immature male DEM-TTZ groups.
* Significantly higher (p<0.05) than non-induced female DEM-Controls.
h Significantly higher (p<0.05) than non-induced DEM-Controls.
1 Significantly higher (p<0.05) than BNF induced DEM-Controls.
j Significantly higher (p<0.05) than non-induced DEM-TTZ treated animals. 
k Significantly higher (p<0.05) than BNF induced DEM-TTZ treated animals.
For dosing protocol see Table 12.
TABLE 53
EFFECT OF DIETHYLMALEATE (DEM) AND 2-THIOTRIAZONE (TTZ) ON HEPATIC MICROSOMAL
7-ETHOXYRESORUFIN-O-DEETHYLASE (EROD) ACTIVITY IN INDUCED AND NON-INDUCED
RATS*.
EROD
pmoles resorufin formed/min/mg/microsoinal protein 





2L (Male BNF Induced)
3L (Male PB Induced)
117.662 ± 80.559 
(66.460 ± 116.557)
66.460 ± 37.981 
(113.754 ± 44.545)
151.066 ± 159.478 
(268.975 ± 234.054)
5276.446 ± 1053.070b 
(6399.681 ± 3329.304)
544.762 ± 381.773“ 
(305.979 ± 196.115)
85.698 ± 65.907 
(238.500 ± 131.187)
55.242 ± 27.887 
(156.538 ± 78.338)
96.100 ± 106.880 
(198.939 ± 208.725)
4416.738 ± 1646.205d 
(5203.894 ± 1150.502)
658.292 ± 424.978^ 
(631.609 ± 496.019)
* Data represent Mean ± SD for n=5 groups of 3 pooled livers per group. 
b Significantly higher (p<0.05) than non-induced DEM-Controls.
* Significantly lower (p<0.05) than BNF induced DEM Controls.
d Significantly higher (p<0.05) than non-induced DEM-TTZ treated animals.
* Significantly lower (p<0.05) than BNF induced DEM-TTZ treated animals. 
For dosing protocol see Table 12.
TABLE 54
EFFECT OF DIETHYLMALEATE (DEM) AND 2-THIOTRIAZONE (TTZ) ON HEPATIC MICROSOMAL 7-
ETHOXYCOUMARIN'O-DEETHYLASE (ECOD) ACTIVITY IN INDUCED AND NON-INDUCED RATS*.
ECOD
nmoles 7-hydroxycoumarin formed/min/mg/microsomal protein 
(nmoleB 7-hydroxycoumarin formed/min/nmole P-450)
GROUP DEM-CONTROL DEM-TTZ
1L (Male) 1.915 ± 1.201 1.057 ± 0.369
(3.541 ± 2.466) (3.904 ± 2.123)
4L (Female) 1.240 ± 1.104 0.810 ± 0.728
(2.017 ± 1.513) (2.214 ± 2.017)
5L (Immature Male) 2.514 ± 0.517 1.952 ± 0.751
(5.119 ± 1.927) (4.706 ± 2.159)
2L (Male BNF Induced) 15.214 ± 3.460" 12.518 ± 3.757d
(19.079 ± 11.983) (15.616 ± 5.975)
3L (Male PB Induced) 5.572 ± 0.621"' 4.142 ± 0.998'’*
(3.310 ± 0.637) (3.877 ± 0.514)
* Data represent Mean ± SD for n=5 groups of 3 pooled livers per group.
" Significantly higher (p<0.05) than non-induced DEM-Controls.
* Significantly lower (p<0.05) than BNF induced DEM-Controls.
d Significantly higher (p<0.05) than non-induced DEM-TTZ treated animals.
* Significantly lower (p<0.05) than BNF induced DEM-TTZ treated animals.
For dosing protocol see Table 12.
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higher than activity in BNF induced animals (Table 52; Figure 34). Both 
EROD and ECOD activity in BNF induced animals were significantly higher 
than activities in PB induced ra ts (Tables 53 and 54; Figures 35 and 36). 
Phenobarhital induced rats treated with DEM and TTZ also had 
significantly lower ECOD activity than PB induced DEM controls.
A comparison of the effects of TTZ and DEM + TTZ in combination on 
organ weights is presented in  Table 55. Lung weights in adult male and 
female and immature male rats were significantly increased when exposed 
to DEM and TTZ in combination compared to control and TTZ treated rats. 
In fact, lungs of adult male ra ts administered DEM and TTZ in combination 
were 3 times as heavy as control ra t  lungs and 2 times as heavy as lungs 
from TTZ treated rats. Female and immature male ra t lungs were 
approximately 2 times as heavy as control and TTZ treated ra t lungs. Liver 
weights were virtually the same in DEM+TTZ treated, DEM control, and 
TTZ treated and control animals. However, immature male ra t liver 
weights in the DEM-TTZ treated group were significantly increased 
compared to DEM controls, and TTZ treated and control livers.
Comparison of the effects of TTZ and DEM + TTZ in combination on organ 
to body weight ratios is shown in Table 56. Lung to body weight ratios in 
rats dosed with the DEM-TTZ combination followed the same pattern as 
organ weights except all lung to body weight ratios in adult male and 
female and immature male ra ts  dosed with the combination were 
approximately 3-fold higher than  controls and 2-fold higher than TTZ
DEMC DEMT BNFDC BNFDT PBDC PBDT
F igure 34 . E ffect o f DEM + TTZ in  com bination on hepatic
m icrosom al aldrin  epoxidase activ ity  in  induced and  
non-induced m ale rats . For id en tifica tion  o f  
abbreviations see  F igure 28 . For dosin g protocol see  
Table 12 . * = S ign ifican tly  d ifferent (p < 0.05) from  
DEM control.
DEMC DEMT BNFDC BNFDT PBDC PBDT
Figure 35 . E ffect o f DEM + TTZ in  com bination on hepatic
m icrosom al EROD activ ity  in  induced  and non-induced  
m ale rats . For id en tifica tion  o f abbreviations see  
F igure 28 . For dosing protocol see  Table 12 .
* c  S ign ifican tly  d ifferent (p < 0.05) from  DEM control.
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DEMC DEMT BNFDC BNFDT PBDC PBDT
F igure 36 . E ffect o f DEM + TTZ in  com bination on  hepatic
m icrosom al ECOD activ ity  in  induced  and non-induced  
m ale rats . F or id en tifica tion  o f abbreviations see  
Figure 28 . For dosing protocol see  Table 12 .
* s  S ign ifican tly  d ifferent (p < 0.05) from  DEM control.
TABLE 55
COMPARISON OF THE EFFECT OF TTZ AND DEM-TTZ IN COMBINATION ON ORGAN WEIGHTS.
TTZa DEMb and TTZ
Sex Organ Control TTZ DEM-CONTROL DEM-TTZ
Male Lung
Liver
1.69 ± 0.27 
13.12 ± 1.15
2.07 ± 0.28c 
13.48 ± 1.06
2.02 ± 0.47 
11.47 ± 1.17




1.22 ± 0.11 
8.92 ± 1.11
2.03 ± 0.39e 
8.57 ± 0.83
1.66 ± 0.54 
7.60 ± 0.80






1.13 ± 0.07 
8.46 ± 0.90
1.41 ± 0.14g 
8.34 ± 0.49
1.06 ± 0.12 
7.18 ± 0.69
2.80 ± 0.71h*n 
10.19 ± 1.90°
a TTZ (10 mg/kg) administered via ip injection. Data represent Mean ± SD for n = 6  animals. 
b DEM (485 mg/kg) administered via ip injection 0.5 h r prior to TTZ exposure. 
c Significantly increased (p<0.05) from male control group.
d Significantly increased (p<0.05) from male DEM-Control group.
e Significantly increased (p<0.05) from female control group.
f Significantly increased (p<0.05) from female DEM-Control group.
g Significantly increased (p<0.05) from immature control group.
h Significantly increased (p<0.05) from immature DEM-control group.
1 Significantly increased (p<0.05) from male control group.
j Significantly increased (p<0.05) from female control group.
k Significantly increased (p<0.05) from immature control group.
1 Significantly increased (p<0.05) from male TTZ group.
m Significantly increased (p<0.05) from female TTZ group. 
n Significantly increased (p<0.05) from male TTZ group.
0 Significantly increased (p<0.05) from immature male control, TTZ treated, and DEM-Control group.
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DEM control groups (Table 56). Liver to body weight ratios were increased 
in adult male rats treated with the DEM + TTZ combination, compared to 
DEM controls. Liver to body weight ratios in immature ra ts  treated with 
the DEM + TTZ combination were significantly increased form DEM control, 
TTZ treated and TTZ control groups.
The effects of TTZ and DEM + TTZ in combination are compared in this 
study. Results show that TTZ alone did not affect hepatic microsomal and 
cytosolic enzymes in non-induced adult male rats (Table 57). There was, 
however, a significant decrease in cytochrome P-450 content in DEM + TTZ 
treated male rats from control and TTZ treated rats. Aldrin epoxidase, 
EROD and ECOD activities were not affected by TTZ or DEM + TTZ in 
adult male rats (Table 58). The combination of DEM and TTZ did not 
significantly affect hepatic microsomal and cytosolic enzymes in adult female 
rats (Table 59). However, cytochrome P-450 content was significantly 
increased in female rats treated with TTZ, and UDP-glucuronosyltransferase 
activity (UDPGT) in  female controls was significantly higher than TTZ 
treated, DEM control and DEM + TTZ treated rats. Aldrin epoxidase, 
EROD and ECOD activity in  female rats was unaffected by TTZ or DEM 
+ TTZ in combination . But, in relation to cytochrome P-450 content aldrin 
epoxidase, EROD and ECOD activities were all induced two-fold (Table 60). 
This coincides with the increase in cytochrome P-450 content in female rats. 
2-Thiotriazone alone did not affect hepatic microsomal and cytosolic enzymes 
in immature male rats. Contrariwise, glutathione-S-transferase (GST) 
activity in TTZ treated immature male rats was significantly lower than
TABLE 56




TTZa DEMb and TTZ
Organ Control TTZ DEM-CONTROL DEM+TTZ
Male Lung 0.51 ± 0.07 0.61 ± 0.08c 0.59 ± 0.15 1.53 ± 0.23^
Liver 3.98 ± 0.23 3.98 ± 0.17 3.34 ± 0.23 3.90 ± 0.33
Female Lung 0.48 ± 0.05 0.78 ± 0.14e 0.64 ± 0.24 1.49 ± 0.37f,k
Liver 3.47 ± 0.35 3.32 ± 0.32 2.92 ± 0.49 3.18 ± 0.48
Immature Lung 0.62 ± 0.05 0.78 ± 0.078 0.59 ± 0.03 1.48 ± 0.33hJ
(Male) Liver 4.50 ± 0.44 4.46 ± 0.41 4.02 ± 0.07 5.34 ± 0.721
a TTZ (10 mg/kg) administered via ip injection. Data represent Mean ± SD for n = 6  animals. 
b DEM (485 mg/kg) administered via ip injection 0.5 hr prior to TTZ exposure. 
c Significantly increased (p<0.05) from male control group.
d Significantly increased (p<0.05) from male DEM-Control group.
e Significantly increased (p<0.05) from female control group.
f Significantly increased (p<0.05) from female DEM-Control group.
8  Significantly increased (p<0.05) from immature control group.
h Significantly increased (p<0.05) from immature male DEM-Control group.
1 Significantly increased (p<0.05) from immature male control and TTZ treated group.
j Significantly increased (p<0.05) from male control and TTZ treated group.
k Significantly increased (p<0.05) from female control and TTZ treated group.
1 Significantly increased (p<0.05) from immature male control and TTZ treated group.
TABLE 57
COMPARISON OP THE EFFECT OF 2-THIOTRIAZONE (TTZ) AND DIETHYLMALEATE (DEM) + TTZ TREATMENT ON HEPATIC
MICROSOMAL AND CYTOSOLIC ENZYMES IN ADULT MALE RATS.
TTZ DEM and TTZ







0.672 ± 0.109 
0.223 ± 0.049 
512.030 * 54.643 
119.432 ± 32.687 
1701.066 ± 502.263 
1.309 ± 0.871
0.718 ± 0.170 
0.236 ± 0.055 
526.434 ± 139.838 
129.481 ± 50.869 
1783.790 ± 493.839 
0.968 ± 0.542
0.572 ± 0.065 
0.2191 0.027 
468.366 ± 48.069 
128.194 ± 46.114 
1643.186 ± 362.269 
0.987 ± 0.423
0.370 ± 0.234* 
0.184 ± 0.040 
521.664 ± 279.899 
89.108 * 17.601 
1638.380 ± 559.287 
0.706 ± 0.591
Data represents the Mean ± SD for n=5 groups of 3 pooled livers per group.
* n mole P-450/mg microsomal protein 
k n mole bjvag microsomal protein
* n mole cytochrome-b6-reduced/min/mg microsomal protein
* n mole cytochrome-C-reduced/min/mg microsomal protein
* n mole l-chloro-2,4-dinitrobenzene conjugated/min/mg microsomal protein 
r n mole p-nitrophenol coigugated/min/rag microsomal protein
1 Significantly different (p<0.05) from TTZ treated group.
TABLE 58
COMPARISON OF THE EFFECT OF 2-THIOTRIAZONE (TTZ) AND DIETHYLMALEATE (DEM) + TTZ TREATMENT ON SELECTED
HEPATIC MICROSOMAL ENZYME ACTTVITIES IN ADULT MALE RATS.
TTZ DEM and TTZ



















(nmoles 7-OH coumarin/min/mg/ 
protein)





























117.662 ± 80.559 
194.201 ± 116.557
85.698 ± 65.907 
238.500 ± 131.870
Data represents the Mean ± SD for n=5 groups of 3 pooled livers per group.
TABLE 59
COMPARISON OF THE EFFECT OF 2-THIOTRIAZONE (TTZ) AND DIETHYLMALEATE (DEM) + TTZ TREATMENT ON HEPATIC
MICROSOMAL AND CYTOSOLIC ENZYMES IN ADULT FEMALE RATS.
TTZ DEM and TTZ







0.456 ± 0.113 
0.214 * 0.069 
533.526 ± 167.126 
107.254 ± 38.119 
1480.552 * 707.729 
3.269 * 1.118u
0.585 ± 0.044* 
0.228 * 0.058 
617.310 ± 91.387 
105.605 ± 29.083 
1368.984 ± 734.334 
1.727 ± 0.381*
0.575 ± 0.193 
0.248 ± 0.061 
585.546 ± 115.481 
118.504 ± 40.582 
1686.776 ± 543.289 
1.779 ± 1.732
0.360 ± 0.108 
0.190 ± 0.033 
499.968 * 48.715 
83.152* 16.720 
1764.322 * 376.001 
1.230 * 0.727
Data represents the Mean * SD for n=5 groups of 3 pooled livers per group.
* n mole P-450/mg microsomal protein 
k n mole b^mg microsomal protein
* n mole cytochrome-bs-reduced/min/mg microsomal protein
* n mole cytochrome-C-reduced/min/mg microsomal protein
* n mole l*chloro-2,4-dinitrobenzene coryugated/min/mg microsomal protein 
' n mole p-nitrophenol conjugated/min/mg microsomal protein
■ significantly different (p<0.05) from control group. 
k significantly different (p<0.05) from DEM-Control group.
1 significantly different (p<0.05) from DEM-Control group.
TABLE 60
COMPARISON OF THE EFFECT OF 2-THIOTRIAZONE (TTZ) AND DIETHYLMALEATE (DEM) + TTZ TREATMENT ON SELECTED
HEPATIC MICROSOMAL ENZYME ACTIVITIES IN ADULT FEMALE RATS.
TTZ DEM and TTZ




0.241 ± 0.287 
0.555 ± 0.574
0.238 ± 0.234 
0.421 ± 0.446







(nmoles 7-OH coumarin/min/mg/ 
protein)
(nmoleB 7-OH coumarin/min/ 
nmole P-460)
0.949 ± 0.800 
1.890 ± 1.217
0.953 ± 0.798 
1.619 ± 1.346











72.870 ± 52.751 
148.511 ± 71.547
60.042 ± 33.922 
107.111 ± 56.903






Data represents the Mean ± SD for n=5 groups of 3 pooled livers per group.
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GST activity in DEM control and DEM + TTZ treated animals, and UDPGT 
activity in TTZ treated immature male rats was also significantly decreased 
from that of control immature rats (Table 61). Aldrin epoxidase activity in 
DEM control and DEM+TTZ treated immature ra ts was significantly lower 
than AE activity in control and TTZ treated immature rats (Table 62). In 
relation to cytochrome P-450 content aldrin epoxidase, EROD and ECOD 
activities were induced approximately two-fold.
Neither TTZ or DEM+TTZ in combination affected hepatic microsomal and 
cytosolic enzymes in BNF induced ra ts (Table 63). Aldrin epoxidase activity 
in BNF induced male rats was not affected. EROD activity, however, was 
significantly decreased from tha t of DEM control animals and in TTZ 
treated rats EROD activity was also significantly decreased from DEM 
controls. The activity of ECOD in DEM+TTZ treated rats was significantly 
decreased from that of DEM controls (Table 64). Administration of TTZ 
alone did not affect hepatic microsomal or cytosolic enzymes in PB induced 
male rats. The combination of DEM and TTZ caused a  significant decrease 
in cytochrome P-450 in PB induced rats. NADH cytochrome-b5-reductase 
activity in DEM control animals was significantly increased from controls, 
DEM controls, and DEM + TTZ treated rats. Glutathione-S-transferase 
activity in DEM controls was significantly increased over th a t of TTZ 
treated, TTZ control and DEM + TTZ treated animals. Glutathione-S- 
transferase activity in DEM + TTZ treated PB induced rats was also 
significantly decreased from values for DEM control rats (Table 65). Aldrin 
epoxidase activity in the DEM + TTZ group was significantly decreased from 
TTZ control, TTZ, and DEM control groups (Table 6 6 ).
TABLE 61
COMPARISON OF THE EFFECT OF 2-THIOTRIAZONE (TTZ) AND DIETHYLMALEATE (DEM) + TTZ TREATMENT ON HEPATIC
MICROSOMAL AND CYTOSOLIC ENZYMES IN IMMATURE MALE RATS (40 DAY OLD).
TTZ DEM and TTZ







0.562 ± 0.230 
0.174 ± 0.066 
373.318 ± 111.214 
101.884 ± 30.406 
1579.632 ± 332.546 
1.469 ± 0.543
0.487 ± 0.243 
0.160 ± 0.072 
329.194 ± 85.296 
94.336 ± 17.163 
1370.162 ± 224.365** 
0.618 ± 0.533*
0.541 ± 0.198 
0.250 ± 0.088 
478.700 ± 80.485 
167.224 * 128.862 
2189.010 ± 664.719 
2.202 ± 1.630
0.441 ± 0.105 
0.189 ± 0.045 
478.760 ± 275.233 
102.213 ± 49.166 
2306.694 ± 763.280 
1.031 ± 1.628
Data represents the Mean ± SD for n=5 groups of 3 pooled livers per group.
* n mole cytochrome P-450/mg microsomal protein 
k n mole b/mg microsomal protein
* n mole cytochrome-b,-reduced/min/mg microsomal protein 
4 n mole cytochrome-C-reduced/min/mg microsomal protein
* n mole l-chloro-2,4-dinitrobenzene cor\jugated/min/mg microsomal protein 
’ n mole p-nitrophenol coqjugated/min/mg microsomal protein
( Significantly different (p<0.05) from DEM-Control group. 
k Significantly different (p<0.05) from DEM+TTZ group.
TABLE 62
COMPARISON OF THE EFFECT OF 2-THIOTRIAZONE (TTZ) AND DIETHYLMALEATE (DEM) + TTZ TREATMENT ON SELECTED
HEPATIC MICROSOMAL ENZYME ACTIVITIES IN IMMATURE MALE RATS (40 DAY OLD).
TTZ DEM and TTZ





















(nmoles 7-OH coumarin/coin/mg/ 
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151.066 * 159.478 
268.975 ± 234.054
96.100 ± 106.880 
198.939 ± 208.725
Data represents the Mean ± SD for n=5 groups of 3 pooled livers per group. 
* significantly different (p<0.05) from control group 
k significantly different (p<0.05) from TTZ treated group
TABLE 63
COMPARISON OF THE EFFECT OF 2-THIOTRIAZONE (TTZ) AND DIETHYLMALEATE (DEM) + TTZ TREATMENT ON HEPATIC
MICROSOMAL AND CYTOSOLIC ENZYMES IN G-NAPTHOFLAVONE (BNF) INDUCED MALE RATS.
TTZ DEM and TTZ







0.934 ± 0.191 
0.319 ± 0.125 
483.310 ± 132.240 
85.022 * 30.227 
1571.626 ± 386.389 
1.573 ± 0.847
0.899 ± 0.206 
0.268 ± 0.032 
499.236 ± 148.890 
89.224 ± 29.551 
1724.722 ± 323.825 
1.685 ± 0.690
0.952 * 0.323 
0.329 ± 0.081 
526.076 ± 93.426 
142.868 * 90.464 
2003.072 ± 369.029 
1.788 ± 1.544
0.876 * 0.327 
0.293 ± 0.082 
587.662 ± 199.962 
109.904 * 61.908 
1903.626 * 506.138 
1.479 ± 0.762
Data represents the Mean ± SD for n={> groups of 3 pooled livers per group. 
e n mole P-450/mg microsomal protein
* n mole b/mg microsomal protein
* n mole cytochrome-bg-reduced/min/mg microsomal protein
* n mole cytochrome-C-reduced/min/mg microsomal protein
* n mole l-chloro-2,4-dinitrobenzene coiyugated/min/mg microsomal protein 
' n mole p-nitrophenol coryugated/min/mg microsomal protein
TABLE 64
COMPARISON OF THE EFFECT OF 2-THIOTRIAZONE (TTZ) AND DIETHYLMALEATE (DEM) + TTZ TREATMENT ON SELECTED
HEPATIC MICROSOMAL ENZYME ACTIVITIES IN P-NAPTHOFLAVONE (BNF) INDUCED MALE RATS.
TTZ DEM and TTZ



















(nmoles 7-OH coumarin/min/mg/ 
protein)
(nmoles 7-OH coumarin/min/ 
nmole P-450)



















4738.238 ± 770.045 
5044.185 ± 891.752
4726.094 ± 392.997 
5497.358 ± 1429.831
5276.446 ± 1053.070 
6399.681 ± 3329.304
4416.738 ± 1646.205* 
5203.894 ± 1150.502
Data represents the Mean ± SD for n=5 groups of 3 pooled livers per group. 
* Significantly different (p<0.05) from DEM-Controls
TABLE 65
COMPARISON OF THE EFFECT OF 2-THIOTRIAZONE (TTZ) AND DIETHYLMALEATE (DEM) + TTZ TREATMENT ON
HEPATIC MICROSOMAL AND CYTOSOLIC ENZYMES IN PHENOBARBITAL (PB) INDUCED MALE RATS.
TTZ DEM and TTZ







1.534 ± 0.405 
0.268 ± 0.059 
244.832 ± 59.575 
149.046 ± 55.332 
2105.576 ± 468.469 
1.080 ± 0.229
1.584 ± 0.338 
0.281 ± 0.033 
271.626 ± 86.491 
210.522 ± 104.363 
2141.044 ± 702.964 
1.137 ± 0.304
1.706 * 0.184 
0.243 ± 0.059 
234.958 ± 40.493 
285.880 ± 155.582" 
2599.830 ± 542.831*" 
1.110 ± 0.689
1.075 ± 0.271*" 
0.242 * 0.057 
304.246 ± 91.634 
118.164 * 51.546** 
1963.354 * 428.114“ 
1.089 * 0.732
Data represents the Mean ± SD for n=5 groups of 3 pooled livers per group.
* n mole P-450/mg microsomal protein. 
b n mole b^mg microsomal protein.
c n mole cytochrome-C-reduced/min/mg microsomal protein 
d n mole cytochrome-C-reduced/min/mg microsomal protein.
* n mole l-chloro-2,4-dinitrobenzene conjugated/min/mg microsomal protein.
' n mole p-nitrophenol conjugated/min/mg microsomal protein.
* Significantly different (p<0.05) from TTZ treated rats. 
b Significantly different (p<0.05) from controls.
1 Significantly different (p<0.05) from DEM-Control group.
J Significantly different (p<0.05) from DEM+TTZ group.
COro
TABLE 66
COMPARISON OF THE EFFECT OF 2-THIOTRIAZONE (TTZ) AND DIETHYLMALEATE (DEM) + TTZ TREATMENT ON SELECTED
HEPATIC MICROSOMAL ENZYME ACTIVITIES IN PHENOBARBITAL (PB) INDUCED RATS.
TTZ DEM and TTZ



















(nmoles 7-OH coumarin/min/mg/ 
protein)





















619.638 ± 464.583 
362.608 ± 220.852
518.750 ± 284.721 
315.209 ± 132.954
544.762 ± 381.773 
305.979 ± 196.115
658.292 ± 424.978 
631.609 ± 496.019
Data represents the Mean ± SD for n=5 groups of 3 pooled livere per group.
* Significantly different (p<0.05) from control, TTZ and DEM-Control groups.
CHAPTER 6 
DISCUSSION
The goal of the present study was to characterize the toxicity of 
2-thiotriazone (TTZ) and to determine its mechanism of action in Spraque 
Dawley rats. Since no previous toxicological research had been performed 
with TTZ, acute toxicity testing in  rats was the first step in characterizing 
its toxicity. TTZ was found to be an acute pulmonary toxicant in male 
rats, producing severe pulmonary edema and effusion. Interest in this 
compound developed because of its marked pulmonary toxicity in affected 
rats a t very low doses (1.25-10 mg/kg). The acute toxicity of TTZ closely 
resembled that of a-napthylthiourea (ANTU). Although there was a 
marked resemblence between TTZ and ANTU, there were also considerable 
differences between the two toxicants.
Description of toxicity
Alpha-napthylthiourea (ANTU) and other thioureas have been shown to 
produce massive pulmonary edema with pleural effusion in susceptible 
animals (Mackenzie and Mackenzie, 1943; Dieke and Richter, 1945; 1946; 
Dieke et al., 1947; Richter, 1945; 1952; Me Closky and Smith, 1945;
Bohm,1966; Cunninham and Hurley, 1972; Meyrick et al., 1972). Marked 
age and species differences in susceptibility have also been demonstrated 
(Dieke and Richter, 1946).
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Acute toxicity testing with TTZ was performed on adult male, adult female 
and immature Spraque-Dawley ra ts of both sexes to determine if  there were 
differences in susceptibility. The acute single oral dose LDr, for TTZ in 
male rats of 4.6 mg/kg and the acute intraperitoneal (ip) LDgo of 1.4 mg/kg 
classifies it  as a highly toxic compound (Buck et al., 1988). The decreased 
LDgo after ip compared to oral administration is not unexpected. This 
could have resulted from incomplete absorption from the gastrointestinal 
tract when TTZ was given orally, slower absorption of the parent compound, 
or a shift from pathways of metabolic activation to deactivation. An LD^ 
could not be determined for female rats dosed orally with TTZ, because a 
maximum of only 40% mortality was produced a t all concentrations tested. 
However, TTZ was not toxic to female rats after ip dosing and an LD5 0  of 
>100 mg/kg was estimated. The reason for decreased mortality observed in 
females after ip administration is not clear. One possible explanation is 
tha t the production of reactive metabolites in the female is rate-limited or 
tha t ip administration results in a greater proportion of the dose being 
metabolized to inactive products. TTZ was not lethal to immature rats 
(30-40 days old) of either sex after either oral or ip dosing and the LD^, was 
estimated to be greater than  1000 mg/kg. These results demonstrate that 
the toxicity of TTZ is both age and sex dependent.
Alpha-napthylthiourea (5mg/kg ip) treated rats developed pulmonary edema 
and effusion within 2 hr, which reached a maximum by 4.5 h r (Cunningham 
and Hurley, 1972). These animals usually died within 8-10 hrs, but in 
survivors the edema and effusion were reabsorbed within 24-48 hr, leaving
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apparently normal lungs. Administration of a  larger dose of ANTU (20 
mg/kg ip) resulted in rapid loss of 2-3% of body weight 5 h r after injection, 
and animals were listless and did not eat or drink. These animals were 
also severely dyspnoeic with marked pulmonary edema and effusion. They 
subsequently died, but did not froth or hemorrhage from the nostrils. 
However, TTZ treated animals showed evidence of pulmonary edema and 
effusion within 1 h r which appeared to reach a maximum within 2-3 hr. 
The end result was death, although a few animals appeared to recover 
completely. Clinical signs of intoxication observed in TTZ affected animals 
included respiratory distress, dyspnea, cyanosis, prostration or listlessness, 
and ruffled fur. In male ra ts that subsequently died a white frothy nasal 
dischage was observed. The macroscopic lesions observed in TTZ affected 
animals (mottling of the lungs, pulmonary edema and effusion) are 
consistent with clinical signs of intoxication. The rapid onset of toxicity 
caused by TTZ in adult male rats could be due to TTZ itself exerting its 
toxic effect before it is metabolized and excreted. It is also possible that 
male rats do not adequately metabolize TTZ to an inactive metabolite before 
it can exert its toxic effect. A third possibility is that male ra ts metabolize 
TTZ to a toxic metabolite and the metabolite causes the toxic effect in the 
lungs. W hether this metabolism could take place in the lungs is an open 
question.
Alpha-napthylthiourea was tested in both male and female ra ts of a specific 
pathogen free derived colony of the Carworth Farm strain of rats ( Ven Den 
Brenk et al., 1976). There was no resistance or decreased toxicity to
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ANTU in female rats, i.e., there were no sex related differences. However, 
decreased toxicity or resistance was observed in TTZ treated adult female 
rats. Female rats were more resistant to TTZ than male rats and only 40% 
mortality was observed when rats were dosed orally. Clinical signs of 
intoxication observed in affected animals were similar to those observed in 
male rats. However, these signs lasted for longer periods of time (4-24 hrs). 
This decreased toxic response to TTZ in female rats could suggest that: 1) 
female rats metabolize TTZ to an inactive metabolite more rapidly than 
males, 2) TTZ is activated to a toxic metabolite in both male and female 
rats, but to a  lesser extent in the latter, 3) female rats have a higher level 
of protective enzyme activity against reactive metabolites than males, or 4) 
the female lung is innately more resistant to damage caused by reactive 
metabolites or the parent compound.
Immature rats of neither sex showed toxic responses (mortality or clinical 
signs of intoxication) to TTZ when dosed either orally or ip. This apparent 
lack of response in immature rats could be due to immaturity of specific 
drug metabolizing enzyme systems, higher activities of protective enzyme 
systems, or a  decreased rate of absorption. Immature rats may also have 
the ability to completely metabolize TTZ to inactive products. Likewise, the 
target cells in the lung may be more resistant to the effect of reactive 
metabolites.
According to studies by Ven Den Brenk et al., (1976), histological changes 
in the lung produced by ANTU typically consist of perivascular and
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peribronchial edematous cuffing and generalized interstitial edema of 
alveolar walls. Intra-alveolar exudation is present but is rather patchy in 
distribution. Significant hemorrhage and cellular infiltration usually have 
not been shown to occur (Ven Den Brenk et al., 1976). No chronic or 
delayed sequelae such as pulmonary fibrosis occurred in rats which were 
allowed to recover after acute severe pulmonary edema and effusion (Ven 
Den Brink et al., 1976).
Histopathologic evaluation of rats treated with TTZ showed no evidence of 
hepatic structural alterations, which may rule out the liver as a possible 
site of action or target organ. However, there is no evidence th a t TTZ is 
not metabolized in the liver to a toxic metabolite that affects the lungs. 
Marked histologic changes were observed in the lungs of affected rats. 
Histopathological examination of adult male ra t lungs after 1 h r exposure 
to TTZ (10 mg/kg ip) showed acute interstitial and perivascular edema. The 
edema fluid was largely restricted to areas around the blood vessels. 
Edema was also noted around the bronchioles with some sepage into the 
alveoli, causing distension of perivascular and peribronchiolar spaces. There 
was also substantially more fluid in the loose periarterial interstitum  than 
around airways within the perivascular bundles, and more edema was 
observed around larger bundles. The extensive perivascular and interstitial 
edema and pleural effusion found in the lungs of affected male animals 
could restrict oxgen transport across the alveoli, thus reducing oxygenation 
of hemoglobin. The edema was also associated with a mild interstitial 
inflammatory response, with minimal numbers of neutrophilic macrophages
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and lymphocytes, suggesting tha t the toxicity was not the result of an 
inflammatory or allergic response. These results also suggest tha t the lung 
is probably the target organ for TTZ induced toxicity.
In male rats the peak response to TTZ occurred within 1 h r and there were 
no apparent differences between responses a t lh r  and 2hr post-dosing. 
Because of massive pulmonary edema and pleural effusion within the lungs 
of male rats the animals usually died within the 2-3 hr post-dosing, and 
relatively few recovered. If  animals recovered there were no noticable 
histopathologic changes observed after 24 hr, the lungs appearing normal. 
Histopathologic changes observed in affected male rats were consistent with 
clinical signs of intoxication (severe respiratory distress, dyspnea, cyanosis, 
prostration or listlessness and a white frothy nasal discharge).
Histopathologic changes observed in affected female rats were similar to 
changes observed in male rats lh r  after exposure to TTZ. However, the 
overall effects of TTZ were milder. Female ra t lungs were less endematous 
with relatively small quantities of perivascular edema. Peribronchial and 
interstitial edema were not present. These observations are consistent with 
the lower degree of toxicity of TTZ observed in female rats. In summary, 
the histopathology of the lungs of females supports the lower mortality 
observed. However, the amount of edema and effusion varied within 
females whereby some animals suffocated and others did not.
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Immature rats of both sexes (under 45 days of age) did not show any 
clinical signs of intoxication, and there were no macroscopic lesions. 
However, lung weights and lung to body weight ratios 1 h r following 
exposure to TTZ were significantly increased in immature (40 day old) rats 
as well as adults. These increased weights and ratios suggest tha t edema 
was present in all ra t lungs.
According to studies with ANTU by Ven Den Brenk et al., (1976), larger 
effusions caused a greater reduction in the volume of air in the lungs by 
displacement. Also, smaller increases in lung weight due to edema often 
accompanied the transfer of fluid from the intrapulmonary compartment to 
the pleural cavity in older rats with larger effusions. The degree of acute 
respiratory embarrassment caused by ANTU was determined more by 
displacement of air by pleural effusion than by pulmonary edema, measured 
as an increase in specific lung weight. This is based on the fact that 
edema was present in all animals dosed with T TZ, but mortality was not 
observed in all animals. Acute respiratory embarrassment and mortality 
produced by TTZ could also be the result of displacement of air by pleural 
effusion instead of pulmonary edema itself.
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Effect of diethvlmaleate (DEM) and L-buthionine-(SR)-sulfoxamine (BSO) on 
TTZ toxicity
Diethylmaleate (DEM) is an <x,P-unsaturated carbonyl compound which 
depletes glutathione from the liver of rats, mice and hamsters (Boyland and 
Chasseaud, 1970; 1967; Plummer et al., 1981). The reaction between DEM 
and glutathione is both spontaneous and catalyzed by a cytosolic 
glutathione transferase. DEM also depletes glutathione in erythrocytes, 
kidney, lung and brain, but to a lesser extent than in liver (Boyland and 
Chasseaud, 1967). DEM has been widely used in toxicological studies to 
investigate the possible role of glutathione-mediated reactions in the 
metabolism of various drugs and chemicals, either in vivo or in isolated 
hepatocytes (Mitchell et al., 1973; Jollow et al., 1974; Sultatos et al., 1982; 
Youner and Siegers, 1981). However, DEM has many non-specific effects 
in addition to depletion of glutathione. For example, it  has been shown to 
affect hepatic microsomal monooxygenase activities (Anders, 1978; Burk and 
Correia, 1979; Chuang and Bresnick, 1978; and Welling and De Vries 
1985); to stimulate bile flow (Barnhart and Combes, 1978) and to impair 
glycogen metabolism (Krack et al., 1980). Costa and Murphy (1986) 
showed tha t DEM (lml/kg) inhibited protein synthesis in brain and liver 
following administration to mice. Other effects of DEM, such as lipid 
peroxidation (Younes and Siegers, 1981; Stacey and Presley, 1978) or acute 
ulcerogenesis (Boyd et al., 1981) may be a consequence of glutathione 
depletion rather than a seperate effect (Boyland and Chasseaud, 1967).
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L-Buthionine-(SR)-suIfoxamine (BSO) is a specific inhibitor of 
gamma-glutamylcysteine synthetase, a major enzyme in glutathione 
synthesis and has been shown to decrease hepatic and renal glutathione 
without affecting other enzymes involved in xenobiotic biotransformation 
(Drew and Miners, 1984; Sun et al., 1985). I t  has been suggested for use 
as a preferable glutathione depletor in the investigation of mechanisms of 
xenobiotic-induced toxicities (Costa and Murphy, 1986). However, BSO 
(1,786 mg/kg) has been shown not to affect pulmonary glutathione levels for 
several hours after a single treatm ent in mice (Mizutani et al., 1987).
Even though DEM appears to have a large number of non-specific effects, 
glutathione depletion caused by lower doses of DEM can be achieved 
without seriously affecting other systems. Compared to BSO, DEM also has 
a more rapid onset of action. Pretreatm ent with a single dose of DEM (485 
mg/kg) 30 min prior to sacrificing the animal sufficiently depletes 80-90% 
of lung and liver GSH levels. By comparison, a sigle dose of BSO (1,780 
mg/kg) depletes hepatic GSH to about 40% of control levels between 2-4 hr 
but it does not deplete GSH concentration in the lung after 6hr in mice.
In this study DEM was administered a t a dose of 485 mg/kg, which is 
one-half the dose that has been shown to cause decreases in protein 
synthesis. This dosage was used because DEM administered a t 970 mg/kg 
was shown to be toxic to 20% of the animals tested. Results in the present 
study show that DEM administered a t 485mg/kg depleted GSH levels by 
80-90% in both the lung and liver of adult male and female rats.
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Diethylmaleate pretreatm ent potentiated the toxicity of TTZ in male 
rats, causing 50% mortality a t lmg/kg ip whereas no toxicity was observed 
a t this concentration previously. BSO, however, was not as effective as 
DEM in enhancing mortality in rats. The reason for this difference could 
be related to the time required for glutathione depletion in lung and liver. 
Previous studies have shown that BSO depletes glutahione levels in the 
liver 2-4 h r after injection while it  takes DEM 30 minutes. Therefore, GSH 
levels were probably not depleted in the BSO pretreated animals a t the 
time that TTZ was administered. This difference could also support the 
contention tha t the toxic metabolite is produced in the lung, since BSO 
would not have reduced glutathione concentrations in the lung a t all when 
TTZ was administered.
Pretreatm ent with DEM potentiated the toxicity of TTZ in adult female 
rats, causing 66% mortality a t lm g TTZ/kg and 100% mortality a t 2.5 and 
10 mg TTZ/kg ip. Previously, no mortality was observed in female rats 
dosed ip with TTZ a t concentrations of 5-100mg/kg, although, 40 % 
mortality was oberved in female rats when dosed orally a t 2.5-1000 mg 
TTZ/kg. These results clearly suggest tha t GSH plays a protective role in 
the metabolism of TTZ in female rats.
Diethylmaleate pretreatm ent also potentiated the effects of TTZ in immature 
rats of both sexes, causing 90% mortality in both 30 and 40 day old males, 
60% mortality in 30 day old females and 90% mortality in 40 day old 
females. These results also suggest that glutathione played a protective role
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in the metabolism of TTZ. Previously, immature rats showed no response 
to TTZ when dosed either orally or ip a t concentrations up to lOOOmg 
TTZ/kg.
It has been shown that there are age and sex differences in glutathione 
levels (Igarashi, et al., 1983). Male and female ra ts 7 weeks of age showed 
no significant differences in GSH concentrations in the fiver. However, 
female rats (7 wk old) showed 1.7 fold higher activities of hepatic 
y-glutamyltranspeptidase (y-GTP) than did males. These workers reported 
tha t there were significant increases in cysteine content in females 
compared to males a t 7 weeks of age, but not a t 12 weeks of age. GSH is 
degraded to cysteine by two successive reactions involving y-GTP and 
dipeptase. Hepatic y-GTP and glutathione peroxidase activities were also 
significantly higher in females than males. This could account for the 
relative resistance to TTZ seen in female rats since cysteine 
(N-acetyl-L-cysteine) has been shown to be protective against glutathione 
depletion by replenishing glutathione (Wong et al., 1986; Cotgreave et al., 
1987).
It has also been reported that GSH resynthesis in  hepatocytes from 
neonatal mice is grater than in those from adult mice after DEM exposure 
(Harman and Henry, 1987). Hepatocytes from young mice have a greater 
capacity to resynthesize GSH after depletion with DEM. It is known that 
DEM rapidly alkylates GSH in the hepatocyte (Chauseaud, 1974). Since 
GSH concentrations in the cell are controlled by a non-allosteric feedback
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mechanism (Richman and Meister, 1975), when GSH concentrations decrease 
rapidly, the hepatocyte will attem pt to resynthesize more GSH. Despite 
deficiency of the GSH-transferase mediated reaction, the ability to rapidly 
resynthesize GSH may explain why neonatal mice were less susceptible to 
toxic electrophillic metabolites compared to adults. The rapid replenishment 
of GSH stores could aid in the protection of vital nucleophilic sites from 
electrophilic attack by reactive metabolites (Harmon and Henry, 1987). 
Therefore, immature rats could also rapidly resynthesize GSH stores and in 
so doing aid in protection against TTZ toxicity. This could explain why 
30-40 day old rats were resistant, although GSH repletion would have to 
happen very rapidly in order to protect against TTZ induced lung damage. 
When immature rats were pretreated with DEM, it  apparently depleted 
GSH stores and allowed TTZ to exert its toxic effect before animals were 
able to resynthesize enough glutathione to counteract the effect.
Clinical signs of intoxication (severe respiratory distress, dyspnea, 
cyanosis, prostration or listlessness, and ruffled fur) were observed in adult 
and immature rats of both sexes in  rats treated with DEM. In rats that 
subsequently died, large amounts of a  white frothy discharge were expelled 
from the nostrils. In previous studies with TTZ alone, immature rats did 
not show any clinical signs of intoxication. This observation in itself 
shows that DEM pretreatm ent potentiated the toxic effects of TTZ in 
immature rats. Clinical signs of intoxication in the adult male and female 
were more severe and occurred with a more rapid onset of action than in 
rats treated with TTZ alone. Death, however, usually occurred within 1-1.5
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hr in both adult and immature rats. Macrosocopic lesions were also more 
severe (mottling of the lungs, pulmonary edema and effusion) than in rats 
treated with TTZ alone.
Histopathologic evaluation of adult male rats treated with DEM and TTZ 
in combination showed no hepatic structural alterations. However, 
histological changes observed in the lungs of male rats pretreated with 
DEM+TTZ in  combination included severe perivascular and interstitial 
edema. Edema was located principally around blood vessels with slight 
infiltration of neutrophils, macrophages and lymphocytes. The changes seen 
were the same as those observed in adult male rats dosed with TTZ alone. 
These results show that the lung is the pricipal site of action or target 
organ for TTZ toxicity.
Diethylmaleate pretreatment potentiated the effects of TTZ in adult female 
rats. Histological changes observed in the lungs of female rats were the 
same as those observed in adult male rats dosed with a  toxic dose of TTZ. 
The pathology was evidenced as large areas of perivascular and 
peribronchiolar edema with some distension into the alveoli (interstitial 
edema), and there also was a  mild interstitial inflammatory response 
(infiltration of neutrophils, macrophages and lymphocytes). Previously only 
small areas of perivascular edema were observed when rats were dosed with 
TTZ alone, and peribronchial and interstitial edema were not present. 
These histological findings correlate well with the DEM-TTZ toxicity study 
in female rats whereby DEM pretreatm ent increased mortality caused by
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TTZ in female rats. These results also suggest that the lung is the target 
organ for TTZ toxcity.
DEM+TTZ in combination did not affect liver weights and liver to body 
weight ratios in adult male and female rats. However, a significant 
increase in liver weight and liver to body weight ratios was observed in 
immature rats. These livers were not subjected to histopathologic 
examination, so the exact mechanism by which this occurs is not fully 
understood. Lung weights and lung to body weight ratios were increased 
in adult male, adult female, and immature rats (40 day old) after exposure 
to DEM and TTZ. These weights and ratios were approximately 2 times 
higher than lung weights and lung to body weight ratios from rats dosed 
with TTZ alone. In summary, DEM pretreatm ent potentiated the toxic 
effects of TTZ in adult male, adult female and immature rats of both sexes.
Innate and TTZ induced resistance
Young or immature rats have been shown to be highly resistant to the toxic 
effects of ANTU during the 3rd, and 4th weeks of life. However, toxicity 
developed rapidly during the following 2 weeks (Dieke and Richter, 1945, 
1946; Ven Den Brink et al., 1976). According to studies by Ven Den Brenk 
et al, (1976), weanling 3-4 week-old female rats weighing from 50-80g were 
very resistant to ANTU; no significant pulmonary edema or effusion 
developed after injection of 100 mg ANTU/kg body weight and there were 
no deaths. This innate resistance of weanlings to ANTU decreased
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relatively rapidly during postnatal development. By the time they were 6 
weeks of age the maximal tolerated dose (MTD) of ANTU had decreased to 
approximatly 5 mg/kg ip.
Immature rats of both sexes showed no toxic response to TTZ when dosed 
either orally or ip. No clinical signs of toxicity were observed up to 6 
weeks (45 days) of age, but toxicity developed rapidly during the next two 
weeks (50-55 days of age) in  male rats. Immature female rats however, 
remained resistant through the 55th day. This apparent resistance in 
immature ra ts could be due to immaturity of drug metabolizing enzyme 
systems (Kato and Kamataki, 1982; Chengelis, 1988). Enzyme activities 
(cytochrome P-450) are low in immature rats but increase with age. Kato 
et al., noted as early as 1964 th a t age related differences in metabolism 
may be responsible for age-related differences in toxicity. It is reasonable 
to suggest that as male ra ts age the rate of metabolism of TTZ to a toxic 
metabolite may increase and it  is that metabolite tha t produces the 
pulmonary toxicity. However, this is not observed to the same degree in 
female rats. Clear sex differences in the activites of drug metablolizing 
ezyme systems are not observed until 30 days of age ( Kato et al., 1962b). 
The activities of microsomal drug metabolizing enzymes are clearly increased 
in male ra ts over those of female ra ts a t 50 days of age. This could explain 
why female rats are still resistant a t 55 days of age and relatively resistant 
(compared to males) as adults.
The prior treatm ent of susceptible, older animals with small sub-lethal doses 
of ANTU produced striking tolerance to subsequent administration of larger 
doses of ANTU (Me Closky and Smith, 1945; Ven Den Brenk et al., 1976; 
Richter, 1946; Meyer and Sanders, 1949; Sabonya and Kleinerman, 1973). 
Ven Den Brenk et al., (1976) found tha t tachyphylaxis to ANTU in 6 week 
old rats was induced rapidly by 3 or 4 daily doses of 2 mg ANTU/kg. The 
subsequent injection of lOOmg ANTU/kg caused no pulmonary edema or 
pleural effusion. The tachyphylaxis was dose-dependent and lasted for 3 
weeks. The pretreatm ent of rats with sub-lethal doses of ANTU daily for 
5 days decreased the activity of the lung mixed-function oxygenase enzyme 
system tha t metabolized parathione and ANTU in vitro (Boyd and Neal, 
1976). A similar effect was observed with CS2 (Bond and De Matteis, 1969), 
and other thiono-sulfur compounds (Hunter and Neal, 1975) on ra t liver 
mixed-function oxygenase activity. The pretreatm ent of ANTU also caused 
a decrease in both covalent binding and pulmonary toxicity of “S-ANTU in 
vivo (Boyd and Neal, 1976). This suggested tha t a decreased rate of 
activation of ANTU in  ANTU-pretreated rats might have been a t least 
partially responsible for the development of tolerance.
Resistance to TTZ in adult male ra ts  (8weeks or older) was produced after 
either prior exposure to a single sublethal dose (lm g TTZ/kg) or in animals 
th a t survived a toxic dose of TTZ (10 mg/kg). This resistance was not 
dose-dependent and lasted for 8 weeks in orally dosed animals. The fact 
tha t TTZ-induced tolerance can be produced by a single sub-lethal dose of 
lmg TTZ/kg is remarkable, and in this respect different from the
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tachyphylaxis produced by ANTU and other thioureas, including 4-ipomeanol 
(another specific pulmonary toxicant). Tolerance to normally lethal doses 
of these compounds can also be produced by prior administration of small, 
non-lethal doses of the toxin itself, but several repeated doses appear to be 
necessary. For example, pretreatm ent of rats for 7 days with 7 mg/kg ip 
of 4-ipomeanol increased the LD50 by nearly three-fold, and ANTU required 
a t least 3 or 4 daily doses of 2 mg/kg for several weeks to produce 
tachyphylaxis. In all cases the covalent binding after a normally lethal 
dose was decreased in the lungs and livers of tolerant rats.
According to Boyd, (1980) there are several possible mechanisms that may 
account for the decreased covalent binding and toxicity of these compounds 
in tolerant rats. First, the amount of reactive metabolite formed in the 
lung after administration of sub-lethal doses may have been sufficient to 
destroy a portion of the enzyme system that mediated its formation, but 
insufficient to cause lethal pulmonary damage. Therefore on subsequent 
challenge with large doses of toxin there may not be sufficient enzyme 
activity remaining to form the toxic metabolite required to cause 
pathological changes seen in affected animals. Secondly, the injury from 
sub-lethal doses might lead to decreased activity of enzymes mediating the 
covalent binding because of a  shift in residual cells to synthetic pathways 
for repair rather than mixed function oxidations. Finally, tolerance 
development could also have been due to induction of metabolic detoxication 
pathways. The exact mechanism of tolerance development to TTZ is not 
clearly understood. The possibility tha t metabolism of a  single
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sub-lethal dose of TTZ would produce a highly reactive metabolite in the 
liver or lung tha t destroys a  significant portion of the enzyme system that 
mediated its formation, thereby causing the enzyme system to remain 
inactive for 8 weeks, is highly unlikely. However, TTZ could delete 
receptors, resulting in resistance, and their restoration would depend on 
DNA-dependent RNA synthesis and post-transcriptional events leading to 
protein synthesis. Intraperitoneal administration of TTZ was more toxic 
than oral dosing and the length of resistance was also decreased from 8 wks 
to 6 wks. This difference could possibly be due to the three-fold increase 
in toxicity when rats were dosed ip with TTZ, thereby causing decreased 
resistance or increased response of animals to a toxic dose.
Effect of sex steroids on TTZ toxicity
Female rats were shown to respond differently to TTZ when dosed on 
different days of the week and mortality ranged from 20-100%. This lead 
to the development of a study testing the effects of changes in the estrous 
cycle on TTZ toxicity. Results showed that changes in estrus did not 
significantly affect TTZ toxicity and variable responses were observed for 
each stage of the cycle ( proestrus, diestrus, estrus, and metestrus). 
However, the highest mortality was obtained a t 62.5 mg TTZ/kg, when rats 
were in the proestrus stage. Due to continued variation in response 
observed in female rats, their relative resistance to TTZ, and resistance in 
immature rats of both sexes, a study was designed to determine if sex 
steroids had an effect on TTZ toxicity. Sex steroids have been shown to
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regulate the concentrations of some enzymes, to including the flavoprotein 
containing monooxygenases. Therefore they could increase or decrease 
metabolism of certain xenobiotics. In this study, neither P-estradiol nor 
testosterone significantly affected TTZ toxicity in adult male, adult female 
or immature rats of either sex, suggesting that they do not influence the 
toxic action of TTZ.
Effect of TTZ and DEM+TTZ in combination on hepatic microsomal and 
cytosolic enzymes
At least two enzyme systems are known tha t might play a role in activating 
toxic thioureas. Cytochrome P-450 dependent oxygenases are known to 
activate certain thionosulfur compounds (Dalvi et al., 1974; Kamataki et al., 
1976; Hunter and Neal, 1975; De Matteis, 1974; De Matteis and Seawright, 
1973; Bond and De Matteis, 1969). In vitro incubation with ANTU 
inhibited the ability of ra t liver microsomes to metabolize parathion and 
benzphetamine and brought about a decrease in the level of cytochrome 
P-450 (Hollinger et al., 1974). ANTU and other thiono-sulfur-containing 
compounds affected these param eters only when incubated with microsomes 
in the presence of NADPH (Dalvi et al., 1974; Hunter and Neal, 1975; De 
Matteis and Seawright, 1973; De Matteis, 1974). These experiments showed 
that metabolism of ANTU was required for it to produce its damaging effect 
on mixed-function oxidase systems in vitro Cunningham and Hurley, (1972) 
suggested that a  metabolite of ANTU produced by the liver, rather than 
ANTU itself, reacts with the lung endothelium as the damaging agent
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because they could provide no explanation for the reason tha t the toxic 
effects of ANTU were restricted to pulmonary vascular endothelium. They 
postulated th a t such a metabolite could damage pulmonary endothelium and 
be inactivated before it  reached the systemic circultation. Butler et al., 
(1970) have shown tha t a  mechanism of this kind is responsible for the lung 
lesions caused by oral administration of the pyrrolizidine alkaloids.
Another mixed-function oxidase system th a t m ust be considered is the 
flavoprotein enzyme described by Poulsen et al., (1974; 1979). This enzyme 
system is capable of NADPH-dependent desulfuration of some thionocarbonyl 
compounds, and it  is reasonable to suspect tha t chemically reactive toxic 
intermediates could also be formed by this route. ANTU has been shown 
to be a  substrate for this system.
Effect on substrate metabolism
Glucuronidation is one of the major conjugation (phase II) reactions in the 
conversion of both exogenous and endogenous compounds to polar, water 
soluble compounds. There are several distinct forms of 
UDP-glucuronyltransferase (UDPGT). One form in particular (GTmc) has 
been shown to be induced by ctochrome P-448 specific inducers such as 
3-methylcholanthrene in the fiver (Bock et al., 1973). Metabolism studies 
by Scheline et al., (1961) showed tha t the highly toxic compound, 
phenylthiourea is metabolized in rats and rabbits by desulphuration to 
phenylcyanamide, as well as hydroxylation to p-hydroxyphenylthiourea. This
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metabolite is metabolized mainly by conjugation with glucuronic acid and 
sulphuric acid. Because of the susceptibilty of certain glucuronides to 
enzymatic and chemical degradation, glucuronides may serve to transport 
potentially reactive compounds from the liver to the target tissues. Whether 
or not this could occur in the lung would depend on the presence of 
P-glucuronidase in that tissue. Hepatic microsomal UDPGT activity in 
adult female and immature male ra ts was significantly decreased, while this 
activity in adult male rats remained unaffected. These results could suggest 
that glucuronidation of TTZ was occurring in adult female and immature 
male rats, and tha t TTZ was being excreted as a non-reactive glucuronide. 
Likewise, the glucuronic acid conjugation of TTZ may occur to a lesser 
extent in adult male rats. There is also the possibility tha t glucuronides 
may transport a reactive metabolite of TTZ to the lungs.
Aldrin epoxidase, EROD and ECOD activities were not affected by TTZ. 
However, aldrin epoxidase activity in female rats was lower than  activities 
in adult and immature male rats. These results show that the P-450 
specific isozyme activity is very low in female rats. Aldrin epoxidase, 
EROD and ECOD activities, relative to cytochrome P-450 content, were 
increased two-fold in both control and TTZ treated immature male and 
female rats. In summary, cytochrome P-450 and cytochrome P-448 specific 
activities remained stable in  the presence of TTZ.
Diethylmaleate+TTZ in combination did not affect UDPGT activity in the 
adult male, adult female or 40 day old rats and did not significantly affect
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cytochrome P-450 or P-448 specific activities such as aldrin epoxidase (AE), 
EROD and ECOD in adult and immature male rats. However female rats 
had lower AE activity compared to non-induced male, immature male and 
induced male rats. This is likely since female rats have very low 
cytochrome P-450 specific isozyme activity. Aldrin epoxidase, EROD and 
ECOD activities in DEM+TTZ treated rats relative to cytochrome P-450 
content were also increased approximately two-fold, which is the same 
response as observed in rats treated with TTZ alone. These results show 
that these activities are stable even when DEM is administered coincident 
with TTZ, i.e. DEM had no effect and did not alter the effect of TTZ.
Effect on components of the hepatic microsomal monooxygenase system
Treatment with TTZ did not produce changes in the cytochrome P-450 
complex in adult male or immature male rats. However, cytochrome P-450 
content in adult female rats was increased. Cytochrome b5 content and 
NADPH cytochrome-C-reductase were unaffected . These latter two do not 
exist as a family of isozymes, but they are important components of the 
cytochrome P-450 electron transport system. The fact th a t these 
components were not affected suggests tha t they were available in  sufficient 
quantities in the liver for metabolism to take place even in  the presence of 
TTZ. It also suggests tha t there was little or no damage to the 
endoplasmic reticulum caused by the production of a reactive metabolite. 
NADH cytochrome-b5 reductase activity was significantly lower in 
immature ra ts than activity in adult male and female rats. However,
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NADH cytochrome b5 reductase activity was much higher than NADPH 
cytochrome-C-reductase activity, which is consistent with previous studies 
by Chengelis (1988). There were also marked age and sex differences 
associated with NADH cytochrome-b6-activity; however, the exact meaning 
of the changes in terms of cytochrome b5 involvement in microsomal MFO 
activity remains to be determined. Although TTZ did not affect the 
components of the hepatic microsomal monooxygenase system in liver, these 
components may be drastically reduced in lung microsomes. Further studies 
should be performed to determine the effects of TTZ on the microsomal 
monooxygenase system in the lung.
DEM and TTZ in combination did not affect the hepatic microsomal 
monooxygenase system components (cytochromes P-450 and b5 content, 
NADPH cytochrome-C-reductase and NADH cytochrome b5 reductase 
activities). However cytochrome P-450 content was decreased in adult male 
rats. These results show th a t TTZ may be affecting cytochrome P-450 
concentration when glutathione stores have been depleted by DEM, or DEM 
itself may be affecting the cytochrome P-450 monooxygenase system by 
inhibiting protein synthesis through some non-specific effect.
Effect on glutathione-S-transferase and GSH concentrations
Glutathione, a  tripeptide consisting of glutamic acid, cysteine, and glycine, 
is a cellular thiol tha t participates in a wide range of protective and 
maintenance processes. Protective functions which receive continuing
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attention include conjugation with electrophillic toxins, reaction with 
oxidants and scavenging of radicals, intracellular transport of amino acids, 
thiol-disulfide exchange with proteins, and provision of coenzymes for several 
biochemical reactions (maintenance functions) (Meister and Anderson, 1983; 
Meister and Tate, 1976). Hepatic glutathione concentrations appear tightly 
regulated by feedback inhibition of y-glutamylcysteine synthetase by 
glutathione itself, and by limiting availability of the sulfur amino acid 
precursor, L-cysteine (Kaplowitz et. al., 1985; Richman and Meister, 1975).
It is well known th a t glutathione-S-transferase (GST) is responsible for GSH 
conjugation of the active metabolites formed via cytochrome P-450- coupled 
monooxygenases. The degree of hepatotoxicity caused by reactive 
metabolites depends directly on the GST activity in liver (Igarashi et al.,
1983). According to studies by Mitchell et al., (1982), the toxicity of many 
indirect hepatotoxins is modulated by the availability of glutathione: toxicity 
is not generally manifested until after the glutathione is consumed in 
reactions with reactive metabolites. Therefore, the availabilty of 
glutathione, not the activity of glutathione-S-transferase, may be a  more 
critical factor in determining sensitivity to hepatotoxins.
Glutathione-S-transferase activity in adult males and females and 40 day 
old males was not affected by TTZ nor was i t  affected by DEM+TTZ in 
combination, thus indicating tha t enzyme was available a t levels sufficient 
for conjugation with metabolites of TTZ. However, TTZ was shown to 
produce a dose-dependent decrease in glutathione (GSH) or non-protein
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sulfhydryls (NPSH) in  the lungs of adult male rats. Glutathione 
concentration was also decreased in the lungs of female rats. However, no 
dose-dependent relationship was observed. TTZ did not affect glutathione 
concentrations in the liver of either adult male or female rats. These 
results suggest tha t glutathione probably plays a protective role in the 
metabolism of TTZ in both male and female rats and tha t glutathione 
concentration in the lung is very important in the detoxification of locally 
produced reactive metabolites.
Evidence for GSH involvement in the protection of the ra t lung against the 
deleterious effects of TTZ was produced by analyzing GSH levels following 
diethylmaleate (DEM) treatm ent. Diethylmaleate reacts with GSH and 
depletes cytoplasmic stores (Anders, 1978; Meredith and Reed, 1982). The 
depletion of hepatocyte glutathione by DEM never exceeds 90% to 95% of 
total cell glutathione content. Hepatocytes thus depleted can remain viable 
for several hours, eventually resynthesizing the orginal complement of GSH 
(Reed and Fariss, 1984).
DEM has been shown to potentiate the hepatotoxic effects of allyl formate 
in trout (Droy, 1988). Hanson and Anders (1978) showed tha t DEM 
pretreatment of rats exposed to normally sub-lethal doses of allyl alcohol 
produced 100% mortality. DEM pretreatm ent also potentiated 
acetominophen-induced hepatic necrosis in mice (Mitchell et al., 1973).
Previous studies by Boyd and Neal (1976) with thioureas and ANTU 
suggested tha t sulfhydryl compounds could modulate susceptibility to the 
toxicitiy of thioureas. DEM depleted the lung and liver GSH levels by 
approximately 80%. Both pulmonary toxicity and in vivo covalent binding 
after the administration of ANTU were strikingly increased by DEM 
pretreatment. They assumed that GSH could detoxify reactive species 
involved in the toxicity of thioureas, possibly by forming non-toxic 
conjugates. The results of in  vitro studies by Hollinger et al., (1976), using 
lung slices, also appeared to be consistent with this hypothesis. In vitro 
binding of radioactivity from 14C thiourea to lung protein could be 
antagonized either by cysteine or by reduced glutathione. Conversely, 
elevated binding of radioactivity was observed when 14C-thiourea was 
incubated with lung slices obtained from animals whose tissues were 
previously depleted of GSH by pretreatm ent with DEM in vivo. This could 
have been due to resynthesis of glutathione because the cytosolic pool of 
glutathione is resynthesized within 2 h r after depletion and peak effects of 
DEM are observed after about 30 min, and decrease thereafter.
DEM itself depleted glutathione stores in both liver (to 10.5% of control) 
and lung (to 7.1% of control) and DEM-TTZ in combination depleted liver 
GSH stores to 1.09% of control and lung GSH to 27.1% of control in adult 
male rats. DEM depleted female GSH in the liver to 25.9% of control and 
lung GSH to 22.1% of control. GSH concentrations in females administered 
DEM-TTZ were depleted to 18% of control in the liver and 43% of control 
in the lungs. Although GSH concentrations in DEM-TTZ treated males and
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females were slightly lower in  the liver and higher in the lungs, they were 
not significantly different. This increase in GSH in the lungs may also be 
due to subsiding effects of DEM, as resynthesis of GSH in the lung is faster 
than resynthesis in the liver. Glutathione concentrations in the lung of 
female rats were twice as high as those of males administered DEM+TTZ. 
The fact tha t higher concentrations of GSH were present in the lungs of 
female rats after depletion with DEM sugggests tha t more GSH was 
available to deactivate reactive metabolites formed by metabolism of TTZ. 
This could also explain why female rats were relatively resistant to TTZ.
Effect of enzyme induction and inhibition on TTZ toxicity
Pretreatm ent of rats with other drugs has been shown to affect ANTU 
toxicity (Ven Den Brenk et al., 1976). Pretreatm ent with 3-4 benzpyrene, 
a cytochrome P-448 isozyme inducer, reduced the toxic effects of ANTU by 
reducing pulmonary edema and effusion (Ven Den Brenk et al., 1976). 
Pretreatm ent of rats with phenobarbital, a  P-450 inducer, was much less 
effective. Neither piperonyl butoxide or SKF-525A, which inhibit the 
induction of microsomal enzymes in liver and other tissues (Conney,1967), 
increased the toxicity of ANTU. SKF-525A had no significant effect and 
piperonyl butoxide actually decreased ANTU-induced lung damage. 
Tachyphylaxis and/or resistance in ANTU treated animals induced by 
pretreatment with iodide and thiourea derivatives as well as by unrelated 
agents such as 3-4 benzpyrene and barbiturates suggested tha t resistance 
resulted from the induction of drug metabolizing enzymes in the animal
(Ven Den Brenk et al., 1976). Cunningham and Hurley (1952) suggested 
tha t a  metabolite of ANTU of hepatic origin, rather than ANTU itself, 
reacted with lung endothelium to produce the damaging event. 
Pretreatm ent with thyroid hormones also increased ANTU induced 
pulmonary edema but thyroidectomy had no significant effect on the toxicity 
of ANTU. It has also been reported tha t the sulfhydryl compounds, cysteine 
(Dubois et al., 1946; Karel and Meyer, 1948), glutathione (Giri and Combs, 
1979; Karel and Meyer, 1948) and 2-aminoethylisothiouronium bromide, 
(Ven Den Brenk et al., 1976) protected rats against the lethal effects of 
thiourea derivatives. Giri and Combs, (1970) found that cysteine and 
reduced glutathione inhibitied both the pulmonary endematogenic effect and 
the hyperglycemic effect of phenylthiourea in rats. These results suggested 
tha t sulfhydryl compounds could modulate susceptibility to the toxicity of 
thioureas and th a t glutathione plays a  protective role in the metabolism of 
ANTU and other thioureas. Lung damage caused by ANTU has been shown 
to be reduced by pretreatm ent with cysteine (Du Bois et al., 1946; Karel 
and Mayer, 1948). However, this was accounted for by loss of fluid into the 
peritoneal cavity due to the irritative effect of cysteine. Another sulfhydryl 
agent, 2-aminoethylisothiouroniom bromide (AET), which did not cause 
peritoneal reactions, greatly reduced the toxic effects of ANTU.
In this study pretreatm ent of rats with other drugs also affected the toxicity 
of TTZ. P-Napthoflavone (BNF) induction of the microsomal mixed function 
monooxygenase system (specifically, cytochrome P-448) in rats completely 
protected adult male rats against the toxicity of TTZ. BNF induced
cytochrome P-448 in the liver as well as the lungs. BNF induced 
protection against TTZ could have occurred because increased metabolism 
of TTZ in the liver resulted in a  decreased concentration of TTZ presented 
to the lungs because of the first pass effect. Phenobarbital (PB) induction 
of the cytochrome P-450 isozyme did not significantly affect TTZ toxicity in 
male rats. This is expected since PB does not induce cytochrome P-450 in 
the lung and TTZ is probably not being metabolized by the cytochrome 
P-450 isozyme. Neither a-napthoflavone (ANF), a cytochrome P-448 
isozyme inhibitor, nor SKF-525A, a cytochrome P-450 isozyme inhibitor in 
liver and other tissues (Coney, 1967; Jenner and Netter, 1972), reversed the 
effects of BNF or PB induction on TTZ toxicity. Specifically, ANF did not 
reverse BNF induced protection against TTZ in adult male rats. This can 
be explained by the fact tha t ANF would have blocked the cytochrome P-448 
mediated metabolism of TTZ to a toxic metabolite in both liver and lung, 
there could be no reversal to toxicity. SKF-525A did not increase or 
decrease the toxicity of TTZ in PB induced adult male rats because PB 
induces the cytochrome P-450 isozyme and not P-448 isozyme. If toxic 
metabolites were produced by cytochrome P-448, PB induction could have 
no effect. In  any event, SKF-525A could not have blocked PB induced 
increases in cytochrome P-450 isozyme mediated metabolism in the lung, 
because PB has been shown not to induce this isozyme in the lung of rats 
(Parke and Ioannides, 1984). These results suggest th a t resistance in male 
rats pretreated with BNF may be due to stimulation of cytochrome P-448 
isozyme activity. This phenomenon is of considerable importance in the 
hepatic metabolism (activation) of many drugs, but it also takes place in the
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lung and other organs (Conney, 1967). These results also suggest tha t the 
cytochrome P-448 isozyme is responsible for metabolism of TTZ to a reactive 
toxic metabolite.
All induced animals (BNF and PB) had significantly higher cytochrome 
P-450 content than non-induced rats, which shows th a t induction did occur. 
TTZ itself did not affect the components of the hepatic microsomal 
monooxygenase system (cytochromes P-450 and b5, NADH cytochrome-b5 and 
NADPH cytochrome-C-reductases), glutathione-S-transferase and 
UDP-glucuronosytransferase activiies in PB or BNF induced rats. Aldrin 
epoxidase , EROD and ECOD activities were also unaffected. However, 
cytochrome P-450 content in PB induced rats administered DEM-TTZ in 
combination was significantly decreased from DEM controls and cytochrome 
P-420 content was also increased in DEM-TTZ treated animals. According 
to studies by Magos and Butler (1972), Bond et al., (1969), and Magos et 
al., (1973), in animals pretreated with phenobarbital, carbon disulfide (CS2) 
causes greater fractional decreases in both drug metabolizing enzymes and 
cytochrome P-450 levels. This effect was aggravated by short-term 
starvation. Starvation significantly decreased the urinary excretion of both 
CS2  and its bivalent sulfur metabolites in exposed ra ts (Magos, 1972) and 
starvation also contributed to the development of liver necrosis in 
phenobarbital-pretreated animals (Bond et al., 1962). It has alo been 
recorded tha t starvation caused glutathione depletion (Reed and Fariss,
1984). Because of this it  was suggested that the effect of phenobarbital on 
carbon disulphide induced hepatotoxicity might not be mediated through the
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formation of a  more toxic metabolite as considered previously by Greim, 
(1970). However, Potter and Neal (1977) suggested th a t the decrease in 
cytochrome P-450 levels and monooxygenase activity was due to covalent 
binding to the sulfur atom released from parathion and carbon disulfide. 
In phenobarbital induced DEM-TTZ treated rats, the decrease of cytochrome 
P-450 levels and monooxygenase activity may also be due to covalent 
binding of P-450 to the sulfur atom of TTZ. Aldrin epoxidase and ECOD 
activities were also decreased which could also be attrubuted to decreased 
cytochrome P-450 specific monooxygenase content.
NADH cytochrome-b5-reductase activity in PB induced DEM control male 
rats was decreased from non-induced and BNF induced rats. NADPH 
reductase activity in PB induced DEM controls was significantly increased 
compared to non-induced rats, while NADH and NADPH reductase activities 
in PB induced DEM-TTZ treated animals was not different from 
non-induced DEM controls, BNF+DEM controls, and TTZ treated 
non-induced and BNF induced animals. Since no differences were observed 
in the DEM-TTZ treated groups from DEM controls, the exact reason for 
the variation observed in  the control group remains to be established. 
However, NADH cytochrome b6 reductase is a cytochrome P-450 specific 
activity and DEM may have decreased its activity through a non-specific 
effect. NADPH cytochrome-C-reductase activity was increased in PB 
controls over that of all non-induced and BNF- induced DEM treated rats. 
Although NADPH reductase activity in PB induced DEM-TTZ rats was 
lower than PB induced DEM controls the values were within the range of
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non-induced and BNF induced DEM treated animals. The exact reason for 
this response remains to be established.
Glutathione-S-transferase (GST) activity in PB induced male rats was 
significantly higher than activity in adult male and female non-induced rats. 
This was not unexpected since it  is known th a t PB induces GST (Lee et al.,
1985). However, GST activity in PB induced DEM+TTZ treated animals 
was not different from PB induced DEM controls suggesting tha t this 
activity was unaffected by DEM-TTZ.
Effect of N-acetvl-L-cvsteine on TTZ toxicity
N-acetyl-L-cysteine, a glutathione precursor, has been shown to 
increase the rate of glutathione synthesis, resulting in prolonged elevation 
of the hepatic glutathione pool (Wong et al., 1986). NAC has been shown 
to be protective against diquat-induced cytotoxicity in isolated hepatocytes 
Cotgreave et al., 1987) and it has been shown to protect the liver against 
allyl formate induced toxicity (Droy, 1988). Additionally,it has been shown 
to lower the cytotoxic effects of allyl and benzyl isothiocyanate in 
hepatocytes (Bruggeman et al., 1986). Pretreatm ent of rats with NAC 
protected them against TTZ toxicity, which indicates tha t glutathione (GSH) 
concentrations are important in preventing the toxicity of TTZ and that 
GSH could play a protective role in its toxicity. This again may indicate 
tha t a reactive metabolite is produced via the cytochrome P-448 isozyme. 
Further evidence supporting a major protective role of GSH was provided
by glutathione studies with NAC and TTZ. NAC maintained glutathione 
concentrations significantly above control values in the liver of adult male 
rats even in the presence of a toxic dose of TTZ. However, lung glutathione 
concentrations were m aintained a t approximately control levels even in the 
presence of TTZ (87.2% of control). This could explain why NAC was 
protective against TTZ toxicity in male rats. Glutathione concentrations in 
the liver of adult female ra ts  were maintained a t approximately control 
values when pretreated with NAC and also in the presence of a toxic dose 
of TTZ (91.2% of control). Female GSH concentrations, compared to GSH 
concentration in male rats, were not increased above control values 
suggesting tha t NAC did not increase the rate of synthesis of GSH in the 
liver of female rats. These results also suggest tha t GSH synthesis in 
females may be high enough to keep up with the depletion caused by TTZ. 
It is also possible, of course, tha t NAC does not replenish GSH stores in 
female rats. Tateishi et al (1974) have shown th a t the concentration of 
cysteine may limit the overall rate of GSH synthesis and he also suggested 
tha t hepatic GSH concentration may be regulated by the activities of y-GTP 
rather than the rate of glutathione synthesis. GSH concentrations in female 
ra t lungs were significantly decreased from control values when pretreated 
with NAC (43% of control), and were decreased even more when female rats 
were pretreated with NAC and dosed with TTZ (33% of control). The exact 
mechanism by which this sex related difference occurs is not understood.
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Effect of DEM and BSO on TTZ and BNF induced resistance
DEM pretreatment abolished the resistance in adult male rats obtained by 
prior exposure to a sublethal dose of TTZ or survival from a toxic dose. 
However, BSO did not affect TTZ induced resistance and rats remained 
non-susceptible to TTZ toxicity. BNF induced resistance was also abolished 
by DEM pretreatment but, BSO pretreatm ent did not affect BNF induced 
resistance. These results indicate th a t when glutahione concentration in 
the lung of TTZ induced and BNF induced resistant animals is reduced by 
DEM they become susceptible to TTZ toxicity. This again suggest that 
glutathione plays a protective role in  the metabolism of TTZ.
Mechanisms of toxic action
According to studies by Boyd and Neal (1976), ANTU toxicity requires the 
microsomal monooxygenase-catalyzed activation of the compound a t the 
thiocarbonyl locus of the molecule. Tolerance to the lung toxicity of 
ANTU may result from decreased monooxygenase activity produced by prior 
dosing either with ANTU itself, or by dosing with 4-ipomeanol. Evidence 
for the involvement of the cytochrome P-450 containing monooxygenase 
system in this activation reaction comes from in vitro studies with other 
thiono-sulfur-containing compounds (Dalvi et al., 1974; 1975; Hunter and 
Neal, 1975; DeMatteis and Seawright, 1973; Norman et al., 1974; Omura 
and Sato, 1964; Norman and Neal, 1976; DeMatteis, 1974). Boyd and Neal 
(1976) also considered the flavin-containing monooxygenase system described
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by Poulsen et al., (1974). This system is capable of NADPH-dependent 
desulfuration of some thionocarbonyl compounds, and it  is reasonable to 
suspect that chemically reactive intermediates could also be produced via 
this route. ANTU has also been shown to be a substrate for this enzyme 
system.
According to studies by Parke and Ioannides (1984), the activation of toxic 
chemicals and carcinogens into reactive metabolites involves oxygenation in 
hindered positions of the molecule by cytochrome P-448 (LM4), flavoprotein 
oxidoreductases, or transoxygenation during prostaglandin biosynthesis. 
Cytochrome P-450 (LM2) does not oxygenate in  hindered positions and 
generally detoxicates carcinogens and toxic chemicals. Vodicnik et al., 
(1981) demonstrated tha t a significant sex difference could be observed with 
the P-448 isozyme. For example, in female ra ts cytochrome P-448 specific 
activity, estimated using ethoxyresorufin as a substrate, was much higher 
than activity in males. These results indicated th a t a P-448 isozyme exists 
in female microsomes in higher quantities or activities than in  microsomes 
from male rats. Ethoxyresorufin has been reported to be a specific 
substrate for P-448, which is inducible with agents such as 
3-methylcholanthrene (Burke and Mayer 1974; 1975; Burke et ad., 1977) 
and BNF (Levin et al., 1977; Ioannides and Parke, 1987). Cytochrome 
P-448 is also found predominately in the neonatal ra t and decreases 
postnatally, whereas P-450 is low in neonates and increases with age 
(Ioannides and Parke, 1987).
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The results of the present study suggest that TTZ may be metabolized to 
a short-lived reactive toxic metabolite in the lung by the cytochrome P-448 
isozyme. Factors supporting this postulated mechanism include: 1)
P-napthoflavone (BNF) induction of the cytochrome P-448 isozyme obliterated 
TTZ toxicity. BNF induction could increase the rate of metabolism of TTZ 
in the liver because of increased P-448 isozyme activity. Since oral or ip 
administration would result in a first-pass effect, the amount of TTZ 
presented to the lungs and the rate of production of a reactive metabolite 
in the lung could be decreased, 2) Glutathione (GSH) concentrations were 
decreased by TTZ in the lung but not in the liver and depletion of 
glutathione stores in the liver and lung by DEM increases TTZ toxicity in 
adult male, adult female and immature rats of both sexes. This suggests 
that GSH probably plays a  major protective role in the metabolism of TTZ. 
Other evidence for glutathione involvement includes: a) L-buthionine-(SR)_ 
sulfoxamine did not increase TTZ toxicity and it  probably did not deplete 
GSH concentrations in the lungs; b) DEM reversed BNF and TTZ induced 
resistance whereas BSO did not; c) DEM increased the toxicity of TTZ in 
female and immature rats; and d) N-Acetyl-L-cysteine (NAC), which is a 
glutathione replenisher, protected against TTZ toxicity in male rats. Since 
GSH protects against electrophyllic metabolite damage, an electrophyllic 
metabolite was probably produced in the lung by the cytochrome P-448 
isozyme.
Some questions concerning the toxicity and metabolism of TTZ in rats 
remain. Immature rats were less susceptible to TTZ toxicity a t 30-40 days
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of age when they should have been more susceptible, since it  is reported 
that P-448 decreases as P-450 increases. However, many studies show that 
overall xenobiotic metabolism increases beyond 30-40 days of age in male 
rats. It could be tha t cytochrome P-448 is also increased in  males. This 
could also relate to postnatal changes in monooxygenase activity in the lung. 
Specifically, it  is not known whether the P-448 isozyme occurs in the lung 
of immature rats i.e., it may not occur until 50-55 days of age. Also, there 
could be enough GSH and glutathione transferase activity in the lung to 
protect immature rats, or the reactive metabolite produced in the lung may 
be less effective for some other reason related to the physiologic 
development of the lung of immature rats. Male vs female differences could 
be related to higher GSH concentrations in female liver and lung. However, 
this is not a complete explanation since toxicity would seem to require the 
production of a toxic metabolite in the lung. The lungs of female rats may 
also have more limited amounts of cytochrome P-448 isozyme activities than 
males.
Higher doses of TTZ definitely increased the concentration of GSH in the 
lungs of female rats. This may be a self-induced protective effect. If this 
is the case, then lower toxicity in females may relate to both low 
cytochrome P-448 in the lung and increases in GSH concentration.
Intraperitoneal administration of TTZ increased toxicity in males but 
decreased toxicity in females. This is difficult to explain since the first 
pass effect should have reduced the amount of TTZ entering the lungs of
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both males and females. It is possible that the first-pass effect is 
overwhelmed in  the male ra ts  and more gets to the lung to be metabolized 
to a toxic metabolite. In females, however, there may be a  saturation 
phenomenon in which an alternate detoxifying mechanism increases in 
importance. This could also explain the finding tha t increasing oral doses 
in the female produced no further increase in toxicity.
There is also the question of TTZ induced resistance. This was studied in 
males only and showed tha t sublethal doses and potentially lethal doses of 
TTZ provided protection against TTZ toxicity for 8 weeks. This could 
suggest tha t TTZ is a  suicide substrate for P-448 which leads to a  decrease 
in the concentration of the cytochrome P-448 isozyme in the lung. It could 
also bind covalently to cytochrome P-448 in the lung, induce an alternate 
pathway in the liver whereby cytochrome P-450 would metabolize it to a 
non-reactive metabolite (which could be conjugated and excreted in the bile), 
cause induction of GSH or glutathione-S-transferase in the lung, or produce 
a self-limiting protective effect in the lung endothelium.
The possibility remains tha t TTZ could be metabolized to a toxic metabolite 
in the liver and transported as such to the lung. However, if this occurs 
the metabolite would have to be protected in some m anner during 
translocation, or it would react before getting to the lung. Theoretically 
TTZ could be conjugated in the liver and then deconjugated in the lung to 
produce a toxic metabolite.
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The flavin containing monooxygenase syustem has been shown to activate 
toxic thioureas, leading to the formation of chemically reactive 
toxic intermediates ( Poulsen et al., 1979). The experiments of these 
authors demonstrated that the microsomal FAD-containing monoooxygenase 
catalyzes the sequential S-oxygenation of thioureido compounds. Lipophilic 
N-substituted thioureas are oxidized to formamidine sulfinic acids through 
intermediate sulfenic acids and each step in  the sequence is enzymatic. The 
oxidation of thioureas to sulfinic acids may be an important pathway in 
their activation to toxic metabolites. Rats exposed to airborne formamidine 
sulfinic acid exhibited pathological changes similar to those observed with 
thioureas and the sulfinic acid was a t least 10-fold more toxic than 
thiourea. The microsomal flavin-containing monooxygenase activity is 
exceptionally high in pigs and humans but is low in rats (Casarett and 
Doull, 1986). However, it  has also been characterized in lung microsomes 
of pregnant rabbits (Williams et al., 1985). If the flavoprotein enzyme is 
uncoupled in the lungs of rabbits and amines are concentrated in the lungs, 
i t  could lead to the localized production of H202 or 02- radicals with 
subsequent peroxidative damage. TTZ may be metabolized and activated to 
a toxic metabolite by this system in  the lung of rats, but this possibility 
was not addressed in this study.
The flavin containing monooxygenase is not under the same regulatory 
control as cytochrome P-450. In fact, it  is repressed rather than induced 
by both phenobarbital and 3-methylcholanthrene treatm ent (Casarette and 
Doull, 1986). Additionally, i t  appears th a t the concentration of the enzyme
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is regulated by steroid sex hormones, with testosterone decreasing and 
progesterone increasing activity. This mitigates against its involvement, 
since sex steroids did not affect TTZ toxicity. In summary, it  is possible 
tha t this system is involved but little evidence was generated concerning its 
involvement in the present study. Ultimately, the answer to this question 
would only come from studies on the metabolism of TTZ in ra t lung.
CHAPTER 7 
SUMMARY AND CONCLUSIONS
1. The acute single oral dose LD50 for 2-thiotriazone (TTZ) in adult male 
rats was determined to 4.6 mg/kg and the acute intraperitoneal LD50 
was 1.4 mg/kg, which classifies it as a  highly toxic compound.
2. An LD50 could not be determined for female rats because the highest 
mortality produced a t concentrations of 2.5-1000 mg TTZ/kg was 40%. 
At concentrations of 5-100 mg/kg it  was not toxic to female rats when 
dose ip and an acute ip LD50 was calculated to >100 mg/kg.
3. TTZ did not produce mortality in immature rats of either sex when 
administered doses of 10-1000 mg/kg either orally or ip. An acute oral 
and ip LD50 was estimated to > 1000 mg TTZ/kg.
4. Acute toxicity testing with TTZ adult and immature rats of both sexes 
revealed tha t TTZ toxicity is both age and sex dependent.
5. Clinical signs of intoxication observed in affected animals included 
severe respiratory distress, dyspnea, labored breathing, cyanosis, 
prostration, ruffled fur and a  white frothy nasal discharge tha t was 
present in rate that subsequently died. In adult male rats these signs 
reached a maximum within 2-3 hr and death usually ensued. Rats
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th a t did not die appeared to recover completely. These signs lasted 
for longer periods of time in female rats (4-24 hr) and a  higher 
percentage of animals recovered. Immature rats did not exhibit any 
signs of intoxication.
6. Marked histologic changes were observed in the lungs of adult male 
rats treated with a toxic dose of TTZ. Major changes included acute 
interstitial and perivascular edema. Edema was largely restricted to 
the region around the blood vessels. Edema was also noted around 
bronchioles with some sepage into the alveoli. There was also 
substantially more fluid in the loose periarterial interstitium  than 
around the airways within the perivascular bundles, and there was 
more edema around the larger bundles. This edema was associated 
with mild inflammatory response with minimal numbers of 
neutrophils, macrophages, and lymphocytes. These changes along with 
macroscopic lesions (mottling of the lungs, pulmonary edema and 
effusion) confirm the lung as the principal site of action or target 
organ.
7. Female ra t lungs were much less edematous than male ra t lungs. 
Histologic examination revealed small quantities of perivascular 
edema. There was no interstitial or peribronchial edema present and 
no inflammatory response in female ra ts treated with TTZ.
8. Lung weights and lung to body weight ratios were significantly
226
increased in adult male, adult female, and 40-day old male rats 
treated with TTZ. However, liver weights and ratios were not 
increased, again confirming the lung as the principal site of action.
9. Toxicity of TTZ in male, female and immature male ra ts was markedly 
potentiated by diethylmaleate (DEM) pretreatment, indicating that 
glutathione plays a  protective role in the metabolism of TTZ. 
However, L-buthionine-(SR)-sulfoxamine (BSO) pretreatm ent did not 
affect TTZ toxicity in adult male rats because GSH stores were not 
depleted by BSO.
10. Clinical signs of intoxication in DEM-TTZ treated male, female and 
immature rats of both sexes were the same as signs observed in TTZ 
treated rats (severe respiratory distress, dyspnea, cyanosis, prostration 
or listlessness, and ruffled fur). In rats tha t subsequently died, large 
amounts of a white frothy discharge were expelled from the nostrils. 
However, these signs were more severe and occurred with a more 
rapid onset of action than in  rats treated with TTZ alone. Death 
usually ensued within 1-1.5 hr in both adult and immature male rats.
11. Histologic changes observed in DEM-TTZ treated adult male and 
female rats were the same as those observed in TTZ treated adult 
male rats. These changes were potentiated in female rats since only 
small amounts of perivascular edema were observed when exposed to 
TTZ alone. There were no changes observed in  the liver of DEM-TTZ
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treated rats. Macroscopic lesions observed in DEM-TTZ treated rats 
included mottling of the lungs, pulmonary edema, effusion, and large 
swollen lungs that filled the chest cavity. These changes also indicate 
that the lung is the site of action or target organ.
12. Lung weights and lung to body weight ratios of DEM-TTZ treated rats 
were 2 times (2x) higher than those of TTZ treated animals. However, 
like TTZ alone, DEM-TTZ in combination did not affect liver weights 
and liver to body weight ratios.
13. Immature rats of both sexes were resistant to TTZ up to 45 days of 
age. Resistance began to diminish by 45 days of age in male rats and 
by 55 days of age it  was completely diminished. However, female rats 
were still resistant up to 55 days of age.
14. Resistance was produced in  adult male rats by administration of a 
sublethal dose of TTZ (1 mg/kg) and in animals th a t survived a toxic 
dose of TTZ. This resistance lasted for 8 weeks in orally dosed rats 
and for 6 weeks in ra ts dosed ip.
15. Sex steroid (13-estradiol and testosterone) did not affect TTZ toxicity 
in adult male, adult female and immature rats of both sexes, 
indicating that they do not influence the toxic action of TTZ. Changes 
in the estrous cycle also did not affect TTZ toxicity in female rats 
indicating tha t changes in estrus do not influence the toxic action of
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TTZ in  females.
16. TTZ itself did not affect UDP-glucuronosyltransferase (UDPGT) activity 
in adult male rats. However, UDPGT activity was decreased in adult 
female and 40-day old male rats, indicating th a t TTZ may be 
metabolized by glucuronidation and excreted as a non-reactive 
glucuronide. Aldrin epoxidase, ECOD and EROD activities in male 
and immature male rats were not affected. However, aldrin epoxidase 
activity was significantly decreased in female rats which was 
consistent with previous reports of low cytochrome P-450 isozyme 
activity. Aldrin epoxidase, EROD and ECOD activities, in  relation to 
specific content of P-450, were increased two-fold in adult male, adult 
female and 40-day old male rats. Pretreatm ent with DEM did not 
cause any TTZ related effect on UDPGT, aldrin epoxidase, EROD or 
ECOD activities in male, female, and immature male rats. These 
results indicate that these activities are stable in  the presence of TTZ 
alone and even when animals are pretreated with DEM and 
administered TTZ, and tha t they are also present in  sufficient 
quantities to carry out metabolism in the liver.
17. Treatment with TTZ did not produce changes in the cytochrome P- 
450 complex in adult male rats. In contrast, the specific content of 
cytochrome P-450 was increased in female rats. Cytochrome b5 specific 
content and NADPH cytochrome-C-reductase activity were unaffected. 
NADH cytochrome-b5 reductase activity was significantly lower in 40- 
day old male rats than in adults. These results indicate th a t the
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components of the hepatic microsomal monooxygenase system are 
available in sufficient quantities in the liver for metabolism to take 
place, even in the presence of TTZ. DEM+TTZ in combination did not 
affect the hepatic microsomal monooxygenase system components. 
However, cytochrome P-450 specific content was decreased in adult 
male rats indicating th a t TTZ may be affecting cytochrome P-450 
when glutathione stores have been depleted with DEM or DEM itself 
may be affecting the cytochrome P-450 monooxygenase system.
18. Glutathione-S-transferase (GST) activity in adult and 40-day old male 
rats was not affected by TTZ alone or by DEM-TTZ in combination, 
indicating tha t GST was available a t levels sufficient for conjugation 
with metabolites of TTZ.
19. TTZ caused a dose-dependent decrease in  glutathione (GSH) content 
in the lung of adult male rats. It also decreased GSH concentration 
in the lung of female rats in  a  dose-independent manner, indicating 
that glutathione plays a protective role in the metabolism of TTZ in 
both male and female rats and tha t glutathione concentration in the 
lung is very important in the detoxification of cytochrome P-448 
mediated metabolite production.
20. Glutathione concentrations in the lungs of female rats administered 
DEM+TTZ in combination were twice as high as that of males 
suggesting tha t more GSH was available to deactivate reactive
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metabolites formed by metabolism of TTZ.
21. B-Napthoflavone induction of the hepatic microsomal monooxygenase 
system (specifically P-448) completely protected against TTZ toxicity 
in male rats. Phenobarbital induction of the cytochrome P-450 
isozyme did not significantly affect TTZ toxicity in male rats. Neither 
alpha-napthoflavone nor SKF-525A reversed the effects of BNF and PB 
induction on TTZ toxicity. These results indicate tha t the cytochrome 
P-450 isozyme is not responsible for the metabolism of TTZ, but that 
the P-448 isozyme could be involved.
22. All induced animals (BNF and PB) had significantly higher cytochrome 
P-450 specific content than non-induced rats, which shows that 
induction did occur. TTZ itself did not affect components of the 
hepatic microsomal monooxygenase system (cytochromes P-450 and b5, 
NADPH cytochrome-C and NADH cytochrome-b5 reductases), and it 
did not affect glutathione-S-transferase in PB and BNF induced rats. 
There were also no changes in substrate metabolism (UDPGT, EROD, 
ECOD and AE activities) attributed to TTZ treatm ent. However, 
cytochrome P-450 specific content in PB induced adult male rats 
administered DEM+TTZ was significantly decreased and cytochrome 
P-450 may be covalently bound with the sulfur atom of TTZ. Aldrin 
epoxidase and EROD activities in PB induced, DEM-TTZ treated rats 
were also decreased, which could be attributed to decreased 
cytochrome P-450 content. NADPH cytochrome-C-and NADH 
cytochrome b5 reductase activities were not affected. Glutathione-S-
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transferase activity was not affected in PB induced DEM-TTZ treated 
animals.
23. N-acetyl-L-cysteine, a glutathione precursor and replenisher, protected 
male rats against TTZ toxicity, indicating th a t GSH plays a protective 
role in the metabolism of TTZ.
24. N-acetyl-L-cysteine (NAC) alone increased GSH in the liver of male 
rats to 158% of control values and maintained GSH concentrations in 
the lung a t 96.9% of control values. I t also maintained GSH in the 
liver of female rats a t 89.8% of control, and lung GSH was decreased 
to 43.3% of control. These results indicate tha t NAC increased GSH 
in the liver and maintained it in the lung of male rats. GSH was 
maintained in the liver of female rats but not in the lungs, suggesting 
that NAC actually decreased GSH stores in female rats.
25. GSH in the liver of adult male rats treated with NAC-TTZ was 
increased to 140.5% of control values and was maintained a t 87.2% of 
control in the lung. GSH in NAC-TTZ treated female rats was 
maintained in the liver a t 91.2% of control values, but it  was 
decreased in the lung to 33.1% of the control, showing tha t NAC 
decreased GSH concentrations in the lung.
26. DEM pretreatm ent reversed or abolished TTZ induced resistance and 
BNF induced resistance in male rats, indicating th a t glutathione plays
a protective role in the metabolism of TTZ. However, BSO, an 
inhibitor of glutathione synthesis, did not affect TTZ induced 
resistance or BNF induced resistance in male rats. This can probably 
be attributed to inadequate depletion of GSH by BSO.
Evidence is presented for the involvement of the cytochrome P-448 
isozyme of the pulmonary monooxygenase system in the production of 
a reactive metabolite which produces the lesions observed with TTZ- 
induced toxicity. The involvement of a non-cytochrome flavin 
containing monooxygenase system, however, cannot be ruled out.
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